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 ABSTRACT 
 
 It is often said that with enough time, money and resources organic chemists can 
synthesize any complex organic small molecule.  While those sentiments are rooted in 
fact, the reality is that chemists are often met with limited time, money and resources.  
As a result, great demand exists for chemical methods that mitigate these factors, thus 
achieving the goals of unconstrained organic synthesis.  In this vein, research in the 
White group has been focused on the utility of C―H activation methodologies allowing 
for the streamlining of total synthesis.   
 Using Pd(II)/sulfoxide catalysis, the White group has made significant 
developments in the area of allylic C―H oxidation and functionalization reactions.  
Using these methodologies, a variety of pharmacologically relevant small molecules 
have been synthesized in highly efficient sequences that minimized overall step counts 
as well as increasing the total synthetic yield.   
 Classical synthetic methods necessitate the use of pre-oxidized starting materials 
en route to the formation of the desired targets.  As a result, many steps within these 
synthetic sequences are not related to the formation of the primary molecular framework.  
Instead, many synthetic routes require secondary manipulations such as 
oxidation/reductions, protecting group manipulations and functional group 
interconversions.  Alternatively, the robust, latent functionality of the terminal olefin 
obviates the need for many of these wasteful steps via C―H activation processes.  
Herein, the development of methodologies for the synthesis of syn-1,3 amino alcohol 
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motifs, syn- and anti- vicinal diamine motifs and chroman heterocycle motifs is 
described.   
 A highly selective and general Pd(II)/bis-sulfoxide-catalyzed allylic C—H 
amination reaction en route to syn-1,3-amino alcohol motifs is first demonstrated. This 
reactivity is achieved under mild conditions through the use of electron-deficient N-nosyl 
carbamate nucleophiles. These nucleophiles are thought to promote functionalization by 
furnishing higher concentrations of anionic species in situ. The reaction is shown to be 
orthogonal to classical C—C bond forming/reduction sequences as well as nitrene-
based C—H amination methods.  Advances made within this research are then used to 
enhance the reaction profile of the previously published C―H amination system 
towards syn-1,2 amino alcohol motifs. 
 Next, intramolecular allylic C—H amination reactions are applied towards rapidly 
diversifying structures containing a sensitive β-lactam core similar to that found in the 
monobactam antibiotic Aztreonam. Pharmacologically interesting oxazolidinone and 
oxazinanone motifs are rapidly installed with predictable and high diastereoselectivities. 
Additionally, it is demonstrated for the first time that intramolecular C—H amination 
processes may be accelerated using catalytic amounts of a Lewis acid co-catalyst.  
 The stereodivergent synthesis of syn- or anti-1,2-diamine precursors is then 
discussed. From a common terminal olefin, the synthesis of these motifs has been 
accomplished using a combination of Pd(II) catalysis with azaphilic Lewis acid co-
catalysis. A Pd(II)/bis-sulfoxide/silver triflate co-catalyst system is demonstrated for the 
first time to lead to syn-1,2-diamine precursors in good to excellent yields and 
diastereoselectivities. It is then shown that simple removal of the bis-sulfoxide ligand 
iii
from this reaction results in a complete reversal in the stereo outcome affording anti- 
products in good yields and excellent diastereoselectivities. Mechanistic studies suggest 
the divergent diastereoselectivities arise from a switch in mechanism from allylic C—H 
cleavage/functionalization to olefin isomerization/oxidative amination. 
 Lastly, the synthesis of biologically active chroman motifs has been 
accomplished using a combination of Pd(II) catalysis and Lewis acid co-catalysis.  High 
yields are achieved by tuning the bis-sulfoxide ligand to retard direct nucleophile-
catalyst interaction of non-acidic nucleophiles.  High substrate generality is shown, 
allowing this method to synthesize chroman motifs found in a variety of biologically 
active pharmacophores. Mechanistic insights suggest that allylic oxidation is proceeding 
through standard allylic C―H oxidation, similar to previously published mechanisms for 
carboxylic acid and N-nosyl carbamate nucleophile functionalization. 
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Chapter 1 
Allylic C—H Amination for the Preparation of syn-1,3-Amino Alcohol Motifs 
 
1.1 INTRODUCTION 
syn-1,3 amino alcohols represent prevalent motifs in a diverse range of natural 
products and pharmaceuticals.  As a result, much research has been devoted to 
efficiently synthesizing this valuable motif. Classical methods such as the Mannich 
reaction1a,b, the Ellman-Aldol1c or conjugate addition reactions using pre-oxidized 
starting materials have shown great utility. However, subsequent hydride reductions of 
the corresponding β-amino ketones and β-hydroxy imines are required to access the 
desired amino alcohols.1 Complementary methods that furnish the desired 1,3 amino 
alcohols with minimal oxidation state manipulations would therefore provide strategic 
advantages in streamlining their syntheses.  Recently, metal nitrene systems for 
aliphatic C—H aminations have provided direct routes for accessing syn-1,3-amino 
alcohols2; however, analogous allylic C—H aminations face challenges in 
chemoselectivity and/or reactivity, particularly with terminal olefins.2b,c,3,4 Due to the 
latent functionality preserved in the terminal olefin moiety, we reasoned that such a 
reaction would be highly valuable for synthetic planning.   
Our group has developed a variety of allylic C―H activation methods using 
Pd/sulfoxide catalyst 1 including esterifications5, alkylations6 and aminations7.  Of 
particular interest is the development of an allylic C―H amination reaction to furnish 
anti-oxazolidinones.7a Initial studies for this method centered on the use of N-tosyl 
carbamates as nitrogen nucleophiles in an effort to achieve similar reactivities to our 
1
previously published branched allylic acetoxylation reaction5b. Although N-tosyl 
carbamates lie in a similar pKa regime to acetic acid (4.75), under similar conditions the 
desired amination was not observed. Promisingly, the necessary C―H cleavage to form 
a Pd-π-allyl species was not hindered in the presence of N-tosyl carbamates (Figure 
1A). The key advance in effecting the desired C―H amination was tethering the 
nitrogen nucleophile to the substrate.  Doing so allowed for the development of an 
excellent method for furnishing syn-1,2 amino alcohol motifs (anti-oxazolidinones) 
(Figure 1B).7a   
We envisioned that applying these conditions to the corresponding bis-
homoallylic N-Tosyl carbamate would allow for a similar functionalization.  Unfortunately, 
exposing a standard substrate to the previously developed reaction conditions failed to 
2
promote the desired reactivity.  Excitingly, the use the more electron deficient N-Nosyl 
carbamate nucleophile enabled access to the desired motif.7b Using this mild 
Pd(II)/sulfoxide-catalyzed allylic amination reaction we were able to access vinyl syn-1,3 
amino alcohol precursors in excellent chemoselectivities and diastereoselectivities from 
simple terminal olefin precursors.   
 
1.2 RESULTS AND DISCUSSION 
1.2.1 Design Principles 
 Mechanistic studies during the development of the allylic C―H amination to form 
5-membered oxazolidinone products indicated a process in which Pd(II)-π-allyl 
intermediate A (Figure 3A) is formed via heterolytic C―H cleavage.7a  Following 
formation of intermediate A, the proximal N-tosyl carbamate pro-nucleophile B is 
deprotonated by the corresponding carboxylate counterion acting as an exogenous 
N
R
H
S S
OO
R' R'
Pd(OAc)2
R' = Ph, Bn
R
Pd (OAc)L
A. Electrophilic C H Cleavage
B. Nucleophilic Functionalization
X = EWG
Pd N
X
LPd(0)
C. Catalyst and Endogenous Base Regeneration
LPd(0) +
O
O
+ 2 AcOH LPd(II)(OAc)2 +
OH
OH
+ AcOH
L
X
PdLNH
X
(OAc)
AcOH
A
B C
Figure 3. Design Principle for Allylic C H Amination
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base (Figure 3B).  Upon deprotonation, the zwitterionic species C is formed allowing for 
anionic nucleophilic functionalization of the cationic Pd(II)-π-allyl electrophile to form the 
desired amination product (Figure 3B).  The catalytic source of weak carboxylic base is 
then regenerated during the reoxidation of Pd(0) with the terminal quinone oxidant 
(Figure 3C). Attempts to promote allylic C―H amination to form a 6-membered 
oxazinanone under identical conditions to the 1,2 amino alcohol system gave poor 
yields and conversions even after 72 h (Table 1, entry 1, 75% recovered starting 
material).7b,8,9  Given the higher kinetic barrier for 6- versus 5-membered ring formation, 
we reasoned that functionalization was likely the problematic step. It has been explicitly 
demonstrated in the oxidative amination of olefins via electrophilic Pd(II) catalysis that 
decreasing the electron density of the nitrogen is known to assist electrophilic metal 
catalysis by preventing nucleophile complexation to the metal.10  Based on this 
knowledge, we hypothesized that even though metal/nucleophile interactions have been 
shown to be tolerated under our previously demonstrated conditions for intramolecular 
amination, switching to a more electron poor amine might promote catalysis by 
increasing the equilibrium concentration of the active anionic species C in situ without 
prohibitively decreasing its nucleophilicity (Figure 3B).11 
 
1.2.2 Reaction Optimization 
Consistent with the hypothesis that increasing the pro-nucleophile’s acidity will 
lead to an improvement in reactivity, examination of a series of 4-substituted N-
arylsulfonyl carbamates revealed a positive correlation between pro-nucleophile acidity 
and product yields.12 By simply changing from an N-tosyl carbamate to an N-(4-
4
chlorophenylsulfonyl) carbamate, a doubling in yield was achieved in one-third the 
reaction time [Table 1, entry 2, 15% (72 h) → 38% (24 h)].  Switching to the more acidic 
N-(4-nitrophenylsulfonyl) carbamate group afforded a dramatic increase in the reaction 
rate (72 h → 24 h) and yield (15% → 67%) of 6-membered ring formation (entry 3).13 
Interestingly, evaluation of the even more acidic N-(2-nitrophenylsulfonyl) carbamate 
O NHSO2R
O
O NSO2R
O
Pd(OAc)2
(10 mol%)
PhBQ (2 equiv.),
BisSO Liganda (5 mol%),
THF (0.66 M), 45°C2a-d ( )-3a-d
1
R'
O NHNs
O
1 (10 mol%)
PhBQ (2 equiv.)
BisSO Ligand (5 mol%)
DCE (0.66M),
45°C, 24 h
R'
O NNs
O
2c,e,f 3c,e,f
Entry R Time Isolated
Yieldb
drc
1
2
3
4
p-Tol
p-ClPh
p-NO2Ph (Ns)
o-NO2Ph
(2a)
(2b)
(2c)
(2d)
72 h
24 h
24 h
24 h
15%
38%
67%
63%
5.1:1
3.7:1
4.4:1
2.6:1
Entry R' Isolated
Yieldb
drc Isolated
Syne
5d
6d
7d
iPropyl
Ethyl
tButyl
(2c)
(2e)
(2f)
80%
87%
84%
6.0:1
4.3:1
6.3:1
65%
67%
68%
S S
OO
Ph Ph
Table 1. Allylic C H Amination Reaction Optimization
a BisSO ligand ) 1,2-bis(phenylsulfinyl)ethane. b Average of two runs. c Determined by GC
analysis (R = p-Tol) or 1H NMR (R = p-ClPh, p-NO2Ph, o-NO2Ph) of crude reaction mixture.
d
Reaction run using 10 mol % p-nitrobenzoic acid and oxygenated DCE. e Isolated yield of major
syn product, >20:1 syn:anti.
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group afforded no further improvement, suggesting that decreasing the electron density 
of a nitrogen pro-nucleophile to increase anion concentration must be balanced with 
decreasing its overall nucleophilicity (entry 4). Additional reaction exploration showed 
that by switching the solvent from THF to DCE and including  additives known to 
promote Pd(0) oxidation (e.g. O2
14a and p-nitrobenzoic acid14b,c) furnished the syn-
oxazinanone in good yields and diastereoselectivities (entry 5). 
Interestingly, reactivity and selectivity in this system are not strongly impacted by 
steric bulk adjacent to the carbamate (Table 1, entries 5-7). This is in stark contrast to 
the allylic C―H amination system furnishing syn-1,2-amino alcohol motifs, where one 
bulky substituent adjacent to the carbamate (generally a branching element) was 
deemed important for achieving good diastereoselectivity; a bulky quaternary alkyl 
substituted carbamate, albeit proceeding with excellent diastereoselectivity, suffered 
from poor reactivity (vide infra)7a. 
 
1.2.3 Reaction Scope 
Signiﬁcantly, use of more electron deﬁcient N-nosyl nitrogen nucleophile proved 
to be a general solution for the formation of a wide range of 6-membered oxazinanones 
(Table 2). Substrates derived from secondary alcohols having diastereotopic  
allylic C―H bonds show good to excellent levels of diastereoselectivity favoring the syn-
1,3-isomer (5, 7-12). The observed stereochemical outcome is consistent with 
functionalization proceeding via a chairlike transition state.11 No conformational biasing 
element is required for effecting cyclization as evidenced by efﬁcient generation of 
oxazinanone 4 (70%) derived from a primary alcohol precursor. Even a substrate  
6
 7
originating from a sterically hindered tertiary alcohol generated syn-1,3-oxazinanone 6 
in good yield.  
 This method is orthogonal to all other current state-of-the-art methods for 
generating this synthetically important motif. The complementary nature of this method 
to C—C and C—N bond forming/reduction sequences is highlighted by the synthesis of 
oxazinanones 7 and 8 having reduction sensitive proximal ketone and ester 
functionalities. In contrast to nitrene-based systems, perfect chemoselectivity is seen for 
allylic C—H amination over benzylic and ethereal C—H amination (9, 10; (+)-15 and (+)-
16, Scheme 1).2 Strikingly, this allylic C—H amination method shows unprecedented 
chemoselectivity for C—H amination of terminal over internal olefins (11 and 12). In all 
cases, syn-oxazinanone products of greater than 20:1 diastereomeric ratio can be 
obtained in good yields after standard column chromatography (see parenthetical yields 
in Table 2).  
Predictable diastereomeric outcomes are crucial for C—H functionalization 
methods to find use at late stages of complex molecule synthesis. Gratifyingly, for 
substrates containing multiple stereogenic centers, the diastereomeric outcome of this 
reaction is controlled by the stereocenter containing the carbamate (Scheme 1).  In 
substrates containing homoallylic (17, 19) or trishomoallylic (13, 14) stereogenic centers 
the reaction is consistently syn-selective relative to the N-nosyl carbamate. 
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1.2.4 Streamlining Total Synthesis 
We have previously demonstrated the ability of predictably selective C—H 
amination reactions to streamline the synthesis of nitrogen containing molecules by 
“skipping” oxygenated intermediates that are burdensome to carry through synthetic 
sequences.15 The ability of this allylic C—H amination reaction to efficiently access 
optically enriched syn-1,3-amino alcohols is highlighted in the synthesis of (+)-
allosedridine, a member of the sedum alkaloids that have shown promising memory 
enhancing properties.16 Starting from commercially available enantioenriched bis-
homoallylic alcohol (+)-21, the nitrogen is introduced at the correct oxidation state via 
O
O
O
NNs
O
O
O
O
NHNs
O
87% Yield, 3.6:1 drb
(61% syn >20:1)c
73% Yield, 4.7:1 drb
(55%, syn >20:1)c
(+)-13-syn-diol
(-)-14-anti-diol
(+)-15 (+)-16
58% Yield,
>20:1 drb
O NNs
O
( )-18
O NHNs
O
( )-17
a
Et
O
OBn
NHNs
O
Et
O
OBn
NNs
O
69% Yield,
2.3:1 drb
(+)-19 (+)-20
O
O
O
NNs
Oa a
a, 72h
syn syn
syn
syn
1.
2.
3.
ethereal
hydrogens
H H
Scheme 1. Origin of Diastereoselectivity
a 1 (10 mol%), 1,2-bis(phenylsulfinyl)ethane (5 mol%), p-nitrobenzoic acid (10 mol%), phenyl
benzoquinone (2 equiv.), oxygenated DCE (0.66 M), 45°C. 24 h. b Isolated yield of major syn-
product. c dr of crude reaction.
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C—H amination in only two steps. Major diastereomer (+)-24 was easily isolated using 
standard flash column chromatography in 61% yield with >20:1 diastereomeric purity 
and with no erosion in enantiomeric excess (>99% ee). Notably, the N-nosyl group can 
be easily deprotected using mild PhSH/K2CO3 conditions to afford the free oxazinanone 
in 91% yield.17 Alkylation furnished (-)-26, whose terminal olefin moieties could be used 
to forge the piperidine core via Grubbs ring-closing metathesis (RCM).18 Hydrogenation, 
followed by basic hydrolysis, completed the total synthesis of (+)-allosedridine 27 in six 
steps and 27% overall yield. By avoiding multiple functional group manipulations and 
exploiting the terminal olefin functionality, an allylic C—H amination route affords the 
shortest and highest yielding synthesis of (+)-27 to date.19 
 
OH O NHNs
O
O NNs
O
(+)-21 (+)-23 (+)-24
(-)-26
HO HN
(+)-allosedridine, 27
6 Steps, 27% Yield
>99% ee
a. NsNCO 22
d. PhSH,f. Grubbs (II);
79% Yield, 4.3:1 dr
(61% syn >20:1)c
• Previous Syntheses: 10 Steps (15.8%, >98% ee)19a & 8 Steps
(2.7%, 85% ee)19b
b.
PhBQ
e. n-BuLi
OTf
g. KOH/EtOH
(73%)
(93%)
(89%)
K2CO3
(91%)
H2, Pd-C
(80%)
O N
O
1
Pd(OAc)2
S S
OO
Ph Ph
Scheme 2. Total Synthesis of (+)-Allosedridinea
a Reagents and Conditions: (a) NsNCO 22 (1.1 equiv.), THF, r.t. (93%); (b) standard
conditions; (c) Isolated yield of major syn- product; (d) PhSH (1.2 equiv.), K2CO3 (3 equiv.),
DMF, 0°C, 4 h (91%); (e) n-BuLi (1.0 equiv.), THF, -78°C; but-3-enyl trifluoromethanesulfonate
25 (1.2 equiv.), -78°C to 0°C, 2 h (89%); (f) Grubbs (II) (8 mol%), toluene, 65°C, 3 h; H2, Pd-C,
MeOH, r.t., 2 h (80%); (g) KOH/EtOH (1.7 M), 45°C, 2 h (73%).
25
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1.2.5. syn-1,2-Amino Alcohol Synthesis 
Significantly, the discovery that N-nosylcarbamate nucleophiles lead to improved 
reactivity for intramolecular allylic C—H aminations could be used to increase the 
efficiency of our previously reported reaction for generating 1,2-amino alcohol motifs. 
Homoallylic N-nosyl carbamates 28b and 28d underwent Pd(II)/sulfoxide 1 catalyzed 
intramolecular allylic C—H amination to furnish anti-oxazolidinones 29b and 29d in 
comparable yields, diastereoselectivities, and a three-fold decrease in reaction times 
(72 h  → 24 h) relative to that reported with the analogous N-tosyl carbamate substrates.  
In contrast to the 1,3-amino alcohol system, however, reactivity with sterically 
congested substrates such as t-butyl 28f and tertiary alcohol derived carbamate 28g 
remained low. These results demonstrate a distinct steric limitation for this chemistry in 
furnishing 5-membered oxazolidinone rings that is not observed in generating 6-
membered oxazinanone rings. Gratifyingly, the allylic C—H amination reaction for 
generating 1,2-amino alcohol motifs also proceeds with outstanding chemoselectivity.  
This is illustrated in the preferential C—H amination of terminal over internal olefins in 
the doubly homoallylic N-nosyl carbamate substrate 28h. Interestingly, syn-
oxazolidinone 29h is obtained in both good yields and diastereoselectivities despite the 
lack of an adjacent branching element, previously deemed to be crucial for obtaining 
synthetically useful diastereomeric outcomes with this system (Table 3, entry 5). 
11
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Table 3. 1,2-Amination Rate Increase Using N-Nosyl Carbamates
a BisSO Ligand = 1,2-bis(phenylsulfinyl)ethane. b Average of two runs. c Determined by GC analysis
(R' = p-Tol) or 1H NMR analysis (R' = p-NO2Ph) of crude reaction mixture.
28a-h 29a-h
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1.3 CONCLUSIONS 
 This work demonstrates the discovery that use of an electron-deficient N-nosyl 
carbamate nucleophile facilitated development of a general Pd(II)-sulfoxide catalyzed 
allylic C—H amination reaction to generate 6-membered syn-oxazinanones under mild 
reaction conditions. The extraordinary chemoselectivity of this method is underscored 
by its demonstrated ability to selectively aminate allylic C—H bonds of terminal olefins 
preferentially to internal olefins. This feature, as well as its orthogonality to nitrene-
based C—H aminations and C—C bond forming/reduction sequences, makes it a 
powerful reaction for 1,3-amino alcohol synthesis.  
This allylic C—H amination reaction is enabled by electronically tuning the pro-
nucleophile in order to increase the equilibrium concentration of active anionic species 
under conditions that employ catalytic amounts of a weak base. The general strategy of 
decreasing the pKa of a pro-nucleophile to promote functionalization has led to a 
significant rate increase for the previously reported allylic C—H amination reaction for 
1,2-amino alcohol synthesis and has the potential for applications to other electrophilic 
metal-catalyzed reactions. 
 
1.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic amination 
reaction were used as received; Pd(OAc)2 (Johnson-Matthey Chemicals) and Pd[1,2-
bis(phenylsulfinyl)ethane](OAc)2 “Catalyst 1” (Strem Chemicals and Sigma-Aldrich) 
were stored in a glove box under an argon atmosphere at -20°C and weighed out in the 
air prior to use. Catalyst 1 was also prepared according to the below procedure6a and 
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used interchangeably with commercial catalyst.  p-Nitrobenzenesulfonyl isocyanate was 
prepared according to the published procedure.20 Tetrahydrofuran was purified prior to 
use by passage through a bed of activated alumina (Glass Contour, Laguna Beach, 
California). 1,2-dichloroethane was obtained from Sigma-Aldrich and used as received. 
All allylic amination reactions were run under oxygen or ambient air with no precautions 
taken to exclude moisture. All other reactions were run over a stream of N2 gas unless 
otherwise stated. Thin-layer chromatography (TLC) was conducted with E. Merck silica 
gel 60 F254 precoated plates (0.25 mm) and visualized with UV and potassium 
permanganate stain. Flash chromatography was performed as described by Still using 
ZEOprep 60 ECO 43-60 micron silica gel (American International Chemical, Inc.).21 1H 
NMR spectra were recorded on a Varian Unity-400 (400 MHz), Varian Inova-500 (500 
MHz), or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sext. = sextet, sept. = septet, m = multiplet, b 
= broad, ap = apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C 
NMR spectra were recorded on a Varian Unity-400 (100 MHz) and Varian Unity-500 
(125 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 77.16 ppm). Diastereoselectivity of the allylic amination reaction was 
determined by 1H NMR analysis of the crude reaction mixture unless otherwise noted. 
IR spectra were recorded as thin films on NaCl plates on a Perkin-Elmer Spectrum BX 
and are reported in frequency of absorption (cm-1). HPLC analysis was performed on an 
Agilent Technologies 1100 HPLC system with a model 1100 Quaternary Pump, Diode 
Array Detector, Thermostat, and Autosampler using a Chiral Technologies Inc. 
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Chiralpak AD-RH column (0.46 cm x 15 cm). High-resolution mass spectra were 
obtained at the University of Illinois Mass Spectrometry Laboratory. Optical rotations 
were obtained using a JASCO DIP-360 digital polarimeter and a 3.5 x 50 mm cell and 
are reported as follows: [a]λ
ToC (c = g/100 mL, solvent). 
 
General Procedure A for the synthesis of bis-homoallylic N-nosyl and N-tosyl 
carbamates : A flame dried 250mL Ar filled round bottom flask was charged 
sequentially with a stir bar, the bis-homoallylic alcohol starting material (1 equiv.) and 
tetrahydrofuran (1 M).  The flask was taken to 0°C followed by the dropwise addition of 
p-Toluenesulfonyl isocyanate (TsNCO, 1.2 equiv.) or the rapid addition of solid p-
Nitrobenzenesulfonyl isocyanate (NsNCO, 1.2 equiv.).   The solution was stirred for 30 
minutes and then quenched by diluting with saturated ammonium chloride. The organic 
layer was washed once with brine then dried over MgSO4, filtered and concentrated in 
vacuo. Purification by flash chromatography (15% EtOAc/hexanes, 1% AcOH) provided 
the pure bis-homoallylic N-nosyl and N-tosyl carbamates. 
 
Procedure for the synthesis of p-Nitrobenzenesulfonyl isocyanate (NsNCO): A 
flame dried 100mL three-neck flask was equipped with a cold-finger, glass stopper and 
a stopcock joint (the stopcock valve is kept closed).  4-nitrobenzenesulfonamide (1.82 g, 
9 mmol), butyl isocyanate (400 µL, 3.6 mmol) and 1,2-dichlorobenzene (14 mL) were 
added and taken to reflux.  Upon the solution turning clear, the phosgene generation 
cartridge (20 mmol) was connected to the stopcock and the stopcock valve was opened.  
The phosgene cartridge was heated to 100°C in a separate oil bath while keeping the 
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three-neck flask at reflux.  After complete evolution of the phosgene (1 hour) the 
cartridge was removed and quenched with absolute ethanol. The reaction flask was 
allowed to cool to room temperature and nitrogen gas was blown over the reaction flask 
for two hours. The 1,2-dichlorobenzene was then distilled away (1.0 torr, 80°C) and the 
remaining dark brown oil was transferred to a Kugelrohr distillation flask and distilled 
(1.0 torr, 170°C) yielding a light yellow solid. The yellow solid was stored under Argon 
atmosphere at -20°C. The NsNCO did not demonstrate decomposition throughout its 
storage at -20°C for 2-3 weeks and is used according to general procedure A without 
any further purification.   
 
1,2-bis(phenylsulfinyl)ethane: A 50 mL flask was charged with a stir bar, 1,2- 
bis(phenylthio)ethane (2.0 g, 8.12 mmol, 1 equiv.), and acetic acid 
(12.2 mL). A solution of H2O2 (50 wt%, 16.24 mmol, 0.94 mL, 2 
equiv.) in acetic acid (6.7 mL) was added dropwise at room temperature. After 
approximately 15 min. the solution became homogeneous and turned a pale yellow. An 
additional 8 mL of acetic acid was then added and the solution was allowed to stir for 24 
h at room temperature. The acetic acid was removed with mild heating (45°C) under 
high vacuum. The pale yellow solid was emulsified in cold ethanol and cold filtered to 
yield a mixture of the meso and racemic 1,2-bis(phenylsulfinyl)ethane (2.088g, 92% 
yield). For spectral data see reference 6a. 
 
Recrystallization of 1,2-bis(phenylsulfinyl)ethane: To a solution of refluxing acetone 
(~100 ml) was added the crude ligand mixture (~2 g). Acetone was then added slowly to 
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the mixture with reflux until the powder dissolved completely. The mixture was allowed 
to cool to room temperature. (NOTE: In the event of over-oxidation, the mono- or di-
sulfone will recrystallize first as large plates in approximately 6-8 hours. In this case the 
mixture was filtered, rinsing with minimal cold acetone). The sulfone free mixture was 
left at room temperature for an hour, then cooled to 4°C over night. IMPORTANT: The 
meso crystallizes first as small white prisms. Extended time is needed to allow the 
racemic (long white needles) to crystallize. The meso crystals were collected via 
filtration with a Buchner funnel and rinsed with cold acetone to give ~75% yield. 
Additional crops may be obtained by evaporating the mother liquor and redissolving the 
white solid in minimal refluxing acetone. 
 
Recrystallization of Pd(OAc)2: Pd(OAc)2 was dissolved in minimal refluxing benzene. 
A black precipitate was removed by hot Acrodisc® filtration. The resulting solution was 
cooled to room temperature without further manipulation. Amber crystals began to form 
after ~2 hours. After 24 hours the solution was filtered to give the recrystallized 
Pd(OAc)2. For spectral data see reference 6a. 
 
 Catalyst 1: A flame dried 250 mL flask fitted with a condenser under argon atmosphere 
was charged with meso-1,2-bis(phenylsulfinyl)ethane (2.53 g, 9.1 
mmol), Pd(OAc)2 (2.04 g, 9.1 mmol), and CH2Cl2 (101 mL). The 
mixture was stirred at 40°C for 24h. The solution becomes dark red and homogenous 
during the reaction time. The solution was concentrated in vacuo and dried with a 
stream of N2 for 6 h to give a dark red solid used without further purification. NOTE: The 
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catalyst must be stored at or below 4°C. The catalyst slowly decomposes at ambient 
temperature; however, it may be stored for prolonged periods (months) at reduced 
temperatures. 1H NMR and IR spectra of this catalyst look like 1,2-
bis(phenylsulfinyl)ethane and Pd(OAc)2. Trace amounts of phenyl vinyl sulfoxide can be 
observed by 1H NMR. 
 
 (±)-2-methylhept-6-en-3-yl tosylcarbamate: Product obtained as a white solid. 1H 
NMR (500MHz, CDCl3) δ 7.90 (d, J = 8.5 Hz, 2H), 7.85 (bs, 1H), 
7.33 (d, J = 8.0 Hz, 2H), 5.63 (ddt, J = 17.0, 10.3, 6.5 Hz, 1H), 4.87 
(m, 2H), 4.63( ap. q, J = 5.5 Hz, 1H), 2.43 (s, 3H), 1.79 (m, 3H), 1.51 
(m, 2H), 0.81 (d, J = 7.0 Hz, 3H), 0.78 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
150.8, 145.0, 137.6, 135.9, 129.7, 128.4, 115.1, 82.1, 31.5, 30.1, 29.6, 21.8, 18.2, 17.4; 
IR (film, cm-1): 3233 (br), 3077, 2965, 2937, 2877, 1745, 1716; HRMS (ESI) m/z calc’d 
for C16H23NO4SNa [M+Na]
+: 348.1245, found 348.1259.  
 
 (±)-2-methylhept-6-en-3-yl 4-chlorophenylsulfonylcarbamate: Product obtained as 
a light yellow solid.  1H NMR (500MHz, CDCl3) δ 7.97 (d, J 
= 9.0 Hz, 2H), 7.87 (bs, 1H), 7.52 (d, J = 8.5 Hz, 2H), 5.66 
(ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 4.89 (m, 2H), 4.65 (dt, J = 
8.0, 5.0 Hz, 1H), 1.85 (m, 2H), 1.79 (m, 1H), 1.54 (m, 2H), 
0.82 (d, J = 6.5 Hz, 3H), 0.81 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.5, 
140.7, 137.4, 137.2, 129.9, 129.4, 115.3, 82.5, 31.5, 30.1, 29.6, 18.2, 17.4; IR (film, cm-
18
1): 3234 (br), 3091, 2966, 2877, 1745; HRMS (ESI) m/z calc’d for C15H20NO4SClNa 
[M+Na]+: 368.0699, found 368.0708. 
 
 (±)-2-methylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate:  Product obtained as a 
light yellow oil. 1H NMR (500MHz, CDCl3) δ 8.40 (m, 2H), 8.25 (m, 
2H), 7.64 (bs, 1H), 5.65 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 4.89 (m, 
2H), 4.65 (dt, J = 8.0, 4.9 Hz, 1H), 1.88 (m, 2H), 1.80 (m, 1H), 1.56 
(m, 2H), 0.83 (d, J = 7.0 Hz, 3H), 0.81 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
150.9, 150.1, 144.2, 137.2, 129.9, 124.3, 115.5, 83.0, 31.5, 30.0, 29.7, 18.3, 17.4; IR 
(film, cm-1): 3239 (br), 3108, 2971, 2879, 1742, 1532; HRMS (ESI) m/z calc’d for 
C15H20N2O6SNa [M+Na]
+: 379.0940, found 379.0952. 
 
 (±)-2-methylhept-6-en-3-yl 2-nitrophenylsulfonylcarbamate:  Product obtained as a 
light yellow solid.  1H NMR (500MHz, CDCl3) δ 8.36 (dd, J = 
7.5, 1.8 Hz, 1H), 7.82 (m, 4H), 5.66 (m, 1H), 4.86 (m, 2H), 4.65 
(dt, J = 8.0, 5.0 Hz, 1H), 1.92 (m, 2H), 1.82 (oct., J = 6.8 Hz, 
1H), 1.59 (m, 2H), 0.84 (d, J = 7.0 Hz, 3H), 0.83 (d, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 150.2, 148.2, 137.4, 135.0, 133.5, 132.6, 131.7, 
125.2, 115.4, 82.7, 31.6, 30.1, 29.7, 18.3, 17.4; IR (film, cm-1): 3251 (br), 3101, 2968, 
2879, 1726, 1547; HRMS (ESI) m/z calc’d for C15H20N2O6SNa [M+Na]
+: 379.0940, 
found 379.0935. 
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 (±)-hept-6-en-3-yl 4-nitrophenylsulfonylcarbamate:  Product obtained as a white 
solid. 1H NMR (500MHz, CDCl3) δ 8.39 (m, 2H), 8.25 (m, 2H), 8.09 
(bs, 1H), 5.67 (dddd, J = 15.5, 9.0, 7.6, 6.5 Hz, 1H), 4.90 (m, 2H), 
4.73 (p, J = 6.5 Hz, 1H), 1.92 (q, J = 7.3 Hz, 2H), 1.61-1.45 (m, 4H), 
0.78 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.9, 150.2, 144.2, 137.2, 129.9, 
124.3, 115.4, 79.9, 32.4, 29.3, 26.8, 9.3; IR (film, cm-1): 3248 (br), 3109, 2974, 2934, 
2878, 1749, 1535; HRMS (ESI) m/z calc’d for C14H18N2O6SNa [M+Na]
+: 365.0783, 
found 365.0788. 
 
 (±)-2,2-dimethylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate: Product obtained 
as a white solid. 1H NMR (500MHz, CDCl3) δ 8.39 (m, 2H), 8.24 (m, 
2H), 7.72 (bs, 1H), 5.59 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 4.86 (d, J = 
9.0 Hz, 1H), 4.82 (dd, J = 17.3, 1.3 Hz, 1H), 4.60 (dd, J = 11.0, 1.5 
Hz, 1H), 1.80 (m, 1H), 1.71 (m, 1H), 1.59 (m, 1H), 1.42 (m, 1H) 0.84 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 150.9, 150.5, 144.3, 137.2, 129.8, 124.3, 115.4, 85.7, 34.9, 30.3, 
28.7, 25.8; IR (film, cm-1): 3247 (br), 3108, 3078, 2967, 2874, 1748, 1536; HRMS (ESI) 
m/z calc’d for C16H22N2O6SNa [M+Na]
+: 393.1096, found 393.1101. 
 
pent-4-enyl 4-nitrophenylsulfonylcarbamate: Product obtained as a light yellow oil. 
1H NMR (500MHz, CDCl3) δ 8.40 (d, J = 8.5 Hz, 2H), 8.26 (d, J = 9.0 Hz, 
2H), 8.06 (bs, 1H), 5.72 (ddt, J = 17.0, 10.5, 6.5, Hz, 1H), 4.98 (m, 2H), 
4.12 (t, J = 6.5 Hz, 2H), 2.04 (q, J = 7.0 Hz, 2H), 1.69 (p, J = 7.0 Hz, 2H); 
13C NMR (125 MHz, CDCl3) δ 150.9, 150.3, 143.9, 136.8, 130.0, 124.4, 115.9, 67.1, 
O
O
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29.7, 27.6; IR (film, cm-1): 3252 (br), 3108, 3079, 2976, 2921, 1753; HRMS (ESI) m/z 
calc’d for C12H14N2O6SNa [M+Na]
+: 337.0470, found 337.0484. 
 
 (±)-1-phenylpent-4-enyl 4-nitrophenylsulfonylcarbamate:  Product obtained as a 
light yellow oil.  1H NMR (500MHz, CDCl3) δ 8.33 (m, 2H), 8.19 (m, 
2H), 7.84 (bs, 1H), 7.30 (m, 3H), 7.19 (m, 2H), 5.71 (ddt, J = 17.0, 
10.8, 6.5 Hz, 1H), 5.61 (t, J = 6.8 Hz, 1H), 4.94 (m, 2H), 2.05-1.81 (m, 
4H); 13C NMR (125 MHz, CDCl3) δ 150.9, 149.6, 144.0, 138.5, 136.8, 129.9, 128.8, 
128.8, 126.7, 124.3, 115.9, 79.9, 34.9, 29.5; IR (film, cm-1): 3254 (bs), 3110, 3076, 3041, 
2938, 2870, 1750; HRMS (ESI) m/z calc’d for C18H18N2O6SNa [M+Na]
+: 413.0783, 
found 413.0781. 
 
 (±)-2,3-dimethylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate: Product obtained 
as a light yellow oil. 1H NMR (400MHz, CDCl3) δ 8.39 (d, J = 9.2 Hz, 
2H), 8.22 (d, J = 9.2 Hz, 2H), 7.74 (bs, 1H), 5.66 (m, 1H), 4.91 (m, 
2H), 2.27 (sept., J = 6.8 Hz, 1H), 1.87 (m, 3H), 1.77 (m, 1H), 1.31 (s, 
3H), 0.78 (d, J = 6.8 Hz, 3H), 0.75 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
150.8, 148.6, 144.4, 137.8, 129.8, 124.3, 115.0, 92.9, 34.4, 34.1, 27.5, 19.8, 17.2, 17.1; 
IR (film, cm-1): 3250 (br), 3108, 3074, 2963, 2941, 2883, 1722, 1641, 1609, 1533; 
HRMS (ESI) m/z calc’d for C16H23N2O6S [M+H]
+: 371.1277, found 371.1291. 
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(±)-7-oxonon-1-en-5-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a light 
yellow oil. 1H NMR (500MHz, CDCl3) δ 8.40 (m, 2H), 8.24 (m, 
2H), 7.90 (bs, 1H), 5.69 (m, 1H), 5.14 (p, J = 6.3 Hz, 1H), 4.94 
(m, 2H), 2.64 (m, 2H), 2.36 (m, 2H), 1.98 (app. q, J = 7.0 Hz, 
2H), 1.67 (app. q, J = 7.2 Hz, 2H), 0.96 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
δ 208.1, 150.8, 150.0, 144.1, 136.8, 129.8, 124.3, 115.7, 73.9, 46.0, 36.5, 33.0, 29.2, 
7.5; IR (film, cm-1): 3232 (br), 3109, 2978, 2940, 1750, 1716, 1532; HRMS (ESI) m/z 
calc’d for C16H20N2O7SNa [M+Na]
+: 407.0889, found 407.0908. 
 
 (±)-methyl 3-(4-nitrophenylsulfonylcarbamoyloxy)hept-6-enoate: Product obtained 
as a light yellow oil. 1H NMR (500MHz, CDCl3) δ 8.39 (m, 2H), 
8.24 (m, 2H), 5.68 (m, 1H), 5.12 (ap. p, J = 6.4 Hz, 1H), 4.94 
(m, 2H), 3.58 (s, 3H), 2.54 (d, J = 6.5 Hz, 2H), 1.99 (ap. q, J = 
7.3 Hz, 2H), 1.69 (m, 2H); 13C NMR (125 MHz, CDCl3) δ170.4, 150.9, 149.9, 144.1, 
136.6, 129.9, 124.3, 115.9, 74.0, 52.1, 38.6, 32.9, 29.1; IR (film, cm-1): 3229 (br.), 3109, 
2954, 2874, 1755, 1538; HRMS (ESI) m/z calc’d for C15H18N2O8SNa [M+Na]
+: 409.0682, 
found 409.0685. 
 
 (±)-1-(benzyloxy)hex-5-en-2-yl 4-nitrophenylsulfonylcarbamate: Product obtained 
as a light yellow oil.  1H NMR (400 MHz, CDCl3) δ 8.29 (m, 2H), 
8.20 (m, 2H), 7.66 (bs, 1H),7.31 (m, 3H), 7.24 (m, 2H), 5.69 (m, 
1H), 4.94 (m, 2H), 4.49 (d, J = 12.0 Hz, 1H), 4.40 (d, J = 11.6 Hz, 
1H), 3.48 (m, 2H), 1.99 (ap. q, J = 7.2 Hz, 2H), 1.69 (m, 2H); 13C NMR (100 MHz, 
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CDCl3) δ 149.8, 144.0, 137.6, 136.9, 130.0, 128.6, 128.1, 127.7, 124.3, 115.8, 115.1, 
76.5, 73.3, 70.5, 29.6, 29.4; IR (film, cm-1): 3244 (br), 3109, 3075, 3033, 2924, 2869, 
1753; HRMS (ESI) m/z calc’d for C20H23N2O7S [M+H]
+: 435.1226, found 435.1219.   
 
 (±)-1-phenylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a 
light yellow oil.  1H NMR (500 MHz, CDCl3) δ 8.39 (m, 2H), 8.26 
(m, 2H), 7.88 (bs, 1H), 7.25 (m, 2H), 7.18 (m, 1H), 7.07 (m, 2H), 
5.68 (ddt, J = 17.5, 9.5, 6.5 Hz, 1H), 4.92 (m, 2H), 4.85 (p, J = 
6.0 Hz, 1H), 2.53 (m, 2H), 1.96 (ap. q, J = 7.0 Hz, 2H), 1.85 (m, 2H), 1.65 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 150.9, 150.0, 144.2, 140.8, 137.0, 129.9, 128.6, 128.2, 126.3, 
124.3, 115.6, 78.3, 35.5, 33.0, 31.4, 29.3; IR (film, cm-1): 3256 (br), 3107, 3082, 3028, 
2922, 2867, 1750; HRMS (ESI) m/z calc’d for C20H22N2O6SNa [M+Na]
+: 441.1096, 
found 441.1105. 
 
 (±)-8-methylnona-1,7-dien-5-yl 4-nitrophenylsulfonylcarbamate: Product obtained 
as a light yellow oil. 1H NMR (500MHz, CDCl3) δ 8.39 (d, J = 
9.0 Hz, 2H), 8.25 (d, J = 9.0 Hz, 2H), 7.79 (bs, 1H), 5.68 (ddt, J 
= 17.0, 10.0, 7.0 Hz, 1H), 4.92 (m, 3H), 4.75 (ap. p, J = 6.0 Hz, 
1H), 2.21 (ap. t, J = 6.3 Hz, 2H), 1.96 (q, J = 7.0 Hz, 2H), 1.61 (s, 3H), 1.59 (m, 2H), 
1.53 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 150.9, 149.9, 144.1, 137.2, 135.6, 129.9, 
124.3, 117.8, 115.5, 78.5, 32.6, 32.4, 29.5, 25.9, 18.0; IR (film, cm-1): 3246 (br), 3115, 
3072, 2977, 2920, 2864, 1749, 1641, 1608, 1535; HRMS (ESI) m/z calc’d for 
C17H22N2O6SNa [M+Na]
+: 405.1096, found 405.1111. 
O
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 (±)-(E)-undeca-1,8-dien-5-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a 
light yellow oil. 1H NMR (500MHz, CDCl3) δ 8.40 (d, J = 
9.0 Hz, 2H), 8.25 (d, J = 8.5 Hz, 2H), 7.51 (bs, 1H), 5.68 
(ddt, J = 17.0, 10.0, 7.0 Hz, 1H), 5.36 (m, 1H), 5.25 (m, 
1H), 4.92 (m, 2H), 4.79 (p, J = 6.0, 1H), 1.94 (m, 4H), 1.87 (q, J = 7.5 Hz, 2H), 1.58 (m, 
4H), 0.92 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.8, 150.2, 144.2, 137.1, 
133.3, 129.9, 127.2, 124.3, 115.4, 78.3, 33.7, 32.9, 29.2, 28.1, 25.6, 13.8; IR (film, cm-
1): 3234 (br.), 3108, 3079, 2961, 2931, 2873, 2851, 1729; LRMS (ESI) m/z calc’d for 
C18H25N2O6S [M+H]
+: 397.14, found 397.10. 
 
 (+)-(R)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-enyl 4-
nitrophenylsulfonylcarbamate: Product obtained as a light 
yellow oil. 1H NMR (500MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 
8.26 (d, J = 9.5 Hz, 2H), 8.20 (bs, 1H), 5.66 (m, 1H), 4.93 (s, 1H), 
4.90 (dd, J = 7.0, 1.5 Hz, 1H), 4.81 (ap. q, J = 6.0 Hz, 1H), 4.05 
(q, J = 6.0 Hz, 1H), 3.97 (dd, J = 8.5, 6.5 Hz, 1H), 3.65 (dd, J = 8.5, 6.0 Hz, 1H), 1.97 (m, 
2H), 1.60 (m, 2H), 1.30 (s, 3H), 1.27 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 150.9, 150.2, 
144.1, 136.7, 130.0, 124.3, 115.9, 110.1, 77.3, 76.2, 65.6, 29.8, 29.2, 26.2, 25.2; IR 
(film, cm-1): 3232 (br), 3110, 3081, 2985, 2935, 2892, 1748, 1532; HRMS (ESI) m/z 
calc’d for C17H23N2O8S [M+H]
+: 415.1175, found 415.1182. [α]D
27 = +9.2° (c = 1.0, 
CHCl3). 
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 (-)-(S)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-enyl 4-nitrophenyl 
sulfonylcarbamate: Product obtained as a light yellow oil. 1H 
NMR (500MHz, CDCl3) δ 8.39 (d, J = 9.0 Hz, 2H), 8.25 (d, J = 
9.0 Hz, 2H), 8.16 (bs, 1H), 5.67 (m, 1H), 4.92 (m, 3H), 4.12 (td, J 
= 6.0, 4.0 Hz, 1H), 3.97 (dd, J = 8.5, 7.0 Hz, 1H), 3.73 (dd, J = 
8.5, 6.0 Hz, 1H), 1.99 (m, 2H), 1.61 (m, 2H), 1.29 (s, 3H), 1.28 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 151.0, 150.0, 144.0, 136.7, 130.0, 124.3, 116.0, 110.0, 76.8, 76.3, 65.1, 
29.4, 29.2, 26.1, 24.8; IR (film, cm-1): 3228 (br), 3110, 3082, 2988, 2936, 2895, 1753, 
1533; HRMS (ESI) m/z calc’d for C17H23N2O8S [M+H]
+: 415.1175, found 415.1160; 
[α]D
27 = -10.2° (c = 1.0, CHCl3). 
 
Synthesis of Alcohol Precursors for D-Mannitol Derived Substrates: 
 
(S)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-en-1-ol:  1H NMR (400MHz, CDCl3) δ 
5.83 (ddt, J = 17.2, 10.2, 6.8 Hz, 1H), 5.06 (ddd, J = 17.2, 3.2, 
1.6 Hz, 1H), 4.99 (dd, J = 10.0, 1.6 Hz, 1H), 4.03 (ddd, J = 6.8, 
6.8, 4.0 Hz, 1H), 3.98 (dd, J = 7.6, 6.4 Hz, 1H), 3.91 (dd, J = 7.6, 
7.4 Hz, 1H), 3.80 (ddd, J = 9.2, 7.2, 3.6 Hz, 1H), 2.34-2.25 (m, 1H), 2.20-2.11 (m, 1H), 
O
O
O
OOH
OH
ref . 22
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O
O
MgBr
THF
column
separation
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O
OH
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O
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1.98 (d, J = 3.2 Hz, 1H), 1.59-1.53 (m, 1H), 1.50-1.43 (m, 1H), 1.43 (s, 3H), 1.37 (s, 3H).  
Spectral data is in agreement with reference 23.  
 
 (±)-(1R,2S)-2-allylcyclohexyl 4-nitrophenylsulfonylcarbamate:  Product obtained as 
a white solid. 1H NMR (500MHz, CDCl3) δ 8.39 (m, 2H), 8.25 (m, 2H), 
7.80 (bs, 1H), 5.60 (dddd, J = 17.5, 10.3, 7.5, 6.9 Hz, 1H), 4.90 (dd, J = 
10.0, 1.0 Hz, 1H), 4.86 (dd, J = 17.3, 1.8 Hz, 1H), 4.42 (m, 1H), 2.06 (m, 
1H), 1.92 (m, 1H), 1.79 (m, 2H), 1.70 (m, 1H), 1.60 (m, 1H), 1.47 (m, 
1H), 1.30-1.10 (m, 3H), 0.98 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 150.9, 150.0, 144.2, 
135.7, 129.9, 124.3, 116.6, 81.0, 41.6, 36.6, 31.6, 30.0, 24.8, 24.3; IR (film, cm-1): 3253 
(br), 3109, 3077, 2939, 2862, 1747, 1535; HRMS (ESI) m/z calc’d for C16H20N2O6SNa 
[M+Na]+: 391.0940, found 391.0948. 
 
 (+)-(3S,4S)-4-(benzyloxy)hept-6-en-3-yl 4-nitrophenylsulfonylcarbamate: Product 
obtained as a light yellow oil. 1H NMR (500MHz, CDCl3) δ 8.38 (bs, 
1H), 8.12 (s, 4H), 7.34 (m, 5H), 5.71 (ddt, J = 17.0, 10.3, 7.0 Hz, 1H), 
5.00 (m, 2H), 4.78 (m, 1H), 4.64 (d, J = 11.0 Hz, 1H), 4.42 (d, J = 
11.0 Hz, 1H), 3.48 (td, J = 6.5, 3.5 Hz, 1H), 2.33 (m, 1H), 2.20 (m, 
1H), 1.62 (m, 2H), 0.76 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.7, 150.3, 
143.9, 137.8, 133.5, 130.1, 128.6, 128.2, 124.1, 118.3, 80.0, 78.5, 72.8, 34.8, 23.5, 9.7; 
IR (film, cm-1): 3249 (br), 3105, 3077, 3035, 2975, 2944, 2875, 1792; HRMS (ESI) m/z 
calc’d for C21H24N2O7SNa [M+Na]
+: 471.1202, found 471.1212; [α]D
29 = +9.8° (c = 1.0, 
CHCl3). 
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Synthesis of Alcohol Precursor for Homoallylic BnO- Substrate: 
 
 
 (+)-(3S,4S)-4-(benzyloxy)hept-6-en-3-ol:  1H NMR (500MHz, CDCl3) δ 7.34 (m, 4H), 
7.29 (m, 1H), 5.87 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H), 5.16-5.08 (m, 
2H), 4.71 (d, J = 11.0 Hz, 1H), 4.49 (d, J = 11.5 Hz, 1H), 3.47 (ap. 
sext., J = 4.7 Hz, 1H), 3.35 (dt, J = 5.7, 5.5 Hz, 1H), 2.49 (m, 1H), 
2.36 (m, 1H), 2.26 (d, J = 5.5 Hz, 1H), 1.56 (m, 1H), 1.47 (m, 1H), 0.96 (t, J = 7.5 Hz, 
3H). Spectral data is in agreement with reference 26.  [α]D
25 = +36.8° (c = 1.0, CH2Cl2) 
[lit. 8 for enantiomer (3R,4R)-4-(benzyloxy)hept-6-en-3-ol [α]D
24 = -32.4° (c = 5.88, 
CH2Cl2). 
 
 (±)-2-methylhex-5-en-3-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a 
light yellow solid.  1H NMR (500MHz, CDCl3) δ 8.40 (d, J = 9.0 Hz, 
2H), 8.24 (d, J = 9.0 Hz, 2H), 7.67 (bs, 1H), 5.56 (m, 1H), 4.92 (m, 
2H), 4.66 (ddd, J = 8.0, 5.8, 4.5 Hz, 1H), 2.29 (m, 1H), 2.18 (m, 1H), 
1.82 (oct., J = 6.5 Hz, 1H), 0.86 (d, J = 7.0 Hz, 3H), 0.82 (d, J = 7.0 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 150.9, 150.0, 144.2, 133.1, 129.9, 124.3, 118.2, 82.3, 35.8, 31.1, 
OH
OBn
27
18.5, 17.5; IR (film, cm-1): 3248 (br), 3111, 2966, 2879, 1747, 1533; HRMS (ESI) m/z 
calc’d for C14H18N2O6SNa [M+Na]
+: 365.0783, found 365.0782. 
 
 (±)-hept-1-en-4-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a light 
yellow solid.  1H NMR (500MHz, CDCl3) δ 8.40 (d, J = 9.0 Hz, 2H), 
8.24 (d, J = 9.0 Hz, 2H), 7.80 (bs, 1H), 5.59 (ddt, J = 16.5, 10.5, 
7.0 Hz, 1H), 4.97 (m, 2H), 4.81 (pent., J = 6.0 Hz, 1H), 2.30 (m, 
1H), 2.22 (m, 1H), 1.48 (m, 2H), 1.20 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 150.9, 150.0, 144.1, 132.6, 129.9, 124.3, 118.6, 77.9, 38.4, 35.5, 18.4, 
13.9; IR (film, cm-1): 3234 (br), 3111, 3080, 2962, 2937, 2875, 1747, 1533; HRMS (ESI) 
m/z calc’d for C14H18N2O6SNa [M+Na]
+: 365.0783, found 365.0775. 
 
 (±)-2,2-dimethylhex-5-en-3-yl 4-nitrophenylsulfonylcarbamate:  Product obtained 
as a light yellow solid.  1H NMR (500MHz, CDCl3) δ 8.39 (d, J = 8.5 
Hz, 2H), 8.22 (d, J = 9.0 Hz, 2H), 7.79 (bs, 1H), 5.49 (m, 1H), 4.77 (m, 
2H), 4.64 (dd, J = 11.0, 2.3 Hz, 1H), 2.32 (m, 1H), 2.04 (m, 1H), 0.87 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 150.8, 150.3, 144.3, 134.1, 129.8, 124.3, 117.8, 
84.6, 34.7, 34.4, 25.8; IR (film, cm-1): 3246 (br), 3114, 2968, 2875, 1751, 1535; HRMS 
(ESI) m/z calc’d for C15H20N2O6SNa [M+Na]
+: 379.0940, found 379.0941. 
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 (±)-2,3-dimethylhex-5-en-3-yl 4-nitrophenylsulfonylcarbamate: Product obtained as 
a light yellow solid.  1H NMR (500MHz, CDCl3) δ 8.40 (d, J = 8.5 Hz, 
2H), 8.22 (d, J = 9.0 Hz, 2H), 8.01 (bs, 1H), 5.51 (m, 1H), 4.88 (m, 
2H), 2.60 (dd, J = 14.5, 7.3 Hz, 1H), 2.48 (dd, J = 14.5, 7.5 Hz, 1H), 
2.25 (sept., J = 6.8 Hz, 1H), 1.29 (s, 3H), 0.84 (d, J = 7.0 Hz, 3H), 0.81 (d, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 150.7, 148.7, 144.3, 132.2, 129.8, 124.2, 118.8, 92.2, 
39.9, 34.0, 19.2, 17.3, 16.9; IR (film, cm-1): 3248 (br), 3109, 3079, 2978, 1745, 1535; 
HRMS (ESI) m/z calc’d for C15H20N2O6SNa [M+Na]
+: 379.0934, found 379.0951. 
 
 (±)-(E)-undeca-1,6-dien-4-yl 4-nitrophenylsulfonylcarbamate: Product obtained as a 
light yellow oil.  1H NMR (500MHz, CDCl3) δ 8.39 (d, J = 9.0 
Hz, 2H), 8.24 (d, J = 9.0 Hz, 2H), 7.81 (bs, 1H), 5.60 (m, 1H), 
5.41 (dt, J = 15.0, 6.9 Hz, 1H), 5.18 (dt, J = 15.5, 7.0 Hz, 1H), 
4.99 (m, 2H), 4.79 (pent., J = 6.5 Hz, 1H), 2.31 (m, 1H), 2.22 (m, 3H), 1.90 (m, 2H), 1.26 
(m, 4H), 0.86 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.9, 149.8, 144.2, 
135.3, 132.6, 129.9, 124.3, 123.4, 118.6, 77.4, 37.7, 36.6, 32.3, 31.5, 22.3, 14.0; IR 
(film, cm-1): 3249 (br), 3109, 2958, 2927, 2872, 1749, 1535; HRMS (ESI) m/z calc’d for 
C18H24N2O6SNa [M+Na]
+: 419.1253, found 419.1263.  
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Optimization of Allylic Amination Reaction 
 
Entry 1: A 1 dram vial (topped with a Teflon-lined cap) was charged with (±)-2-
methylhept-6-en-3-yl tosylcarbamate 2a (325.3 mg, 1.00 mmol). The following solids 
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O NSO2R
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Pd(OAc)2
(10 mol%)
PhBQ (2 equiv.),
BisSO Liganda (5 mol%),
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Entry R Time Isolated
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3
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p-Tol
p-ClPh
p-NO2Ph (Ns)
o-NO2Ph
(2a)
(2b)
(2c)
(2d)
72 h
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15%
38%
67%
63%
5.1:1
3.7:1
4.4:1
2.6:1
Entry R' Isolated
Yieldb
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5d
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iPropyl
Ethyl
tButyl
(2c)
(2e)
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80%
87%
84%
6.0:1
4.3:1
6.3:1
65%
67%
68%
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Allylic C H Amination Reaction Optimization
a BisSO ligand ) 1,2-bis(phenylsulfinyl)ethane. b Average of two runs. c Determined by GC
analysis (R = p-Tol) or 1H NMR (R = p-ClPh, p-NO2Ph, o-NO2Ph) of crude reaction mixture.
d
Reaction run using 10 mol % p-nitrobenzoic acid and oxygenated DCE. e Isolated yield of major
syn product, >20:1 syn:anti.
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were all first weighed to wax paper then sequentially added to the vial: phenyl 
benzoquinone (368.4 mg, 2.0 mmol), 1,2-bis(phenylsulfinyl)ethane (13.9 mg, 0.05 
mmol), 1 (50.3 mg, 0.10 mmol), Teflon stir bar.  THF (1.51 mL) was added, the vial was 
capped and placed in a 45°C oil bath and stirred for 72 hours.  The reaction mixture was 
transferred to a separatory funnel and diluted with CH2Cl2 (25 mL). Saturated NH4Cl (15 
mL) and brine (15 mL) were added and the aqueous and organic layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo. A portion of the crude 
reaction mixture was analyzed by GC to obtain the crude diastereoselectivity. After 
analysis, this sample was added back to the total crude reaction mixture. Purification by 
flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) 
provided a mixture of syn- and anti- (±)-6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one. 
Run 1: (49.8 mg, 0.15 mmol, 15% yield [5.3:1 dr]); Run 2: (45.3 mg, 0.14 mmol, 14% 
yield [4.9:1 dr]). Average: 15% yield, 5.1:1 dr (syn: anti). 
 
Entry 2: A 1 dram vial (topped with a Teflon-lined cap) was charged with (±)-2-
methylhept-6-en-3-yl 4-chlorophenylsulfonylcarbamate 2b (103.7 mg, 0.30 mmol). The 
following solids were all first weighed to wax paper then sequentially added to the vial: 
phenyl benzoquinone (110.5 mg, 0.6 mmol), 1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.02 
mmol), 1 (15.1 mg, 0.03 mmol), Teflon stir bar.  THF (453 µL) was added, the vial was 
capped and placed in a 45°C oil bath and stirred for 24 hours.  The reaction mixture was 
transferred to a separatory funnel using a minimal amount of methylene chloride and 
diluted with Et2O (30 mL). The organic layer was washed with saturated aqueous 
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NaHSO3 (25 mL), water (15 mL), 5% aqueous K2CO3 (25 mL), and water (15 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. A portion of 
the crude reaction mixture was analyzed by GC to obtain the crude diastereoselectivity. 
After analysis, this sample was added back to the total crude reaction mixture. 
Purification by flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-
2.5% acetone) provided a mixture of syn- and anti- (±)-3-(4-chlorophenylsulfonyl)-6-
isopropyl-4-vinyl-1,3-oxazinan-2-one. Run 1: (37.1 mg, 0.108 mmol, 36% yield [3.4:1 
dr]); Run 2: (40.2 mg, 0.117 mmol, 39% yield [4.0:1 dr]). Average: 38% yield, 3.7:1 dr 
(syn: anti). 
 
Entry 3: A 1 dram vial (topped with a Teflon-lined cap) was charged with (±)-2-
methylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate 2c (106.9 mg, 0.30 mmol). The 
following solids were all first weighed to wax paper then sequentially added to the vial: 
phenyl benzoquinone (110.5 mg, 0.6 mmol), 1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.02 
mmol), 1 (15.1 mg, 0.03 mmol), Teflon stir bar.  THF (453 µL) was added, the vial was 
capped and placed in a 45°C oil bath and stirred for 24 hours.  The reaction mixture was 
transferred to a separatory funnel using a minimal amount of methylene chloride and 
diluted with Et2O (30 mL). The organic layer was washed with saturated aqueous 
NaHSO3 (25 mL), water (15 mL), 5% aqueous K2CO3 (25 mL), and water (15 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. A portion of 
the crude reaction mixture was analyzed by GC to obtain the crude diastereoselectivity. 
After analysis, this sample was added back to the total crude reaction mixture. 
Purification by flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-
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2.5% acetone) provided a mixture of syn- and anti- (±)-6-isopropyl-3-(4-
nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one. Run 1: (72.3 mg, 0.204 mmol, 68% 
yield [4.4:1 dr]); Run 2: (70.2 mg, 0.198 mmol, 66% yield [4.4:1 dr]). Average: 67% 
yield, 4.4:1 dr (syn: anti). 
 
Entry 4: A 1 dram vial (topped with a Teflon-lined cap) was charged with (±)-2-
methylhept-6-en-3-yl 2-nitrophenylsulfonylcarbamate 2d (106.9 mg, 0.30 mmol). The 
following solids were all first weighed to wax paper then sequentially added to the vial: 
phenyl benzoquinone (110.5 mg, 0.6 mmol), 1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.02 
mmol), 1 (15.1 mg, 0.03 mmol), Teflon stir bar.  THF (453 µL) was added, the vial was 
capped and placed in a 45°C oil bath and stirred for 24 hours.  The reaction mixture was 
transferred to a separatory funnel using a minimal amount of methylene chloride and 
diluted with Et2O (30 mL). The organic layer was washed with saturated aqueous 
NaHSO3 (25 mL), water (15 mL), 5% aqueous K2CO3 (25 mL), and water (15 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. A portion of 
the crude reaction mixture was analyzed by GC to obtain the crude diastereoselectivity. 
After analysis, this sample was added back to the total crude reaction mixture. 
Purification by flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-
2.5% acetone) provided a mixture of syn- and anti- (±)-6-isopropyl-3-(2-
nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one. Run 1 (67.0 mg, 0.189 mmol, 63% 
[2.5:1 dr]); run 2 (65.9 mg, 0.186 mmol, 62% [2.6:1 dr]).  Average Yield: 63%, 2.6:1 dr 
(syn:anti). 
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Entry 5: A 1 dram vial (topped with a Teflon-lined cap) was charged with (±)-2-
methylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate 2c (106.9 mg, 0.30 mmol). The 
following solids were all first weighed to wax paper then sequentially added to the vial: 
phenyl benzoquinone (110.5 mg, 0.6 mmol), 1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.02 
mmol), p-nitrobenzoic acid (5.1 mg, 0.03 mmol), 1 (15.1 mg, 0.03 mmol), Teflon stir bar.  
DCE (453 µL, O2 was bubbled through the solvent for 30 minutes prior to addition) was 
then added to the vial followed by blowing a stream of O2 over the vial for 5 seconds 
before sealing and placed in a 45°C oil bath and stirred for 24 hours.  The reaction 
mixture was transferred to a separatory funnel using a minimal amount of methylene 
chloride and diluted with Et2O (30 mL). The organic layer was washed with saturated 
aqueous NaHSO3 (25 mL), water (15 mL), 5% aqueous K2CO3 (25 mL), and water (15 
mL). The organic layer was dried over MgSO4, filtered, and concentrated in vacuo. A 
portion of the crude reaction mixture was analyzed by 1HNMR to obtain the crude 
diastereoselectivity. After analysis, this sample was added back to the total crude 
reaction mixture. Purification by flash chromatography (1:1 hexanes:methylene chloride, 
gradient 1.0-2.5% acetone) provided a mixture of syn- and anti- (±)-6-isopropyl-3-(4-
nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one. Run 1: (87.2 mg, 0.25 mmol, 82% yield 
[5.8:1 dr]); Run 2: (82.9 mg, 0.23 mmol, 78% yield [6.2:1 dr]). Average: 80% yield, 
6.0:1 dr (syn: anti). 
 
Entry 6:  Following the procedure outlined in Entry 4 (±)-hept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate 2e (102.7 mg, 0.30 mmol) was used.  Run 1: (84.8 mg, 
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0.25 mmol, 83% yield [4.3:1 dr]); Run 2: (91.9 mg, 0.27 mmol, 90% yield [4.3:1 dr]). 
Average: 87% yield, 4.3:1 dr (syn: anti). 
 
Entry 7:  Following the procedure outlined in Entry 4 (±)-2,2-dimethylhept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate 2f (111.1 mg, 0.30 mmol) was used.  Run 1: (96.2 mg, 
0.26 mmol, 87% yield [6.3:1 dr]); Run 2: (89.5 mg, 0.24 mmol, 81% yield [6.2:1 dr]). 
Average: 84% yield, 6.3:1 dr (syn: anti). 
 
Use of DIPEA to promote reactivity:  A 1 dram vial (topped with a Teflon-lined cap) 
was charged with (±)-2-methylhept-6-en-3-yl tosylcarbamate 2a (325.3 mg, 1.00 mmol). 
The following solids were all first weighed to wax paper then sequentially added to the 
vial: phenyl benzoquinone (368.4 mg, 2.0 mmol), 1,2-bis(phenylsulfinyl)ethane (13.9 mg, 
0.05 mmol), 1 (50.3 mg, 0.10 mmol), Teflon stir bar.  To a separate vial was added 
DIPEA (10.5 µL, 0.06 mmol) and transferred to the solids vial using THF (1.51 mL 
divided into three equal portions). The vial was capped and placed in a 45°C oil bath 
and stirred for 24 hours.  The reaction mixture was transferred to a separatory funnel 
and diluted with CH2Cl2 (25 mL). Saturated NH4Cl (15 mL) and brine (15 mL) were 
added and the aqueous and organic layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. A portion of the crude reaction mixture was 
analyzed by GC to obtain the crude diastereoselectivity. After analysis, this sample was 
added back to the total crude reaction mixture. Purification by flash chromatography 
(1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided a mixture of syn- 
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and anti- (±)-6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one. Run 1: (124.2 mg, 0.384 
mmol, 38% yield [1.8:1 dr]); Run 2: (116.1 mg, 0.384 mmol, 36% yield [1.8:1 dr]). 
Average: 37% yield, 1.8:1 dr (syn: anti). 
 
Scope of Allylic Amination Reaction 
 
General Procedure B for Allylic Amination Reaction:  In a one dram vial was added 
the corresponding carbamate starting material (1 equiv.), phenyl benzoquinone (2 
equiv.), p-nitrobenzoic acid (0.10 equiv.), 1,2-bis(phenylsulfinyl)ethane (0.05 equiv), 
Pd(OAc)2/ 1,2-bis(phenylsulfinyl)ethane catalyst 1 (0.10 equiv., Aldrich Chemical 
Company) and a Teflon stir bar.  In a separate flask, O2 gas was simultaneously 
bubbled through 1,2-dichloroethane for thirty minutes.  The oxygenated 1,2-
dichloroethane (0.66 M) was then added to the previous one dram vial, O2 gas was 
blown over the vial for 5 seconds, and the vial was sealed with a Teflon lined cap. The 
reaction vial was then vortexed until the solution appeared homogeneous and stirred in 
a 45°C oil bath for 24 hours.  The solution was allowed to cool to room temperature and 
then transferred using a minimum amount of dichloromethane to a 250 mL separatory 
funnel.  The solution was diluted with 15 mL of diethyl ether and rinsed 1x 15 mL 
aqueous sodium bisulfite (sat.), 1x 15 mL water, 1x 15 mL 5% aqueous K2CO3/H2O and 
1x 15 mL water.  The organic layer was collected and dried over MgSO4, filtered and 
concentrated in vacuo. The crude reaction mixture was purified using flash column 
chromatography.  In general, the major syn-diastereomer can be isolated by flash 
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chromatography (25-35% gradient EtOAc/hexanes) directly from the crude 
reaction mixture. 
 The stereochemistry of the syn- and anti-diastereomers was determined through 
their vicinal coupling constants (3JH5H6). In general, syn-oxazinanones show a coupling 
constant between C5Ha and C5Hb with C6H within 7.5-8.0 Hz and 9.5-10.5 Hz 
respectively, and the anti-oxazinanones show a coupling constant within 2.5-3.5 Hz and 
4.5-5.5 Hz respectively. Reference 27 provides a more detailed description of this data. 
A representative example of both syn- and anti- products are shown below.  The relative 
stereochemistry was also confirmed through the crystal structure of (±)-(4S,4aS,8aR)-3-
(4-nitrophenylsulfonyl)-4-vinyloctahydro-2H-benzo[e][1,3]oxazin-2-one and (4R,6S)-6-
((R)-1,2-dihydroxyethyl)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one. 
 
 
 
 
 
 (±)-(4R,6S)-6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one: Racemic 2-methylhept-
6-en-3-yl tosylcarbamate (325.4 mg, 1.0 mmol) was reacted 
according to Table 1, entry 1. Purification by flash chromatography 
(500:500:10-25 gradient Hexanes:Methylene Chloride:Acetone) 
provided the mixture of anti- and syn- oxazinanone products as a white solid. Run 1: 
(49.8 mg, 0.15 mmol, 15% yield [5.3:1 dr]); Run 2: (45.3 mg, 0.14 mmol, 14% yield 
[4.9:1 dr]). Average: 15% yield, 5.1:1 dr (syn: anti). 1H NMR (500MHz, CDCl3) δ 7.96 
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(d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 5.54 (ddd, J = 17.0, 10.0, 8.0 Hz, 1H), 5.46 
(d, J = 17.0 Hz, 1H), 5.22 (d, J = 10.0 Hz, 1H), 4.88 (ap. Q, J = 8.7 Hz, 1H), 3.98 (ddd, J 
= 11.5, 6.0, 2.0 Hz, 1H), 2.41 (s, 3H), 2.28 (ddd, J = 14.0, 8.3, 1.8 Hz, 1H), 1.85 (m, 1H), 
1.66 (ddd, 14.0, 11.3, 10.3 Hz, 1H), 0.96 (d, J = 6.5 Hz, 3H), 0.93 (d, J = 7.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 150.6, 144.8, 137.1, 136.1, 129.7, 129.2, 118.7, 80.9, 
59.0, 33.1, 31.3, 21.7, 17.7, 17.7; IR (film, cm-1): 3073, 2964, 2932, 2875, 1739, 1958; 
HRMS (ESI) m/z calc’d for C16H22NO4S [M+H]
+: 324.1270, found 324.1274. 
 
 (±)-(4R,6S)-3-(4-chlorophenylsulfonyl)-6-isopropyl-4-vinyl-1,3-oxazinan-2-one: 
Racemic (±)-2-methylhept-6-en-3-yl 4-
chlorophenylsulfonylcarbamate (103.7 mg, 0.30 mmol) was 
reacted according to Table 1, entry 2.  Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 
1.0-2.5% acetone) provided the mixture of anti- and syn- oxazinanone products as a 
white solid. Run 1 (37.1 mg, 0.11 mmol, 36% [3.4:1 dr]); run 2 (40.2 mg, 0.12 mmol, 
39% [4.0:1 dr]). Average Yield: 38%, 3.7:1 dr (syn:anti).  1H NMR (500MHz, CDCl3) δ 
8.05 (d, J = 8.5 Hz, 2H), 7.47 (d, J = 8.5 Hz, 2H), 5.51 (ddd, J = 17.5, 9.0, 8.0 Hz, 1H), 
5.38 (d, J = 17.0 Hz, 1H), 5.25 (d, J = 10.0 Hz, 1H), 4.89 (ap. q., J = 9.0 Hz, 1H), 4.03 
(ddd, J = 11.5, 6.0, 1.5 Hz, 1H), 2.30 (ddd, J = 14.0, 8.0, 1.5 Hz, 1H), 1.88 (oct., J = 6.5 
Hz, 1H), 1.67 (dt, J = 14.0, 10.8 Hz, 1H), 0.99 (d, J = 7.0 Hz, 3H), 0.96 (d, J = 6.5 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 150.6, 140.5, 137.5, 136.7, 131.3, 128.9, 119.2, 81.2, 
59.3, 33.2, 31.4, 17.8, 17.7; IR (film, cm-1): 3093, 2968, 2933, 2879, 1730; HRMS (ESI) 
m/z calc’d for C15H19NO4SCl [M+H]
+: 344.0723, found 344.0706. 
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  (±)-(4R,6S)-6-isopropyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: 
Racemic (±)-2-methylhept-6-en-3-yl 4-nitrophenylsulfonylcarbamate 
(106.9 mg, 0.30 mmol) was reacted according to general procedure 
B. Purification by flash chromatography (1:1 hexanes:methylene 
chloride, gradient 1.0-2.5% acetone) provided the mixture of anti- and syn- oxazinanone 
products. Run 1 (87.2 mg, 0.25 mmol, 82% [5.8:1 dr]); run 2 (82.9 mg, 0.23 mmol, 78% 
[6.2:1 dr]).  Average Yield: 80%, 6.0:1 dr (syn:anti). Purification by flash 
chromatography (25-35% gradient EtOAc/hexanes, previous purification not necessary) 
of a third run provided 0.20 mmol of the syn-oxazinanone (65%).  The major 
diastereomer was obtained as a light yellow oil.  1H NMR (500MHz, CDCl3) δ 8.32 (m, 
4H), 5.50 (ddd, J = 17.0, 9.5, 8.0 Hz, 1H), 5.42 (d, J = 17.0 Hz, 1H), 5.30 (d, J = 9.8 Hz, 
1H), 4.91 (dt, J = 10.0, 8.0 Hz, 1H), 4.07 (ddd, J = 11.5, 6.0, 2.0 Hz, 1H),  2.33 (ddd, J = 
14.0, 8.0, 2.0 Hz, 1H), 1.90 (m, 1H), 1.70 (ddd, J = 14.3, 11.5, 10.3, Hz, 1H), 1.00 (d, J 
= 6.5 Hz, 3H), 0.96 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.6, 150.4, 
144.5, 136.3, 131.2, 123.7, 119.9, 81.5, 59.7, 33.1, 31.4, 17.7, 17.7; IR (film, cm-1): 
3110, 2970, 2940, 2881, 1737, 1531; HRMS (ESI) m/z calc’d for C15H19N2O6S [M+H]
+: 
355.0964, found 355.0981. 
 
 (±)-(4S,6S)-6-isopropyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: 
Product obtained as a light yellow oil. 1H NMR (500MHz, CDCl3) δ 
8.35 (m, 2H), 8.23 (m, 2H), 5.90 (ddd, J = 17.0, 10.5, 5.0 Hz, 1H), 
5.46 (dd, J = 10.5, 1.5 Hz, 1H), 5.37 (dd, J = 16.8, 1.8 Hz, 1H), 5.23 
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(m, 1H), 4.17 (ddd, J = 11.5, 6.3, 3.5 Hz, 1H), 2.05 (ddd, J = 14.0, 3.5, 2.5 Hz, 1H), 2.00 
(ddd, J = 14.0, 11.5, 5.0 Hz, 1H), 1.86 (m, 1H), 0.97 (d, J = 6.5 Hz, 3H), 0.93 (d, J = 7.0 
Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 150.8, 148.5, 144.1, 135.2, 131.0, 123.8, 119.3, 
80.9, 56.5, 32.2, 30.1, 17.8, 17.6; IR (film, cm-1): 3109, 2970, 2931, 2880, 1721;  HRMS 
(ESI) m/z calc’d for C15H19N2O6S [M+H]
+: 355.0964, found 355.0968. 
 
 (±)-6-isopropyl-3-(2-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: Racemic (±)-
2-methylhept-6-en-3-yl 2-nitrophenylsulfonylcarbamate (106.9 
mg, 0.30 mmol) was reacted according to Table 1, entry 4. 
Purification by flash chromatography (1:1 hexanes:methylene 
chloride, gradient 1.0-2.5% acetone) provided an inseparable 
mixture of anti- and syn- oxazinanone products as a white solid.  Run 1 (67.0 mg, 0.189 
mmol, 63% [2.5:1 dr]); run 2 (65.9 mg, 0.186 mmol, 62% [2.6:1 dr]).  Average Yield: 
63%, 2.6:1 dr (syn:anti).  Major syn-diastereomer:  1H NMR (500MHz, CDCl3) δ 8.41 
(m, 1H), 7.76 (m, 3H), 5.94 (ddd, J = 17.0, 10.0, 7.5 Hz, 1H), 5.45 (d, J = 17.0 Hz, 1H), 
5.31 (d, J = 10.5 Hz, 1H), 4.77 (dt, J = 10.5, 7.5 Hz, 1H), 4.18 (ddd, J = 11.0, 6.0, 2.0 Hz, 
1H), 2.38 (ddd, J = 14.0, 7.0, 2.0 Hz, 1H), 1.85 (m, 2H), 0.97 (d, J = 6.5 Hz, 3H), 0.94 (d, 
J = 7.0 Hz, 3H); Minor anti-diastereomer: 1H NMR (500MHz, CDCl3) δ 8.50 (m, 1H), 
7.75 (m, 3H), 5.93 (m, 1H), 5.56 (dd, J = 17.5, 2.0 Hz, 1H), 5.45 (m, 1H), 5.04 (m, 1H), 
4.20 (m, 1H), 2.20 (ddd, J = 14.0, 12.5, 5.0 Hz, 1H), 2.02 (dt, J = 14.3, 2.5 Hz, 1H), 1.87 
(m, 1H), 0.96 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 7.0 Hz, 1H); Carbon signals, IR 
wavenumbers and mass spectrometry signals for both syn- and anti- listed together: 13C 
NMR (125 MHz, CDCl3) δ 149.8, 148.8, 148.2, 137.0, 136.1, 136.0, 135.8, 135.0, 134.8, 
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132.7, 132.1, 131.9, 124.7, 124.5, 118.6, 118.6, 81.4, 80.9, 59.1, 57.0, 32.9, 32.1, 31.5, 
28.4, 17.8, 17.7, 17.6; IR (film, cm-1): 3103, 2970, 2933, 2879, 1724, 1545; HRMS (ESI) 
m/z calc’d for C15H19N2O6S [M+H]
+: 355.0964, found 355.0962. 
 
 (±)-(4R,6R)-6-ethyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one:   Racemic 
(±)-hept-6-en-3-yl 4-nitrophenylsulfonylcarbamate (102.7 mg, 0.30 
mmol) was reacted according to general procedure B.  Purification 
by flash chromatography (1:1 hexanes:methylene chloride, gradient 
1.0-2.5% acetone) provided the mixture of anti- and syn- oxazinanone products.  Run 1 
(84.8 mg, 0.25 mmol, 83% [4.3:1 dr]); run 2 (91.9 mg, 0.27 mmol, 90% [4.3:1 dr]).  
Average Yield: 87%, 4.3:1 dr (syn:anti).  Further purification by flash chromatography 
(25-35% gradient EtOAc/hexanes) provided 0.20 mmol of the syn-oxazinanone (67%).  
Major diastereomer obtained as a light yellow solid. 1H NMR (500MHz, CDCl3) δ 8.32 
(m, 4H), 5.52 (ddd, J = 17.5, 9.0, 7.6 Hz, 1H), 5.41 (d, J = 16.5 Hz, 1H), 5.30 (d, J = 9.5 
Hz, 1H), 4.95 (app. q, J = 8.3 Hz, 1H), 4.26 (dddd, J = 11.0, 7.0, 5.5, 2.0 Hz, 1H), 2.37 
(ddd, J = 14.5, 8.0, 2.3 Hz, 1H), 1.80-1.60 (m, 3H), 1.00 (t, J = 7.3, 3H); 13C NMR (125 
MHz, CDCl3) δ 150.7, 150.3, 144.5, 136.3, 131.2, 123.8, 119.9, 78.3, 59.5, 35.4, 27.2, 
9.2; IR (film, cm-1): 3109, 2974, 2942, 2884, 1736, 1531; HRMS (ESI) m/z calc’d for 
C14H17N2O6S [M+H]
+: 341.0807, found 341.0801. 
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 (±)-(4R,6S)-6-tert-butyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: 
Racemic (±)-2,2-dimethylhept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate (111.1 mg, 0.30 mmol) was reacted 
according to procedure B.  Purification by flash chromatography (1:1 
hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided the mixture of anti- 
and syn- oxazinanone products.  Run 1 (96.2 mg, 0.26 mmol, 87% [6.3:1 dr]); run 2 
(89.5 mg, 0.24 mmol, 81% [6.2:1 dr]). Average Yield: 84%, 6.3:1 dr (syn:anti).  
Further purification by flash chromatography (25-35% gradient EtOAc/hexanes) 
provided 0.20 mmol of the syn-oxazinanone (68%). Major diastereomer obtained as a 
white solid. 1H NMR (500MHz, CDCl3) δ 8.33 (m, 4H), 5.45 (m, 2H), 5.30 (m, 1H), 4.88 
(dt, J = 10.2, 7.8 Hz, 1H), 3.96 (dd, J = 11.8, 1.8 Hz, 1H), 2.32 (ddd, J = 14.0, 7.8, 1.8 
Hz, 1H), 1.67 (ddd, J = 14.0, 11.5, 10.5 Hz, 1H), 0.97 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 150.7, 150.6, 144.6, 136.3, 131.2, 123.8, 120.1, 84.0, 59.9, 33.5, 31.5, 25.4; 
IR (film, cm-1): 3112, 2970, 2874, 1732, 1531; HRMS (ESI) m/z calc’d for C16H21N2O6S 
[M+H]+: 369.1120, found 369.1114. 
 
 (±)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: Pent-4-enyl 4-
nitrophenylsulfonylcarbamate (94.3 mg, 0.30 mmol) was reacted 
according to general procedure B. Purification by flash chromatography 
(1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided 3-
(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one as a light yellow oil. Run 1 (63.7 mg, 
0.20 mmol, 68%); run 2 (67.5 mg, 0.22 mmol, 72%).  Average Yield: 70%. 1H NMR 
(500MHz, CDCl3) δ 8.35 (m, 2H), 8.23 (m, 2H), 5.89 (ddd, J = 17.0, 10.5, 5.5 Hz, 1H), 
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5.48 (dd, J = 10.5, 1.5 Hz, 1H), 5.39 (dd, J = 17.5, 1.5 Hz, 1H), 5.26 (m, 1H), 4.37 (m, 
2H), 2.33 (m, 1H), 2.04 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 150.8, 148.3, 144.0, 
134.6, 131.0, 123.9, 119.6, 65.0, 57.0, 27.4; IR (film, cm-1): 3110, 2987, 2921, 1729; 
HRMS (ESI) m/z calc’d for C12H13N2O6S [M+H]
+: 313.0494, found 313.0487. 
 
 (±)-(4R,6S)-3-(4-nitrophenylsulfonyl)-6-phenyl-4-vinyl-1,3-oxazinan-2-one:  
Racemic (±)-1-phenylpent-4-enyl 4-nitrophenylsulfonylcarbamate 
(117.1 mg, 0.30 mmol) was reacted according to procedure B. 
Purification by flash chromatography (1:1 hexanes:methylene 
chloride, gradient 1.0-2.5% acetone) provided the mixture of anti- and syn- oxazinanone 
products.  Run 1 (96.7 mg, 0.25 mmol, 83% [6.5:1 dr]); run 2 (95.5 mg, 0.25 mmol, 82% 
[7.0:1 dr]). Average Yield: 83%, 6.8:1 dr (syn:anti). Further purification by flash 
chromatography (25-35% gradient EtOAc/hexanes) provided 0.19 mmol of the syn-
oxazinanone (64%). Major product obtained as a white solid. 1H NMR (500MHz, 
CDCl3) δ 8.35 (s, 4H), 7.40-7.30 (m, 5H), 5.54 (ddd, J = 17.0, 9.3, 8.0 Hz, 1H), 5.46 (dd, 
J = 17.0, 1.0 Hz, 1H), 5.36 (dd, J = 11.3, 2.3 Hz, 1H), 5.32 (d, J = 9.5 Hz, 1H), 5.10 (dt, 
J = 9.5, 8.0 Hz, 1H), 2.60 (ddd, J = 14.5, 8.0, 2.0 Hz, 1H), 2.11 (ddd, J = 14.5, 11.0, 
10.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 150.7, 150.0, 144.4, 136.3, 136.0, 131.3, 
129.3, 129.0, 126.1, 123.8, 120.3, 78.0, 59.6, 38.0; IR (film, cm-1): 3110, 3072, 3039, 
2982, 2932, 2869, 2257, 1737; HRMS (ESI) m/z calc’d for C18H17N2O6S [M+H]
+: 
389.0807, found 389.0822. 
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 (±)-(4R,6S)-6-isopropyl-6-methyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-
one: Racemic (±)-2,3-dimethylhept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate (111.1 mg, 0.30 mmol) was reacted 
according to general procedure B. Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 1.0-3.5% acetone) provided 
the mixture of anti- and syn- oxazinanone products. Run 1 (90.6 mg, 0.25 mmol, 82% 
[2.6:1 dr]); run 2 (90.1 mg, 0.24 mmol, 82% [2.4:1 dr]).  Average Yield: 82%, 2.5:1 dr 
(syn:anti). Further purification by flash chromatography (10-15% gradient 
EtOAc/hexanes) provided 0.15 mmol of the syn-oxazinanone (51%). The major 
diastereomer was obtained as a white solid. 1H NMR (400MHz, CDCl3) δ 8.31 (m, 4H), 
5.62 (ddd, J = 16.8, 9.8, 7.7 Hz, 1H), 5.43 (d, J = 16.8 Hz, 1H), 5.33 (d, J = 10.0 Hz, 1H), 
4.91 (ap. q, J = 7.6 Hz, 1H), 2.15 (dd, J = 14.4, 7.6 Hz, 1H), 1.89 (m, 1H), 1.84 (m, 1H), 
1.42 (s, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 150.6, 149.3, 144.7, 136.3, 131.0, 123.8, 119.6, 85.1, 57.6, 37.5, 36.7, 19.5, 
17.0, 16.6; IR (film, cm-1): 3108, 2971, 2940, 2881, 1727, 1532; HRMS (ESI) m/z calc’d 
for C16H21N2O6S [M+H]
+: 369.1120, found 369.1125. 
 
 (±)-(4R,6S)-3-(4-nitrophenylsulfonyl)-6-(2-oxobutyl)-4-vinyl-1,3-oxazinan-2-one: 
Racemic (±)-7-oxonon-1-en-5-yl 4-nitrophenylsulfonyl-
carbamate  (114.7 mg, 0.30 mmol) was reacted according to 
procedure B. Purification by flash chromatography (1:1 
hexanes:methylene chloride, gradient 3.5-5.0% acetone) provided the mixture of anti- 
and syn- oxazinanone products.  Run 1 (85.6 mg, 0.23 mmol, 75% [3.5:1 dr]); run 2 
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(87.9 mg, 0.23 mmol, 77% [3.2:1 dr]). Average Yield: 76%, 3.4:1 dr (syn:anti). Further 
purification by flash chromatography (35-50% gradient EtOAc/hexanes) provided 0.16 
mmol of the syn-oxazinanone (53%). Major product obtained as a white solid. 1H NMR 
(500MHz, CDCl3) δ 8.31 (m, 4H), 5.52 (ddd, J = 17.5, 9.8, 7.6 Hz, 1H), 5.43 (d, J = 16.5 
Hz, 1H), 5.32 (d, J = 10.0 Hz, 1H), 5.00 (app. q, J = 8.0 Hz, 1H), 4.79 (m, 1H), 2.96 (dd, 
J = 17.5, 5.5 Hz, 1H), 2.64 (dd, J = 17.5, 7.5 Hz, 1H), 2.55-2.40 (m, 3H), 1.72 (dt, J = 
14.0, 10.5 Hz, 1H), 1.06 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 206.8, 150.7, 
149.7, 144.3, 136.0, 131.2, 123.8, 120.2, 73.0, 59.4, 45.7, 37.0, 35.7, 7.6; IR (film, cm-
1):3109, 2980, 2941, 1732, 1532; HRMS (ESI) m/z calc’d for C16H19N2O7S [M+H]
+: 
383.0913, found 383.0900. 
 
 (±)-methyl-2-((4R,6S)-3-(4-nitrophenylsulfonyl)-2-oxo-4-vinyl-1,3-oxazinan-6-
yl)acetate: Racemic (±)-methyl 3-(4-
nitrophenylsulfonylcarbamoyloxy)hept-6-enoate (Run 1: 115.9 
mg, 0.30 mmol; Run 2: 77.3 mg, 0.20 mmol) was reacted 
according to general procedure B. Purification by flash chromatography (1:1 
hexanes:methylene chloride, gradient 1.0-3.5% acetone) provided the mixture of anti- 
and syn- oxazinanone products. Run 1 (81.9 mg, 0.21 mmol, 71% [4.1:1 dr]); run 2 
(56.9 mg, 0.15 mmol, 74% [4.4:1 dr]).  Average Yield: 73%, 4.3:1 dr (syn:anti). 
Further purification by flash chromatography (500 mL 1:1 Hexanes:Methylene Chloride 
followed by 1:1 hexanes:methylene chloride, slow gradient 1.0-4.5% acetone) of run 1 
provided 0.15 mmol of the syn-oxazinanone (50%). The major diastereomer was 
obtained as a light yellow oil.  1H NMR (500MHz, CDCl3) δ 8.35 (m, 2H), 8.30 (m, 2H), 
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5.53 (ddd, J = 17.0, 9.5, 8.0 Hz, 1H), 5.44 (d, J = 16.5 Hz, 1H), 5.33 (d, J = 10.0 Hz, 1H), 
5.01 (ap. q, J = 8.5 Hz, 1H), 4.76 (m, 1H), 3.73 (s, 3H), 2.83 (dd, J = 16.8, 6.5 Hz, 1H), 
2.60 (dd, J = 16.8, 7.3 Hz, 1H), 2.54 (ddd, J = 14.0, 8.0, 2.3 Hz, 1H), 1.81 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 169.3, 150.8, 149.5, 144.3, 136.0, 131.2, 123.8, 120.2, 73.1, 
59.2, 52.4, 38.6, 35.5; IR (film, cm-1): 3118, 3101, 2958, 2920, 2853, 1747, 1719, 1536; 
HRMS (ESI) m/z calc’d for C15H17N2O8S [M+H]
+: 385.0706, found 385.0708. 
 
 (±)-(4R,6S)-6-(benzyloxymethyl)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-
one: Racemic (±)-1-(benzyloxy)hex-5-en-2-yl 4-
nitrophenylsulfonylcarbamate (130.4 mg, 0.30 mmol) was 
reacted according to general procedure B. Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided 
the mixture of anti- and syn- oxazinanone products. Run 1 (97.3 mg, 0.23 mmol, 75% 
[4.5:1 dr]); run 2 (109.0 mg, 0.25 mmol, 84% [4.3:1 dr]).  Average Yield: 80%, 4.4:1 dr 
(syn:anti). Purification by flash chromatography (25-35% gradient EtOAc/hexanes, 
previous purification not necessary) of a third run provided 0.19 mmol of the syn-
oxazinanone (63%). The major diastereomer was obtained as a light yellow oil. 1H 
NMR (400 MHz, CDCl3) δ 8.32 (m, 4H), 7.33 (m, 5H), 5.54 (ddd, J = 17.2, 9.4, 8.0 Hz, 
1H), 5.41 (d, J = 16.8 Hz, 1H), 5.30 (d, J = 10.0 Hz, 1H), 4.98 (ap. q, J = 8.4 Hz, 1H), 
4.55 (s, 2H), 4.49 (m, 1H), 3.63 (dd, J = 10.6, 4.6 Hz, 1H), 3.62 (dd, J = 10.8, 4.8 Hz, 
1H), 2.43 (ddd, J = 14.4, 8.0, 2.4 Hz, 1H), 1.95 (ddd, J = 14.4, 10.6, 9.6 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 150.7, 149.7, 144.3, 137.3, 136.1, 131.2, 128.7, 128.2, 127.9, 
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123.8, 120.0, 75.7, 73.8, 69.8, 59.3, 32.5; IR (film, cm-1): 3109, 2925, 2872, 1737, 1531; 
HRMS (ESI) m/z calc’d for C20H21N2O7S [M+H]
+: 433.1069, found 433.1057. 
 
 (±)-(4R,6R)-3-(4-nitrophenylsulfonyl)-6-phenethyl-4-vinyl-1,3-oxazinan-2-one: 
Racemic (±)-1-phenylhept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate (125.6 mg, 0.30 mmol) was 
reacted according to general procedure B. Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided 
the mixture of anti- and syn- oxazinanone products. Run 1 (106.2 mg, 0.26 mmol, 85% 
[5.3:1 dr]); run 2 (101.2 mg, 0.24 mmol, 81% [5.3:1 dr]).  Average Yield: 83%, 5.3:1 dr 
(syn:anti). Further purification by flash chromatography (25-35% gradient 
EtOAc/hexanes) provided 0.20 mmol of the syn-oxazinanone (65%). The major 
diastereomer was obtained as a light yellow oil. 1H NMR (500 MHz, CDCl3) δ 8.31 (m, 
4H), 7.30 (m, 2H), 7.22 (m, 1H), 7.17 (m, 2H), 5.53 (ddd, J = 17.0, 10.0, 8.3 Hz, 1H), 
5.41 (d, J = 17.0 Hz, 1H), 5.31 (d, J = 10.0 Hz, 1H), 4.93 (ap. q, J = 8.7 Hz, 1H), 4.30 (m, 
1H), 2.83 (m, 1H), 2.72 (m, 1H), 2.36 (ddd, J = 14.5, 7.8, 2.3 Hz, 1H), 2.03 (m, 1H), 1.89 
(m, 1H), 1.77 (ddd, J = 14.5, 11.0, 10.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 150.6, 
150.1, 144.4, 140.3, 136.2, 131.1, 128.7, 128.5, 126.5, 123.7, 119.9, 76.2, 59.3, 35.7, 
35.7, 30.9; IR (film, cm-1): 3108, 3028, 2930, 2869, 1732, 1607, 1532; HRMS (ESI) m/z 
calc’d for C20H21N2O6S [M+H]
+: 417.1120, found 417.1131. 
 
 
 
O
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 (±)-(4R,6R)-6-(3-methylbut-2-enyl)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-
2-one:  Racemic (±)-8-methylnona-1,7-dien-5-yl 4-
nitrophenylsulfonylcarbamate was reacted according to 
general procedure B.  Purification by flash chromatography 
(1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided the mixture of 
anti- and syn- oxazinanone products. Run 1 (74.2 mg, 0.20 mmol, 65% [4.3:1 dr]); run 2 
(78.7 mg, 0.21 mmol, 69% [4.6:1 dr]). Average Yield: 67%, 4.5:1 dr (syn:anti). Further 
purification by flash chromatography (15-25% gradient EtOAc/hexanes) provided 0.16 
mmol of the syn-oxazinanone (52%). Major diastereomer obtained as a white solid. 1H 
NMR (500MHz, CDCl3) δ 8.31 (m, 4H), 5.52 (ddd, J = 17.5, 9.8, 8.0 Hz, 1H), 5.41 (d, J = 
16.5 Hz, 1H), 5.30 (d, J = 9.5 Hz, 1H), 5.08 (ap. t, J = 7.3 Hz, 1H), 4.93 (ap. q, J = 8.8 
Hz, 1H), 4.29 (m, 1H), 2.44 (m, 1H), 2.36 (ddd, J = 14.5, 8.0, 2.0 Hz, 1H), 2.29 (m, 1H), 
1.71 (s, 3H), 1.69 (m, 1H), 1.61 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 150.6, 150.2, 
144.5, 136.7, 136.3, 131.2, 123.7, 119.9, 116.7, 76.9, 59.6, 35.1, 32.6, 25.9, 18.1; IR 
(film, cm-1): 3107, 2976, 2916, 2867, 1739, 1532; HRMS (ESI) m/z calc’d for 
C17H21N2O6S [M+H]
+: 381.1120, found 381.1128. 
 
 (±)-(4R,6R)-6-((E)-hex-3-enyl)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: 
racemic (E)-undeca-1,8-dien-5-yl 4-
nitrophenylsulfonylcarbamate (39.7 mg, 0.10 mmol) was 
reacted according to general procedure B for 48 hours. 
Purification by flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-
2.5% acetone) provided the mixture of anti- and syn- oxazinanone products.  Run 1 
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(26.4 mg, 0.067 mmol, 67% [4.2:1 dr]); run 2 (26.3 mg, 0.067 mmol, 67% [4.2:1 dr]). 
Average Yield: 67%, 4.2:1 dr (syn:anti).  The reaction was run a third time using 0.30 
mmol of starting carbamate and purified directly by flash column chromatography (15-
25% gradient EtOAc/hexanes) to yield 0.15 mmol of the syn-oxazinanone (50%). 
Major diastereomer obtained as a yellow oil.  1H NMR (500MHz, CDCl3) δ 8.32 (m, 4H), 
5.51 (m, 2H), 5.41 (d, J = 17.0 Hz, 1H), 5.35 (m, 1H), 5.30 (d, J = 9.5 Hz, 1H), 4.94 (ap. 
q, J = 8.7 Hz, 1H), 4.32 (m, 1H), 2.37 (ddd, J = 14.5, 8.0, 2.0 Hz, 1H), 2.13 (m, 2H), 
2.00 (p, J = 7.0 Hz, 2H), 1.78 (m, 1H), 1.72 (m, 1H), 1.62 (m, 1H), 0.96 (t, J =7.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 150.7, 150.2, 144.5, 136.2, 134.1, 131.2, 126.8, 
123.8, 120.0, 76.5, 59.5, 35.8, 33.9, 27.7, 25.7, 13.9; IR (film, cm-1): 3111, 2961, 2930, 
2873, 2852, 1736, 1532; LRMS (ESI) m/z calc’d for C18H23N2O6S [M+H]
+: 395.12, found 
395.20. 
 
 (+)-(4R,6S)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4-nitrophenylsulfonyl)-4-vinyl-
1,3-oxazinan-2-one: (-)-(S)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-
yl)pent-4-enyl 4-nitrophenylsulfonylcarbamate (41.4 mg, 0.10 
mmol) was reacted according to general procedure B. 
Purification by flash chromatography (1:1 hexanes:methylene 
chloride, gradient 1.0-2.5% acetone) provided the mixture of anti- and syn- oxazinanone 
products. Run 1 (36.7 mg, 0.09 mmol, 89% [3.8:1 dr]); run 2 (34.6 mg, 0.08 mmol, 84% 
[3.4:1 dr]).  Average Yield: 87%, 3.6:1 dr (syn:anti). Purification by flash 
chromatography (25-35% gradient EtOAc/hexanes, previous purification not necessary) 
of a third run (0.30 mmol scale) provided 0.18 mmol of the syn-oxazinanone (61%). 
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The major diastereomer was obtained as a light yellow solid. 1H NMR (500MHz, CDCl3) 
δ 8.35 (m, 2H), 8.29 (m, 2H), 5.57 (ddd, J = 17.5, 9.8, 7.8 Hz, 1H), 5.43 (d, J = 17.0 Hz, 
1H), 5.33 (d, J = 10.0 Hz, 1H), 5.00 (ap. q, J = 8.5 Hz, 1H), 4.18 (ddd, J = 10.5, 7.8, 2.8 
Hz, 1H), 4.12 (dd, J = 9.0, 6.0 Hz, 1H), 4.05 (m, 1H), 3.98 (dd, 8.8, 4.3 Hz, 1H), 2.59 
(ddd, J = 14.5, 8.0, 2.5 Hz, 1H), 1.85 (dt, J = 14.5, 9.5 Hz, 1H), 1.42 (s, 3H), 1.33 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 150.8, 149.2, 144.2, 136.0, 131.2, 123.8, 120.1, 
110.5, 77.2, 75.4, 66.8, 59.3, 32.5, 26.9, 25.0; IR (film, cm-1): 3107, 2988, 2934, 2897, 
1739, 1608, 1532; HRMS (ESI) m/z calc’d for C17H21N2O8S [M+H]
+: 413.1019, found 
413.1023; [α]D
27 = +9.6° (c = 1.0, CHCl3). 
 
 (4R,6S)-6-((R)-1,2-dihydroxyethyl)-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-
2-one: (+)- (4R,6S)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4-
nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one was dissolved in  
5% HCl/EtOH and stirred at room temperature until completion 
as seen by TLC.  The crude reaction mixture was concentrated in vacuo and 
crystallized using a minimum amount of methylene chloride in hexanes.   
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  (+)-(4S,6R)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4-nitrophenylsulfonyl)-4-vinyl-
1,3-oxazinan-2-one: (+)-(R)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-
yl)pent-4-enyl 4-nitrophenylsulfonylcarbamate (Run 1: 41.4 mg, 
0.10 mmol; Run 2: 124.3 mg, 0.30 mmol) was reacted according 
to general procedure B. Purification by flash chromatography 
(1:1 hexanes:methylene chloride, gradient 1.0-3.5% acetone) provided the mixture of 
anti- and syn- oxazinanone products. Run 1 (30.9 mg, 0.08 mmol, 75% [4.7:1 dr]); run 2 
(86.6 mg, 0.21 mmol, 70% [4.6:1 dr]).  Average Yield: 73%, 4.7:1 dr (syn:anti).  
Purification by flash chromatography (25-35% gradient EtOAc/hexanes, previous 
purification not necessary) of a third run (0.30 mmol scale) provided 0.17 mmol of the 
syn-oxazinanone (55%). The major diastereomer was obtained as a light yellow oil. 1H 
NMR (500MHz, CDCl3) δ 8.33 (m, 4H), 5.54 (dt, J = 17.0, 8.6 Hz, 1H), 5.45 (d, J = 17.0 
Hz, 1H), 5.33 (d, J = 9.5 Hz, 1H), 4.97 (ap. q, J = 8.7 Hz, 1H), 4.37 (m, 1H), 4.24 (m, 
1H), 4.06 (dd, J = 8.5, 7.0 Hz, 1H), 3.95 (dd, J = 9.0, 6.3 Hz, 1H), 2.36 (ddd, J = 14.5, 
8.0, 2.0 Hz, 1H), 1.93 (ap. dt, J = 14.0, 10.8 Hz, 1H), 1.41 (s, 3H), 1.35 (s, 3H); 13C 
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NMR (125 MHz, CDCl3) δ 150.8, 149.7, 144.3, 136.0, 131.3, 123.8, 120.4, 110.6, 75.4, 
74.8, 64.7, 59.4, 31.7, 26.2, 25.2; IR (film, cm-1): 3108, 2986, 2934, 1739, 1533; HRMS 
(ESI) m/z calc’d for C17H21N2O8S [M+H]
+: 413.1019, found 413.1015. [α]D
28 = +3.1° (c = 
0.5, CHCl3). 
 
 (±)-(4S,4aS,8aR)-3-(4-nitrophenylsulfonyl)-4-vinyloctahydro-2H-
benzo[e][1,3]oxazin-2-one: Racemic (±)-(1R,2S)-2-allylcyclohexyl 4-
nitrophenylsulfonylcarbamate (110.5 mg, 0.30 mmol) was reacted 
according to procedure B. Purification by flash chromatography (1:1 
hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided the 
syn- oxazinanone product.  Run 1 (66 mg, 0.18 mmol, 60% [>20:1 dr]); run 2 (60.5 mg, 
0.17 mmol, 55% [>20:1 dr]). Average Yield: 58%, >20:1 dr (syn:anti).  Relative 
configuration was determined through crystallographic analysis (Recrystallization 
performed with EtOAc/Hexanes). Product obtained as a white solid. 1H NMR (500MHz, 
CDCl3) δ 8.32 (m, 4H), 5.41 (m, 3H), 4.38 (m, 1H), 4.05 (td, J = 10.9, 4.7 Hz, 1H), 2.20 
(m, 1H), 1.96 (m, 1H), 1.88 (m, 1H), 1.78 (m, 1H), 1.47 (m, 1H), 1.30 (m, 2H), 1.20 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 150.6, 150.1, 144.6, 135.3, 131.3, 123.7, 121.3, 78.4, 
66.0, 44.2, 30.5, 28.1, 24.4, 23.6; IR (film, cm-1): 3118, 2942, 2869, 1732, 1531; HRMS 
(ESI) m/z calc’d for C16H19N2O6S [M+H]
+: 367.0964, found 367.0966. 
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  (-)-(4R,5S,6S)-5-(benzyloxy)-6-ethyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-
oxazinan-2-one: (+)-(3S,4S)-4-(benzyloxy)hept-6-en-3-yl 4-
nitrophenylsulfonylcarbamate (89.7 mg, 0.20 mmol) was reacted 
according to general procedure B for 72 hours. Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 1.0-3.5% 
acetone) provided the mixture of anti- and syn- oxazinanone products. Run 1 (61.6 mg, 
0.14 mmol, 69% [2.2:1 dr]); run 2 (60.7 mg, 0.14 mmol, 68% [2.3:1 dr]).  Average Yield: 
69%, 2.3:1 dr (syn:anti). The major diastereomer was obtained as a light yellow oil.  1H 
NMR (500MHz, CDCl3) δ 8.32 (m, 4H), 7.32 (m, 3H), 7.25 (m, 2H), 5.73 (ddd, J = 17.5, 
9.0, 8.1 Hz, 1H), 5.53 (d, J = 17.0, 1H), 5.43 (d, J = 10.0 Hz, 1H), 4.99 (dd, J = 9.0, 6.0 
Hz, 1H), 4.65 (d, J = 11.0 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 4.21 (ddd, J = 8.0, 6.0, 2.0 
Hz, 1H), 4.00 (dd, J = 6.0, 1.5 Hz, 1H), 1.86 (m, 1H), 1.63 (m, 1H), 0.93 (t, J = 7.5 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 150.7, 149.6, 144.5, 136.6, 132.9, 131.1, 128.7, 
128.5, 128.2, 123.8, 121.7, 81.5, 75.0, 74.9, 64.4, 23.2, 9.8; IR (film, cm-1): 3110, 3072, 
3034, 2974, 2934, 2880, 1729, 1607, 1533; HRMS (ESI) m/z calc’d for C21H23N2O7S 
[M+H]+: 447.1226, found 447.1243; [α]D
27 = -10.8° (c = 1.0, CHCl3). 
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Synthesis of (+)-allosedridine 
 
 (+)-(S)-hex-5-en-2-yl 4-nitrophenylsulfonylcarbamate: In a flame dried 250mL flask 
was added (S)-(+)-5-Hexen-2-ol (99.2 mg, 0.99 mmol, >99% ee) and 
tetrahydrofuran (10 mL).  The flask was cooled to 0°C followed by the 
addition of p-nosylsulfonyl isocyanate (251.0 mg, 1.1 mmol).  The 
solution was stirred for 60 minutes and then quenched with saturated aqueous 
ammonium chloride (15 mL), extracted once with brine (15 mL) and dried over MgSO4.  
The crude mixture was concentrated in vacuo and purified by flash column 
chromatography (15% EtOAc/hexanes, 1% AcOH) yielding 302.3 mg (93%) of a light 
yellow oil.  1H NMR (500MHz, CDCl3) δ 8.40 (m, 2H), 8.25 (m, 2H), 7.68 (bs, 1H), 5.70 
(ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 4.94 (m, 2H), 4.82 (ap. sext., J = 6.0 Hz, 1H), 1.99 (ap 
q, J = 7.3 Hz, 2H), 1.66 (m, 1H), 1.56 (m, 1H), 1.20 (d, J = 6.5 Hz, 3H);  13C NMR (125 
MHz, CDCl3) δ 150.7, 149.5, 143.9, 136.8, 129.7, 124.0, 115.3, 75.1, 34.6, 29.2, 19.6; 
IR (film, cm-1): 3237 (br), 3115, 2982, 2937, 2873, 1748; HRMS (ESI) m/z calc’d for 
C13H16N2O6SNa [M+Na]
+: 351.0627, found 351.0642; [α]D
27 = +5.7° (c = 1.0, CHCl3). 
 
 (+)-(4S,6S)-6-methyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-one: (+)-(S)-
hex-5-en-2-yl 4-nitrophenylsulfonylcarbamate (98.5 mg, 0.30 mmol) 
was reacted according to general procedure B. Purification by flash 
column chromatography (1:1 hexanes:methylene chloride, gradient 1.0-
2.5% acetone) provided the mixture of anti- and syn- oxazinanone products. Run 1 
(76.4 mg, 0.23 mmol, 78% [4.1:1 dr]); run 2 (77.3 mg, 0.24 mmol, 79% [4.5:1 dr]).  
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Average Yield: 79%, 4.3:1 dr (syn:anti). Further purification by flash chromatography 
(10-25% gradient EtOAc/hexanes) provided 0.18 mmol of the syn-oxazinanone (61%). 
The major diastereomer was obtained as a light yellow oil. 1H NMR (500MHz, CDCl3) δ 
8.30 (m, 4H), 5.53 (ddd, J = 17.0, 9.5, 8.0 Hz, 1H), 5.36 (d, J = 17.0 Hz, 1H), 5.29 (d, J 
= 10.0 Hz, 1H), 4.95 (ap q, J = 8.7 Hz, 1H), 4.48 (m, 1H), 2.38 (ddd, J = 14.0, 8.0, 2.0 
Hz, 1H), 1.73 (dt, J = 14.5, 10.5, 1H), 1.38 (d, J = 6.0 Hz, 3H), 13C NMR (125 MHz, 
CDCl3) δ 150.6, 150.1, 144.4, 136.2, 131.1, 123.7, 119.9, 73.6, 59.4, 37.3, 20.0; IR (film, 
cm-1): 3110, 2985, 2936, 2875, 1732, 1533; HRMS (ESI) m/z calc’d for C13H15N2O6S 
[M+H]+: 327.0651, found 327.0651; [α]D
27 = +4.0° (c = 1.0, CHCl3).  
Racemic standard (±)-(4S,6S)-6-methyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-
oxazinan-2-was synthesized according to this procedure.  Chrial HPLC (Chiral 
Technologies Inc. Chiralpak AD-RH column (0.46 cm x 15 cm)) was used to determine 
the enantio-purity of (+)-22 which was determined to be >99% ee. This indicates that 
the allylic C—H amination proceeds with no erosion of ee.   
 
 (-)-(4S,6S)-6-methyl-4-vinyl-1,3-oxazinan-2-one: To a 10 mL flame dried flask was 
added (+)-(4S,6S)-6-methyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-
oxazinan-2-one (372.5 mg,  1.14 mmol), K2CO3 (472.6 mg, 3.42 mmol) 
and a Teflon stir bar.  The reaction flask was purged with argon 
followed by the addition of DMF (2.85 mL).  The mixture was cooled to 0°C then PhSH 
was added (140 µL, 1.37 mmol) dropwise slowly.  The reaction mixture was stirred for 
30 minutes then filtered over a silica plug followed by 150 mL of 10% MeOH/methylene 
chloride.  The crude mixture was concentrated in vacuo under high heat (50-60°C) to 
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remove the remaining DMF.  Purification by flash column chromatography (3% 
MeOH/methylene chloride) yielded 146.4 mg (91%) of a light yellow oil. 1H NMR 
(500MHz, CDCl3) δ 5.95 (bs, 1H), 5.71 (ddd, J = 17.0, 10.0, 7.0 Hz, 1H), 5.28 (d, J = 
17.0 Hz, 1H), 5.18 (d, J = 10.5 Hz, 1H), 4.40 (ap. dtd, J = 18.0, 6.3, 2.0 Hz, 1H), 3.98 
(ddd, J = 11.5, 7.0, 4.5 Hz, 1H), 2.00 (m, 1H), 1.51 (dt, J = 13.5, 11.5 Hz, 1H), 1.37 (d, J 
= 6.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 154.4, 137.3, 117.5, 73.3, 53.9, 35.5, 21.1; 
IR (film, cm-1): 3248 (br), 3115, 2980, 2931, 1704; HRMS (ESI) m/z calc’d for C7H12NO2 
[M+H]+: 142.0868, found 142.0864; [α]D
27 = -0.4 (c = 1.0, CHCl3). 
 
 (-)-(4S,6S)-3-(but-3-enyl)-6-methyl-4-vinyl-1,3-oxazinan-2-one:  To a 10 mL flask 
was added (4S,6S)-6-methyl-4-vinyl-1,3-oxazinan-2-one (102.6 
mg, 0.73 mmol).  Toluene (1mL) was then added to the flask and 
removed in vacuo three times.  A Teflon stir bar was then added 
followed by purging the flask with an argon balloon.  THF (1.5 mL) was added to the 
flask then cooled to -78°C.  n-BuLi (0.45mL, 1.6M in hexanes) was then added dropwise.  
The reaction was stirred for 30 minutes followed by the quick addition of but-3-enyl 
trifluoromethanesulfonate (178.1 mg, 0.87 mmol).  The reaction was stirred at -78°C for 
an additional 30 minutes then warmed to 0°C for 30 minutes.  The reaction was 
quenched with water, extracted with Et2O (3 x 25 mL) and the combined organic 
extracts were dried over MgSO4.  The crude mixture was concentrated in vacuo and 
purified by flash column chromatography (1.5% MeOH/methylene chloride) yielding 
126.3 mg (89%) of a light yellow oil. 1H NMR (500MHz, CDCl3) δ 5.74 (m, 1H), 5.59 (dt, 
J = 17.0, 9.5 Hz, 1H), 5.27 (d, J = 17.0 Hz, 1H), 5.22 (d, J = 10.0 Hz, 1H), 5.06 (dd, J = 
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17.0, 1.5 Hz, 1H), 5.02 (d, J = 10.0 Hz, 1H), 4.26 (ap. dtd, J = 17.5, 6.0, 2.0 Hz, 1H), 
3.93 (ap. dq, J = 9.0, 5.5 Hz, 1H), 3.76 (ddd, J = 14.0, 8.0, 6.5 Hz, 1H), 3.09 (ddd, J = 
14.0, 8.0, 6.0 Hz, 1H), 2.37 (m, 1H), 2.23 (m, 1H), 2.02 (ddd, J = 14.0, 5.8, 2.0 Hz, 1H), 
1.66 (dt, 14.0, 11.0 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
154.2, 138.1, 135.4, 118.6, 117.0, 71.5, 59.0, 44.7, 37.1, 32.0, 20.9; IR (film, cm-1): 
3078, 2978, 2934, 1699, 1641; HRMS (ESI) m/z calc’d for C11H18NO2 [M+H]
+: 196.1338, 
found 196.1341; [α]D
28 = -17.0° (c = 1.0, CHCl3). 
 
 (-)-(3S,4aR)-3-methylhexahydropyrido[1,2-c][1,3]oxazin-1(3H)-one: To a 50 mL 
sealed tube was added  (-)-(4S,6S)-3-(but-3-enyl)-6-methyl-4-vinyl-1,3-
oxazinan-2-one (126.5 mg, 0.65 mmol), Grubb’s (II) catalyst (44.0 mg, 
0.05 mmol), toluene (13.0 mL) and a Teflon stir bar. The reaction was 
heated to 65°C for 3 hours. The solution was then allowed to cool to room temperature 
then passed through a silica plug using 5% EtOAc:methylene chloride to remove the 
catalyst then 10% EtOAc:Methylene Chloride to remove the product.  The crude mixture 
was concentrated in vacuo and taken on to the next step without further purification. To 
a flame dried flask was added Pd-C (10% w/v, 99.0 mg), MeOH (6.5 mL) and a Teflon 
stir bar.  H2 gas was bubbled through the solution for 30 minutes followed by the 
addition of crude (3S,4aS)-3-methyl-4,4a,7,8-tetrahydropyrido[1,2-c][1,3]oxazin-1(3H)-
one.  The mixture was stirred until complete conversion was shown by TLC.  The 
mixture was filtered through a celite plug then concentrated in vacuo.  Purification by 
flash column chromatography (0.5% MeOH:methylene chloride) yielding 87.7 mg (80%) 
of a white solid. 1H NMR (500MHz, CDCl3) δ 4.46 (m, 1H), 4.27 (dqd, J = 12.5, 6.5, 2.0 
O N
O
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Hz, 1H), 3.27 (tdd, J = 11.5, 5.5, 2.5 Hz, 1H), 2.65 (td, J = 13.0, 3.0 Hz, 1H), 2.05 (ddd, 
J = 13.5, 5.8, 1.8 Hz, 1H), 1.81 (m, 2H), 1.69 (m, 1H), 1.56 (dt, J = 13.5, 11.5 Hz, 1H), 
1.45 (m, 1H), 1.37 (m, 1H), 1.32 (d, J = 6.0 Hz, 3H), 1.07 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 153.8, 71.4, 53.9, 44.6, 37.5, 33.5, 25.0, 23.6, 20.8; IR (film, cm
-1): 2976, 2935, 
2857, 1693, 1431; HRMS (ESI) m/z calc’d for C9H16NO2 [M+H]
+: 170.1181, found 
170.1181; [α]D
27 = -16.8 (c = 1.0, CHCl3). 
 
 (+)-allosedridine: (-)-(3S,4aR)-3-methylhexahydropyrido[1,2-c][1,3]oxazin-1(3H)-one 
(16.9 mg, 0.10 mmol) was added to a 10 mL sealed tube followed by 
KOH:EtOH solution (2.7 mL, 1.7M) and a Teflon stir bar.  The reaction 
was stirred in a 45°C oil bath for 2 hours.  The solution was then transferred to a 100 
mL flask and diluted with 20mL of methylene chloride.  The reaction mixture was dried 
over MgSO4 and concentrated under stream of N2.  The product was purified by 
sublimation yielding 10.5 mg (73%) of a white solid. [α]D
26 = +17.7 (c = 1.0, MeOH) 
[lit.10 [α]D
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 = +16.2 (c = 4.01, MeOH)]. 
1H NMR (500MHz, CDCl3) δ 6.1 (bs, 1H), 3.99 
(dtd, J = 16.5, 6.0, 2.0 Hz, 1H), 3.03 (ddd, J = 13.5, 7.0, 2.0 Hz, 1H), 2.70 (tt, J = 11.0, 
2.3 Hz, 1H), 2.58 (m, 1H), 1.83-1.79 (m, 1H), 1.64-1.57 (m, 2H), 1.55-1.45 (m, 2H), 
1.30-1.22 (m, 2H), 1.12 (d, J = 6.0 Hz, 3H), 1.11-1.03 (m, 1H). Spectral properties 
match reported values.28 
 
Expansion of Scope for 1,2-Amination System 
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General Procedure C for Allylic Amination Reaction:  In a one dram vial was added 
the corresponding carbamate starting material (1.00 equiv.), phenyl benzoquinone (1.05 
equiv.), 1,2-bis(phenylsulfinyl)ethane (0.05 equiv.), Pd(OAc)2/ 1,2-
bis(phenylsulfinyl)ethane catalyst 1 (0.10 equiv.) and a Teflon stir bar.  THF (0.66 M) 
was then added to the vial and sealed with a Teflon lined cap.  The reaction vial was 
then vortexed until the solution appeared homogeneous then added to a 45° C oil bath 
and stirred for 24 hours.  The solution was allowed to cool to room temperature and 
then transferred using dichloromethane to a 250 mL separatory funnel.  15 mL of 
saturated aqueous ammonium chloride was added to the separatory funnel.  The 
aqueous layer was rinsed 3x 15 mL dichloromethane. The organic layer was collected 
and dried over MgSO4, filtered and concentrated in vacuo. The crude reaction mixture 
was purified using flash column chromatography (1:1 hexanes:methylene chloride, 
gradient 1.0-2.5% acetone) providing the mixture of anti- and syn- oxazolidinone 
products. 
 
 
 (±)-(4R,5R)-5-isopropyl-3-(4-nitrophenylsulfonyl)-4-vinyloxazolidin-2-one: Racemic 
(±)-2-methylhex-5-en-3-yl 4-nitrophenylsulfonylcarbamate (102.7 mg, 
0.30 mmol), was reacted according to general procedure C.  The 
product was obtained as a white solid.  Run 1 (76.2 mg, 0.224 mmol, 
75% [5.0:1 dr]); run 2 (81.2 mg, 0.239 mmol, 80% [4.9:1 dr]).  Average 
Yield: 78%, 5.0:1 dr (anti:syn). 1H NMR (500MHz, CDCl3) δ 8.38 (m, 2H), 8.23 (m, 2H), 
5.74 (ddd, J = 17.0, 10.0, 8.5 Hz, 1H), 5.50 (d, J = 16.5 Hz, 1H), 5.42 (d, J = 10.0 Hz, 
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1H), 4.68 (dd, J = 9.0, 3.8 Hz, 1H), 3.99 (dd, J = 6.0, 3.8 Hz, 1H), 1.97 (oct., J = 7.0 Hz, 
1H), 0.98 (d, J = 7.0 Hz, 3H), 0.98 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
151.2, 151.0, 143.6, 133.9, 130.1, 124.3, 121.5, 85.2, 62.2, 32.1, 17.2, 16.7; IR (film, 
cm-1): 3109, 2968, 2937, 2879, 1782, 1533; HRMS (ESI) m/z calc’d for C14H17N2O6S 
[M+H]+: 341.0807, found 341.0797. 
 
 (±)-(4R,5R)-3-(4-nitrophenylsulfonyl)-5-propyl-4-vinyloxazolidin-2-one: Racemic 
(±)-hept-1-en-4-yl 4-nitrophenylsulfonylcarbamate (102.7 mg, 0.30 
mmol) was reacted according to general procedure C. Flash column 
chromatography providing an inseparable mixture of anti- and syn- 
oxazolidinone products as a white solid. Run 1 (78.6 mg, 0.231 mmol, 77% [1.7:1 dr]); 
run 2 (82.7 mg, 0.243 mmol, 81% [1.7:1 dr]).  Average Yield: 79%, 1.7:1 dr (anti:syn). 
Major anti-diastereomer:  1H NMR (500MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 8.26 (d, 
J = 8.5 Hz, 2H), 5.75 (ddd, J = 17.0, 10.0, 8.8 Hz, 1H), 5.50 (d, J = 17.0 Hz, 1H), 5.43 (d, 
J = 10.0 Hz, 1H), 4.53 (dd, J = 8.5, 4.0 Hz, 1H), 4.21 (dt, J = 7.5, 4.5 Hz, 1H), 1.72-1.39 
(m, 6H), 0.96 (t, J = 7.3 Hz, 3H); Minor syn-diastereomer: 1H NMR (500MHz, CDCl3) δ 
8.36 (m, 2H), 8.26 (m, 2H), 5.58 (m, 1H), 5.50 (m, 2H), 4.89 (dd, J = 8.5, 7.0 Hz, 1H), 
4.67 (m, 1H), 1.72-1.39 (m, 6H), 0.93 (t, J = 7.0 Hz, 3H); Carbon signals, IR 
wavenumbers and mass spectrometry signals for both anti- and syn- listed together: 13C 
NMR (125 MHz, CDCl3) δ 151.2, 151.1, 143.6, 143.5, 133.2, 130.4, 130.2, 129.3, 124.4, 
124.2, 123.6, 121.7, 80.7, 79.7, 64.9, 64.0, 35.8, 31.6, 18.7, 17.8, 13.7, 13.6; IR (film, 
cm-1): 3109, 2964, 2937, 2875, 1782, 1533; HRMS (ESI) m/z calc’d for C14H17N2O6S 
[M+H]+: 341.0807, found 341.0806. 
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  (±)-(4R,5R)-5-tert-butyl-3-(4-nitrophenylsulfonyl)-4-vinyloxazolidin-2-one: Racemic 
(±)-2,2-dimethylhex-5-en-3-yl 4-nitrophenylsulfonylcarbamate (106.9 mg, 
0.30 mmol) was reacted according to general procedure C for 72 h. The 
product was obtained as a white solid. Run 1 (20.3 mg, 0.057 mmol, 
19% [>20:1 dr]); run 2 (22.5 mg, 0.063 mmol, 21% [>20:1 dr]).  Average 
Yield: 20%, >20:1 dr (anti:syn). 1H NMR (500MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 
8.25 (d, J = 9.0 Hz, 2H), 5.75 (ddd, J = 17.0, 10.0, 8.5 Hz, 1H), 5.50 (d, J = 17.0 Hz, 1H), 
5.42 (d, J = 10.0 Hz, 1H), 4.75 (dd,  8.5, 3.3 Hz, 1H), 3.90 (d, J = 4.0 Hz, 1H), 0.96 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 151.3, 151.0, 143.7, 134.4, 130.1, 124.3, 121.2, 87.9, 
60.3, 35.1, 24.2; IR (film, cm-1): 3109, 2962, 2927, 2873, 2854, 1782, 1535; HRMS 
(ESI) m/z calc’d for C15H19N2O6S [M+H]
+: 355.0964, found 355.0954. 
 
 (±)-(4R,5R)-5-isopropyl-5-methyl-3-(4-nitrophenylsulfonyl)-4-vinyloxazolidin-2-
one: Racemic (±)-2,3-dimethylhex-5-en-3-yl 4-
nitrophenylsulfonylcarbamate (106.9 mg, 0.30mmol) was reacted 
according to general procedure C for 72 h. No products were observed 
by 1H NMR. 
 
 (±)-(4R,5R)-5-((E)-hept-2-enyl)-3-(4-nitrophenylsulfonyl)-4-vinyloxazolidin-2-one: 
Racemic (±)-(E)-undeca-1,6-dien-4-yl 4-
nitrophenylsulfonylcarbamate (119.0 mg, 0.30 mmol) was 
reacted according to general procedure C. The product was 
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obtained as a white solid.  Run 1 (78.1 mg, 0.198 mmol, 66% [5.4:1 dr]); run 2 (82.8 mg, 
0.210 mmol, 70% [5.3:1 dr]).  Average Yield: 68%, 5.4:1 dr (anti:syn). 1H NMR 
(500MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 8.23 (d, J = 9.0 Hz, 2H), 5.74 (ddd, J = 
17.0, 10.0, 8.5 Hz, 1H), 5.66 (dt, J = 15.0, 7.0 Hz, 1H), 5.46 (d, J = 17.5 Hz, 1H), 5.42 (d, 
J = 10.0 Hz, 1H), 5.30 (dt, J = 15.0, 7.0 Hz, 1H), 4.62 (dd, J = 8.3, 3.5 Hz, 1H), 4.24 (td, 
J = 6.0, 4.0 Hz, 1H), 2.43 (ap. t, J = 6.5 Hz, 2H), 2.01 (m, 2H), 1.31 (m, 4H), 0.89 (t, J = 
7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 151.1, 151.0, 143.6, 137.8, 133.2, 130.1, 
124.3, 121.6, 120.5, 80.1, 63.5, 36.7, 32.4, 31.3, 22.3, 14.0; IR (film, cm-1): 3109, 2958, 
2929, 2872, 2858, 1784, 1533; HRMS (ESI) m/z calc’d for C18H23N2O6S [M+H]
+: 
395.1277, found 395.1278. 
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Chapter 2 
Diversification of a β-Lactam Pharmacophore via Allylic C—H Amination 
 
2.1 INTRODUCTION 
The most prevalent means for generating diversity among a common molecular 
skeleton follows the modern synthetic planning paradigm that relies on the manipulation 
of “reactive” oxidized functionality. In medicinal chemistry, a molecule containing a 
pharmacophoric unit (i.e. structural feature in a molecule responsible for its biological 
activity) may be subjected to a series of orthogonal functionalizations of pre-existing 
reactive sites with the expectation of refining or improving biological activity and/or 
therapeutic profiles. The introduction of new functionality using ubiquitous and inert C—
H bonds presents an opportunity for a powerful new mode of accessing diversity. 
Methods are emerging that directly transform C—H bonds into C—O, C—N, or C—C 
bonds.1 Importantly, for these reactions to be applied to complex molecules with 
reactive pharmacophores, they must be mild and proceed with predictable and high 
selectivities.  We have developed methods using Pd(II)/bis-sulfoxide catalyst 1 that 
allow oxygen,2 nitrogen3 and carbon functionalities4 to be installed directly from allylic 
C—H bonds and demonstrated that these reactions can be strategically employed at 
late stages in complex molecule syntheses to streamline the route and improve overall 
yields.5  
Azetidin-2-ones (β-lactams) are powerful pharmacophores. Molecules containing 
this structural unit comprise an important class of clinically used antibiotics (e.g. 
penicillin, cephalophorin, imipenem) and have recently appeared in pharmaceutical 
agents for cholesterol absorption inhibition, thrombin inhibition, and prostate specific 
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antigen inhibition.6 β-lactams have also found increased use as synthons because 
stereocenters can be readily defined through asymmetric ketene-imine cycloadditions 
and the strained cyclic structure can be easily opened via acid and base catalyzed 
nucleophilic carbonyl openings.7 However, the high strain-energy associated with the 
four-membered azetidin-2-one ring makes derivatizations in the presence of this core 
challenging.8 
 
The prevalence of nitrogen functionality in biologically important small molecules, 
along with the extensive functional group manipulations (FGMs) commonly employed to 
install nitrogen, underscores the potential utility of direct C—H to C—N bond forming 
reactions for increasing product diversity. We anticipated that using allylic C—H 
amination reactions would provide a highly efficient means of introducing 
pharmacologically interesting nitrogen functionality (i.e. oxazolidinones, oxazinanones9) 
onto molecules containing sensitive β-lactam cores (Figure 4).    
 
2.2 RESULTS AND DISCUSSION 
2.2.1 Reaction Optimization 
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Allylic C—H amination reactions meet with significant chemoselectivity and 
reactivity challenges that must be overcome to effect catalysis. In palladium-mediated 
processes, direct addition of the nitrogen nucleophile to the olefin (aminopalladation) is 
often the dominant pathway.10 Traditional strategies for promoting functionalization 
employ the use of stoichiometric anionic nucleophiles and strong σ-donating ligands, 
and are incompatible with electrophilic Pd(II)-mediated C—H cleavage.  We reported 
that Pd(OAc)2/bis-sulfoxide catalyst 1 promoted intramolecular allylic C—H amination 
with weak carbamate nucleophiles to furnish oxazolidinone (1,2 C―H amination3b) and 
oxazinanone (1,3 C—H amination3e) structures in good yields and preparatively useful 
diastereoselectivities (Table 4). Critical to the success of this reaction is the bis-
sulfoxide ligand that diverts aminopalladation and promotes Pd-mediated heterolytic, 
allylic C—H cleavage to furnish π-allylPd intermediates. Intramolecular functionalization 
with the acidic carbamate pro-nucleophile is then promoted by the palladium 
carboxylate counterion acting as a base.3b Decreasing the electron density of the 
nitrogen promotes catalysis by increasing the equilibrium concentration of active anionic 
species without prohibitively decreasing its nucleophilicity.3e For example, switching 
from N-tosyl carbamates to N-(4-nitrophenylsulfonyl) carbamates  (N-nosyl carbamates) 
resulted in a significant decrease in the reaction time for furnishing oxazolidinones (72h 
 24h) and a dramatic improvement in yield for furnishing oxazinanones (15%  67%), 
(Table 4A, entries 1 and 2; Table 4B, entries 1 and 2).  
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 O NHSO2R
O Cat. 1 (10 mol%)
PhBQ (1.05 equiv.)
BisSO (5 mol%)
THF (0.66M), 45 oC
p-Tol
R Additive
(6 mol%)
Isolated Yieldb drc
none
Timea
72 h 76% 6:1
p-NO2Ph
p-NO2Ph
none
Cr(salen)Cl 31d
24 h 78% 5:1
O NHSO2R
O Cat. 1 (10 mol%)
PhBQ (1.05 equiv.)
BisSO (5 mol%)
THF (0.66M), 45 oC
O NSO2R
O
p-Tol
R Isolated Yieldb drc
none
Timea
72 h 6% 5:1
p-NO2Ph
p-NO2Ph
none
31
24 h
5 h
62%
77%
4:1
p-Tol
31
4:1
87%
80% 4:1
2.5 h 3:1
A. 1,2 C H Amination
B. 1,3 C H Amination
6 h
a All reactions were run to complete conversion. b Generally, average of two runs, see Supporting
Information (SI). c Determined by GC analysis (R = p-Tol) or 1H NMR analysis (R = p-NO2Ph) of
crude reaction mixture. d Cr(salen)Cl = (1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-
butylsalicylidene)]chromium(III) chloride. e Optimized conditions for 1,3-amination reaction: Cat. 1
(10 mol%), PhBQ (2 equiv.), BisSO (5 mol%), oxygenated DCE (0.66 M). f Conditions: Cat. 1 (10
mol%), 2,5-dimethylbenzoquinone (2 equiv.), BisSO (5 mol%), oxygenated DCE (0.66 M). g Yield
determined through 1H NMR analysis (81% remaining starting material).
NSO2RO
O
Entry
1
2
3
Entry
1
2
3
4
26a,b 27a,b
2a,c 3a,c
Additive
(6 mol%)
p-NO2Ph none 80%24 h 6:15
e
p-NO2Ph 31 89%1.5 h 4:16
e
7f p-NO2Ph 31 1.5 h 9%
g
---
Table 4. The Effect of Lewis Acid Additive [Cr(III)(salen)Cl] on Intramolecular
Allylic C H Aminations.
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In the context of intermolecular allylic C―H functionalization with N-tosyl 
carbamate nucleophiles we have demonstrated the use of a Lewis acid co-catalyst 
[Cr(III)(salen)Cl]3c 31 that acts with a π-acidic ligand (e.g. BQ) to activate electrophilic π-
allylPd intermediates towards nucleophilic attack. We hypothesized that Lewis acid 
activation may have a beneficial effect on intramolecular allylic C—H amination 
reactions by increasing the rate of functionalization. This may become particularly 
important for densely functionalized substrates where steric and/or electronic factors 
can inhibit functionalization.3b Consistent with this hypothesis, we found that the addition 
of catalytic amounts of [Cr(III)(salen)Cl] (6 mol%) appreciably improved the reaction 
times of both the 1,2- and 1,3- intramolecular allylic C—H amination reactions (Table 4). 
Significantly, for substrates containing the N-tosyl carbamate nucleophile, a dramatic 
positive impact was observed on both the reaction time (72h  5h) and yield (6%  
77%) of 6-membered ring product formation (Table 4B, entries 1 and 3). Substrates 
having an N-nosyl carbamate nucleophile showed an improvement in reaction times for 
both 5- and 6-membered ring formations (24h  6h, Table 4A, entries 2 and 3;  24h  
2.5h, Table 4B, entries 2 and 4, respectively), albeit with  a decrease in 
diastereoselectivity (5:1  4:1, Table 4A, entries 2 and 3; 4:1  3:1, Table 4B, entries 2 
and 4, respectively).  
 
2.2.2 β-Lactam Reactivity 
Importantly, the reactivity trends found for these simple hydrocarbon substrates 
were predictive for complex, β-lactam containing substrates. Homoallylic N-nosyl 
carbamate substrate 32 gave a modest 46% yield of oxazolidinone 33 even after 72h 
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(Table 5A, entry 1). This result is consistent with our previous observations that 
reactivity and selectivity for generating 5-membered oxazolidinones via allylic C—H 
amination is strongly impacted by steric bulk adjacent to the carbamate. Specifically, in 
the case of sterically congested substrates, the diastereoselectivity is high but the 
reactivity is low, even after incorporation of a more acidic N-nosyl carbamate group. 
Importantly, the inclusion of catalytic amounts of [Cr(III)(salen)Cl] (6 mol%) in this 
reaction resulted in a substantial increase in yield (46%  76%) and improvement in 
reaction time  (72h  24h) for furnishing the oxazolidinone 33 (Table 5A, entry 2). This 
reaction is highly diastereoselective, as the syn-oxazolidinone diastereomer could not 
be detected. Importantly, this result suggests that in some cases steric limitations for the 
allylic C—H amination reaction in forming 5-membered oxazolidinone products can be 
overcome through the inclusion of catalytic [Cr(III)(salen)Cl]. 
In contrast, we previously noted that reactivity and selectivity for generating 6-
membered oxazinanones via intramolecular allylic C—H amination was not strongly 
impacted by the steric bulk adjacent to the carbamate. Consistent with this, we found 
that β-lactam-containing bis-homoallylic N-nosyl carbamate substrate 34 furnished 
oxazinanone 35 in high yields (76%) and preparatively useful diastereoselectivities (6:1) 
(Table 5B, entry 1). Although the inclusion of [Cr(III)(salen)Cl] led to a 2-fold decrease in 
reaction times, this was accompanied by a significant decrease in diastereoselectivity 
(3:1 dr) making the rate acceleration not beneficial overall (Table 5B, entry 2).  This 
result suggests that while the addition of Lewis acid may be beneficial in increasing 
reactivity in oxazinanone formation (Table 4B, entry 3), the improved reaction times may 
be offset by a decrease in selectivity.  
72
 2.3 CONCLUSIONS 
The Pd(II)/bis-sulfoxide 1 catalyzed intramolecular allylic C—H amination 
reactions are shown to proceed with predictable and high selectivities for introducing 
pharmacologically interesting oxazolidinones and oxazinanones to substrates 
containing sensitive β-lactam functionality. This underscores the potential for using such 
allylic C—H functionalization reactions to rapidly introduce new functionality in any 
NTBS
O
BocHN
O
O
NHNs
NTBS
O
BocHN
O
O
NNs
(-)-32 (-)-33
Cat. 1 (10 mol%)
PhBQ (1.05 equiv.)
BisSO (5 mol%)
THF (0.66M), 45 oC
1
Entry Additive
(6 mol%)
Isolated Yield dra
-
Time
72 h 46% >20:1b
2 Cr(salen)Cl 31 24 h 76% >20:1b
NTBS
O
BocHN
O
O
NHNs
NTBS
O
BocHN
O
O
NNs
(+)-35
1
Entry Isolated Yield dra
-
Time
24 h 76% 6:1
2 Cr(salen)Cl 31 6 h 81% 3:1
(-)-34
Cat. 1 (10 mol%)
PhBQ (2 equiv.)
BisSO (5 mol%)
p-Nitrobenzoic acid (10 mol%)
DCE (0.66M), 45 oC
a Determined by 1H NMR analysis of crude reaction mixture. b Minor syn diastereomer not observed by
1H NMR analysis.
Additive
(6 mol%)
A.
B.
Table 5. Diversifying -Lactam Containing Molecules with Intramolecular Allylic
C H Aminations.
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molecule of biological interest that is amenable to appendage with an allyl unit. 
Additionally, we demonstrate for the first time that the Lewis acid additive 
[Cr(III)(salen)Cl] may act as a co-catalyst to promote intramolecular allylic C—H 
amination processes, presumably by increasing the rates of functionalization. This effect 
may be used to shorten lengthy reaction times and to overcome the steric limitations 
previously noted in furnishing 5-membered oxazolidinones. 
 
2.4 EXPERIMENTAL SECTION 
The following commercially obtained reagents for the allylic amination reaction 
were used as received: N,N-diisopropylethylamine (DIPEA, Aldrich), (+)-(R,R)-
Cr(salen)Cl 31 (Strem Chemicals), p-benzoquinone (Sigma-Aldrich), 2,5-
dimethylbenzoquinone (Acros Organics),  tert-butyl methyl ether (TBME, anhydrous) 
and 1,2-dichloroethane (DCE), (Sigma-Aldrich). Dry Solvents tetrahydrofuran (THF), 
methylene chloride (CH2Cl2), dimethylformamide (DMF) and diethyl ether (Et2O), were 
purified prior to use by passage through a bed of activated alumina (Glass Contour, 
Laguna Beach, California). Catalyst 1 was prepared according to the published 
procedure and stored in a glove box under an argon atmosphere at -20°C then weighed 
out in the air prior to use. All allylic amination reactions were run under oxygen or 
ambient air with no precautions taken to exclude moisture. All other reactions were run 
over a stream of nitrogen gas with dry solvent in flame-dried glassware unless 
otherwise stated. Solvents were removed by rotatory evaporation at ca. 40 torr, unless 
otherwise stated. Thin-layer chromatography (TLC) was conducted with E. Merck silica 
gel 60 F254 precoated plates (0.25 mm) and visualized with UV, potassium 
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permanganate, ceric ammonium molybdate, and ninhydrin staining. Flash column 
chromatography was performed by using ZEOprep 60 ECO 43-60 micron silica gel 
(American International Chemical, Inc.). 1H NMR spectra were recorded on a Varian 
Unity-400 (400 MHz), Varian Inova-500 (500 MHz), or Varian Unity-500 (500 MHz) 
spectrometer and are reported in ppm using solvent as an internal standard (CHCl3 at 
7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, 
m = multiplet, b =broad, ap  = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 13C NMR spectra were recorded on a Varian Unity-400 (100 MHz) or Varian 
Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an internal 
standard (CDCl3 at 77.16 ppm). Diastereoselectivity of the allylic amination reaction was 
determined by 1H NMR analysis of the crude reaction mixture unless otherwise noted. 
IR spectra were recorded as thin films on NaCl plates on a Mattson Galaxy Series FTIR 
5000 and are reported in frequency of absorption (cm-1). High-resolution mass spectra 
were obtained at the University of Illinois Mass Spectrometry Laboratory. Optical 
rotations were obtained using a JASCO DIP-360 digital polarimeter and a 3.5 x 50 mm 
cell and are reported as follows: [a]λ
T°C (c = g/100 mL, solvent). 
 
The effect of Lewis Acid additive [Cr(III)(salen)Cl] on intramolecular allylic C–H 
aminations.  
 
Table 4A Entry 1 and 2 and Table 4B Entry 5: See reference4e for experimental data 
and spectral information regarding compounds 28a, 28b, 29a, 29b, 30a, 30b, 31a, and 
31b. 
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 O NHSO2R
O Cat. 1 (10 mol%)
PhBQ (1.05 equiv.)
BisSO (5 mol%)
THF (0.66M), 45 oC
p-Tol
R Additive
(6 mol%)
Isolated Yieldb drc
none
Timea
72 h 76% 6:1
p-NO2Ph
p-NO2Ph
none
Cr(salen)Cl 31d
24 h 78% 5:1
O NHSO2R
O Cat. 1 (10 mol%)
PhBQ (1.05 equiv.)
BisSO (5 mol%)
THF (0.66M), 45 oC
O NSO2R
O
p-Tol
R Isolated Yieldb drc
none
Timea
72 h 6% 5:1
p-NO2Ph
p-NO2Ph
none
31
24 h
5 h
62%
77%
4:1
p-Tol
31
4:1
87%
80% 4:1
2.5 h 3:1
A. 1,2 C H Amination
B. 1,3 C H Amination
6 h
a All reactions were run to complete conversion. b Generally, average of two runs, see Supporting
Information (SI). c Determined by GC analysis (R = p-Tol) or 1H NMR analysis (R = p-NO2Ph) of
crude reaction mixture. d Cr(salen)Cl = (1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-
butylsalicylidene)]chromium(III) chloride. e Optimized conditions for 1,3-amination reaction: Cat. 1
(10 mol%), PhBQ (2 equiv.), BisSO (5 mol%), oxygenated DCE (0.66 M). f Conditions: Cat. 1 (10
mol%), 2,5-dimethylbenzoquinone (2 equiv.), BisSO (5 mol%), oxygenated DCE (0.66 M). g Yield
determined through 1H NMR analysis (81% remaining starting material).
NSO2RO
O
Entry
1
2
3
Entry
1
2
3
4
26a,b 27a,b
29a,c 29a,c
Additive
(6 mol%)
p-NO2Ph none 80%24 h 6:15
e
p-NO2Ph 31 89%1.5 h 4:16
e
7f p-NO2Ph 31 1.5 h 9%
g
---
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Table 4A Entry 3: A 1 dram vial (topped with a Teflon-lined cap) was charged with the 
2-methylhex-5-en-3-yl tosylcarbamate (102.6 mg, 0.30 mmol, 1.0 equiv.) and THF (0.45 
mL, 0.66 M). The following solids were all first weighed to wax paper then sequentially 
added to the vial: Pd(OAc)2/bis-sulfoxide catalyst 1 (15.1 mg, 0.03 mmol, 0.1 equiv.), 
1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.015 mmol, 0.05 equiv.), Cr(III)(salen)Cl (11.4 
mg, 0.018 mmol, 0.06 equiv.) and phenylbenzoquinone (58.0 mg, 0.32 mmol, 1.05 
equiv.). The reaction was finally charged with a stir bar, topped with a Teflon lined cap 
and allowed to stir at 45°C. After 6 h the reaction mixture was transferred to a 
separatory funnel and diluted with CH2Cl2 (25 mL). Saturated NH4Cl (5 mL) and brine (5 
mL) were added and the aqueous and organic layers were separated. The aqueous 
layer was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo. The diastereoselectivity was obtained 
by 1H NMR analysis of the crude reaction mixture. Purification by flash chromatography 
provided a mixture of syn- and anti-oxazolidinone products. Run 1 (82 mg, 0.24 mmol, 
80% yield [4.0:1 dr]); run 2 (81 mg, 0.24 mmol, 79% yield [4.0:1 dr]); Average yield: 
80%, 4.0:1 dr (anti:syn). 
 
Table 4B Entry 1: A 1 dram vial (topped with a Teflon-lined cap) was charged with 2-
methylhept-6-en-3-yl tosylcarbamate (97.5 mg, 0.3 mmol, 1.0 equiv.). The following 
solids were all first weighed to wax paper then sequentially added to the vial: 
phenylbenzoquinone (58.0 mg, 0.315 mmol, 1.05 equiv.), 1,2-bis(phenylsulfinyl)ethane 
(4.2 mg, 0.015 mmol, 0.05 equiv.), Pd(OAc)2/bis-sulfoxide catalyst 1 (15.1 mg, 0.03 
mmol, 0.1 equiv.), Teflon stir bar. THF (0.45 mL, 0.66 M) was added, the vial was 
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capped and placed in a 45°C oil bath and stirred for 72 hours. The reaction mixture was 
transferred to a separatory funnel and diluted with CH2Cl2 (25 mL). Saturated NH4Cl (15 
mL) and brine (15 mL) were added and the aqueous and organic layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo. A portion of the crude 
reaction mixture was analyzed by GC to obtain the crude diastereoselectivity. After 
analysis, this sample was added back to the total crude reaction mixture. Purification by 
flash chromatography (1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) 
provided a mixture of syn- and anti- 6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one (6 
mg, 0.02 mmol, 6% yield [5.0:1 dr]). 
 
Table 4B Entry 2: Following the procedure outlined in Table 4B, Entry 1, 2-
methylhept-6-en-3-yl (4-nitrophenyl)sulfonylcarbamate (106.8 mg, 0.30 mmol, 1.0 
equiv.) was used. After 24h the reaction was quenched. The diastereoselectivity was 
obtained by 1H NMR analysis of the crude reaction mixture. Purification by flash 
chromatography (1:1 hexanes:methylene chloride, gradient 1.0-2.5% acetone) provided 
a mixture of syn- and anti- 6-isopropyl-3-(4-nitrophenylsulfonyl)-4-vinyl-1,3-oxazinan-2-
one (66 mg, 0.19 mmol, 62% yield [4.1:1 dr]). 
 
Table 4B Entry 3: A 1 dram vial (topped with a Teflon-lined cap) was charged with 2-
methylhept-6-en-3-yl tosylcarbamate (97.5 mg, 0.3 mmol, 1.0 equiv.). The following 
solids were all first weighed to wax paper then sequentially added to the vial: phenyl 
benzoquinone (58.0 mg, 0.315 mmol, 1.05 equiv.), 1,2-bis(phenylsulfinyl)ethane (4.2 
78
mg, 0.015 mmol, 0.05 equiv.), Pd(OAc)2/bis-sulfoxide catalyst 1 (15.1 mg, 0.03 mmol, 
0.1 equiv.), Cr(III)(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv.), Teflon stir bar. THF 
(0.45 mL, 0.66 M) was added, the vial was capped and placed in a 45°C oil bath and 
stirred for 5 hours. The reaction mixture was transferred to a separatory funnel and 
diluted with CH2Cl2 (25 mL). Saturated NH4Cl (15 mL) and brine (15 mL) were added 
and the aqueous and organic layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 x 25 mL). The combined organic layers were dried over MgSO4, filtered, 
and concentrated in vacuo. A portion of the crude reaction mixture was analyzed by GC 
to obtain the crude diastereoselectivity. After analysis, this sample was added back to 
the total crude reaction mixture. Purification by flash chromatography provided a mixture 
of syn- and anti- 6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one. Run 1: (78 mg, 0.24 
mmol, 80% yield [4.3:1 dr]); Run 2: (72 mg, 0.22 mmol, 74% yield [4.0:1 dr]). Average: 
77% yield, 4.2:1 dr (syn:anti). 
 
Table 4B Entry 4: Following the procedure outlined in Table 4B, Entry 3, 2-
methylhept-6-en-3-yl (4-nitrophenyl)sulfonylcarbamate (106.8 mg, 0.30 mmol, 1.0 
equiv.) was used. After 2.5 h the reaction was quenched. The diastereoselectivity was 
obtained by 1H NMR analysis of the crude reaction mixture. Run 1 (92 mg, 0.26 mmol, 
87% yield [2.9:1 dr]); Run 2: (92 mg, 0.26 mmol, 87% yield [2.8:1 dr]). Average: 87% 
yield, 2.9:1 dr (syn:anti). 
 
Table 4B Entry 6: In a one dram vial was added 2-methylhept-6-en-3-yl (4-
nitrophenyl)sulfonylcarbamate starting material (106.8 mg, 0.30 mmol, 1.0 equiv.), 
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Cr(III)(salen)Cl (11.4 mg, 0.018 mmol, 0.06 equiv.), phenylbenzoquinone (110.5 mg, 0.6 
mmol, 2 equiv.), p-nitrobenzoic acid (5.1 mg, 0.03 mmol, 0.10 equiv.), 1,2-
bis(phenylsulfinyl)ethane (4.2 mg, 0.015 mmol, 0.05 equiv.), Pd(OAc)2/ 1,2-
bis(phenylsulfinyl)ethane catalyst 1 (15.1 mg, 0.03 mmol, 0.10 equiv.) and a Teflon stir 
bar. In a separate flask, O2 gas was simultaneously bubbled through 1,2-dichloroethane 
for thirty minutes. The oxygenated 1,2-dichloroethane (0.66 M) was then added to the 
previous one dram vial, O2 gas was blown over the vial for 5 seconds, and the vial was 
sealed with a Teflon lined cap. The reaction vial was stirred in a 45° C oil bath for 1.5 
hours. The solution was allowed to cool to room temperature and then transferred using 
dichloromethane (30 mL) to a 60 mL separatory funnel. The organic solution was 
washed with sat. aq. NH4Cl solution (25 mL) and brine (30 mL). The organic solution 
was dried over MgSO4, filtered and concentrated in vacuo. The crude reaction mixture 
was checked by 1H NMR to determine the dr and then purified using flash column 
chromatography. Run 1 (92 mg, 0.26 mmol, 87% [4.2:1 dr]); run 2 (97 mg, 0.27 mmol, 
91% [4.4:1 dr (syn:anti)]). Average Yield: 89%, 4.3:1 dr (syn:anti). 
 
Table 4B Entry 7:  Following the procedure outlined in Table 4B, Entry 6, 2-
methylhept-6-en-3-yl (4-nitrophenyl)sulfonylcarbamate (35.6 mg, 0.10 mmol, 1.0 equiv.) 
and 2,5-Dimethylbenzoquinone (27.2 mg, 0.20 mmol, 2.0 equiv.) was used.  The yield 
and remaining starting material were determined through 1H NMR analysis using 
nitrobenzene (0.04 mmol) as an internal standard.  Run 1 (7% Yield syn [anti product 
not observed by 1H NMR due to low levels of product formation], 82% remaining starting 
material); run 2 (10% Yield syn [anti product not observed by 1H NMR due to low levels 
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of product formation], 80% remaining starting material).  Average Yield: 8.5%; 
Average Remaining Starting Material: 81%. 
 
β-Lactam Reactivity 
 
 (-)-tert-Butyl-((2R,3R)-1-(tert-butyldimethylsilyl)-2-((R)-1-((((4-
nitrophenyl)sulfonyl)carbamoyl)oxy)but-3-en-1-yl)-4-
oxoazetidin-3-yl)carbamate (-)-32: A flame dried 250 mL 
round bottom flask was charged sequentially with a stir bar, 
the homoallylic alcohol mixture of two diastereomers 
starting material (320 mg, 0.86 mmol, 1 equiv.) and tetrahydrofuran (1 mL). The flask 
was cooled to 0°C followed by the rapid addition of solid p-nitrobenzenesulfonyl 
isocyanate (NsNCO [for procedure of NsNCO synthesis see below], 217 mg, 0.95 mmol, 
1.1 equiv.). The solution was stirred for 30 minutes and then quenched by diluting with 
saturated ammonium chloride. The organic layer was washed once with brine then dried 
over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography 
(15%-40% EtOAc/hexanes, 1% AcOH) provided the two diastereomers (468 mg, 91% 
total yield). Further purification by flash chromatography (10%-30% gradient 
EtOAc/hexanes, 0.5% AcOH) provided one pure diastereomer, tert-butyl ((2R,3R)-1-
(tert-butyldimethylsilyl)-2-((R)-1-((((4-nitrophenyl)sulfonyl) carbamoyl)oxy)but-3-en-1-yl)-
4-oxoazetidin-3-yl)carbamate 8 as white solid (210 mg, 0.38 mmol, 44% yield). 1H NMR 
(500 MHz, CD3OD) 8.43 (2H, d, J = 9.0 Hz, Ns), 8.22 (2H, d, J = 9.0 Hz, Ns), 7.81 (1H, 
d, J = 9.0 Hz, BocNHCH), 5.59 (1H, m, CH=CH2), 5.02-4.99 (1H, m, BocNHCH), 4.95-
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4.88 (2H, m, CH=CH2), 4.74 (1H, bd, J = 10.0 Hz, CH2=CHCH2CHOCONHNs), 3.86 (1H, 
dd, J = 10.0, 5.8 Hz, NTBSCH), 2.27 (1H, bd, J = 13.5 Hz, CH2=CHCH2CHOCONHNs), 
2.09 (1H, p, J = 7.6,  Hz CH2=CHCH2CHOCONHNs), 1.41 (9H, s, Boc), 0.85 (9H, s, 
TBS), 0.17 (3H, s, TBS), 0.15 (3H, s, TBS); 13C NMR (125 MHz, CDCl3) 173.9, 155.3, 
150.7, 150.1, 144.0, 131.8, 129.8, 124.2, 119.1, 81.0, 75.8, 59.4, 57.6, 36.0, 28.2, 26.3, 
18.8, -5.0, -5.2; IR (film, cm-1):3500–3300 (br), 3109, 3084, 2958, 2931, 2860, 1751, 
1728, 1535, 1456, 1367, 1350, 1253, 1223, 1161, 1090, 1061, 1014, 899, 843, 825, 737, 
607; HRMS (ESI) m/z calc’d for C25H39N4O9SiS [M+H]
+: 599.2207, found 599.2212; 
[a]D
25-40.0 (c 1.0, CHCl3). 
The syn/anti configuration of Cx and Cy in this diastereomer 32 can be 
determined by comparison of their 1H NMR data with that reported in the literature for 
related compounds.11 In this way, the vicinal coupling constant between Hx and Hy is 
larger for syn-isomers (5.3-7.8 Hz) than for anti-isomers (2.4-5.9 Hz). For substrate 32, 
3JHxHy of the syn-isomers 32 is 6.0 Hz, which is assigned to be the syn-isomers. The 
anti-isomer 32 showed a 3JHxHy of 0.0 Hz (see spectrum).  More detailed discussion 
about the configuration assignments for β-lactams can be found in the literature.12 
 
 (-)-tert-Butyl-((2R,3R)-1-(tert-butyldimethylsilyl)-2-((R)-1-((((4-
nitrophenyl)sulfonyl)carbamoyl)oxy)pent-4-en-1-yl)-4-
oxoazetidin-3-yl)carbamate (-)-34: A flame dried 250mL 
round bottom flask was charged sequentially with a stir bar, 
the homoallylic alcohol, tert-butyl ((2R,3R)-1-(tert-
butyldimethylsilyl)-2-((R)-1-hydroxypent-4-en-1-yl)-4-oxoazetidin-3-yl)carbamate (192 
NTBS
O
BocHN
O NHNs
O
x
y
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mg, 0.5 mmol, 1 equiv.) and tetrahydrofuran ( 3 mL). The flask was taken to 0°C 
followed by the rapid addition of solid p-nitrobenzenesulfonyl isocyanate (NsNCO, 125 
mg, 0.55 mmol, 1.1 equiv.). The solution was stirred for 30 minutes and then quenched 
by diluting with saturated ammonium chloride. The organic layer was washed once with 
brine then dried over MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography (15%-40% EtOAc/hexanes, 1% AcOH) provided two diastereomers of 
bishomoallylic N-nosyl carbamates 34. (270 mg, white solid, 88% total yield). Further 
purification by flash chromatography (10-30% gradient EtOAc/hexanes/0.5% AcOH) 
provided one pure diastereomer, tert-butyl-((2R,3R)-1-(tert-butyldimethylsilyl)-2-((R)-1-
((((4-nitrophenyl)sulfonyl)carbamoyl)oxy)pent-4-en-1-yl)-4-oxoazetidin-3-yl)carbamate (-
)-34 as white solid (236 mg, 77% yield). 1H NMR (500 MHz, CD3OD) 8.45 (2H, d, J = 
9.0 Hz, Ns), 8.25 (2H, d, J = 9.0 Hz, Ns), 6.82 (1H, d, J = 10.5 Hz, BocNHCH), 5.70-
5.62 (1H, m, CH=CH2), 5.20 (1H, dd, J = 10.0, 5.5 Hz, BocNHCH), 5.14 (1H, ap t, J = 
6.5 Hz, CHOCO), 4.91-4.89 (2H, m, CH=CH2), 3.96 (1H, dd, J = 5.5, 1.5 Hz, NTBSCH), 
1.98-1.88 (2H, m, CH2=CHCH2CH2), 1.62 (2H, ap q, J = 7.5 Hz, CH2=CHCH2CH2), 1.48 
(9H, s, Boc), 0.84 (9H, s, TBS), 0.13 (3H, s, TBS), -0.07 (3H, s, TBS); 13C NMR (125 
MHz, d4-MeOH) 175.8, 157.0, 152.3, 152.0, 146.0, 138.0, 130.8, 125.5, 116.1, 81.5, 
76.0, 59.9, 59.8, 30.8, 30.6, 28.7, 26.7, 20.0, -5.5, -6.2; IR (film, cm-1): 3500–3200 (br), 
2958, 2931, 2883, 2858, 1757, 1714, 1535, 1456, 1394, 1352, 1311, 1280, 1253, 1224, 
1165, 1090, 1060, 1029, 1012, 920, 843, 825, 789, 768, 739, 683, 609, 565; HRMS 
(ESI) m/z calc’d for HRMS (ESI) m/z calc’d for C26H40N4O9SSi [M+H]
+: 613.2364, found 
613.2385. [a]D
27-12.8 (c 1.0, MeOH). 
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Configuration of the diastereomer was confirmed by the 1H NMR data of coupling 
constant of 3JHxHy, the vicinal coupling constant between Hx and Hy is larger for syn-
isomers than for anti-isomers. For substrate 34, 3JHxHy of anti-isomer 34 is 1.5 Hz, but 
3JHxHy of syn-isomers 34 is 5.5 Hz. (see spectrum).
14 
 
 (-)-tert-Butyl-((2R,3R)-1-(tert-butyldimethylsilyl)-2-((4S,5S)-3-((4-
nitrophenyl)sulfonyl)-2-oxo-4-vinyloxazolidin-5-yl)-4-
oxoazetidin-3-yl)carbamate (-)-33: A half dram vial (topped 
with a Teflon-lined cap) was charged with the homoallylic N-
nosylcarbamate substrate (-)-32 (0.10 mmol, 59.8 mg, 1.0 
equiv.) and THF (0.15 mL, 0.66 M). The following solids were all first weighed to wax 
paper then sequentially added to the vial: Pd(OAc)2/bis-sulfoxide catalyst 1 (5.02 mg, 
0.01 mmol, 0.1 equiv.),1,2-bis(phenylsulfinyl)ethane (1.4 mg, 0.005 mmol, 0.05 equiv.), 
phenylbenzoquinone (19.3 mg, 0.105 mmol, 1.05 equiv.) and Cr(III)(salen)Cl (3.8 mg, 
0.006 mmol, 0.06 equiv.).The reaction was finally charged with a stir bar and allowed to 
stir at 45°C°C. After 72h the reaction mixture was transferred to a separatory funnel and 
diluted with ether (25 mL). K2CO3 (5%) was added and the organic solution was washed 
by K2CO3 (5%) 3 times. The aqueous and organic layers were separated. The aqueous 
layer was extracted with ether (3 x 25 mL). The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo. The diastereoselectivity was obtained 
by 1H NMR analysis of the crude reaction mixture. The crude reaction mixture was 
purified using flash column chromatography to provide a white solid. Run 1 (45 mg, 
0.076 mmol, 76% [>20:1 dr]); run 2 (45 mg, 0.076 mmol, 76% [>20:1 dr]). Average 
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Yield: 76%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDC13) 8.39 (2H, d, J = 9.0 Hz, 
Ns), 8.25 (2H, d, J = 8.5 Hz, Ns), 5.73-5.66 (1H, m, CH=CH2), 5.50 (1H, d, J = 17.0 Hz, 
CH=CH2), 5.44 (1H, d, J = 10.0 Hz, CH=CH2), 5.08-5.11 (2H, m, BocNHCH and 
BocNHCH), 4.77 (1H, br. d, J = 8.0 Hz, OCHCHNNs), 4.28 (1H, d, J = 9.5 Hz, 
OCHCHNNs), 3.81-3.78 (1H, m, TBSNCH), 1.45 (9H, s, Boc), 0.93 (9H, s, TBS), 0.24 
(3H, s, TBS), 0.23 (3H, s, TBS); 13C NMR (125 MHz, CDCl3) 171.8, 155.4, 151.1, 150.3, 
143.3, 131.6, 130.3, 124.4, 122.1, 81.7, 81.6, 61.5, 59.8, 57.9, 28.4, 26.5, 18.7, -5.2, -
5.4; IR (film, cm-1): 2962, 2931, 2899, 2860, 1792, 1759, 1743, 1716, 1535, 1383, 1367, 
1350, 1254, 1182, 1120, 1061, 1012, 845, 825, 739, 683, 617; HRMS (ESI) m/z calc’d 
for C25H37N4O9SiS [M+H]
+: 597.2051, found 597.2056;[a]D
20-24.8 (c 0.5, CHCl3). 
The same reaction was set up without Cr(III)(salen)Cl providing the same product 
with full conversion. (Run 1 (25 mg, 0.042 mmol, 42% [>20:1 dr]); run 2 (30 mg, 0.050 
mmol, 50% [>20:1 dr]). Average Yield: 46%, >20:1 dr (anti:syn). 
 
 (+)-tert-Butyl-((2R,3R)-1-(tert-butyldimethylsilyl)-2-((4S,6R)-3-((4-
nitrophenyl)sulfonyl)-2-oxo-4-vinyl-1,3-oxazinan-6-yl)-
4-oxoazetidin- 3-yl)carbamate (+)-35: In a one dram vial 
was added the tert-butyl ((2R,3R)-1-(tert butyldimethylsilyl)-
2-((R)-1-((((4-nitrophenyl)sulfonyl)carbamoyl)oxy)pent-4-
en-1-yl)-4-oxoazetidin-3-yl)carbamate starting material (-)-34 (61 mg, 0.1 mmol, 1 
equiv.), phenyl benzoquinone (37 mg, 0.2 mmol, 2 equiv.), p-nitrobenzoic acid (1.7 mg, 
0.01 mmol, 0.10 equiv.), 1,2-bis(phenylsulfinyl)ethane (1.4 mg, 0.005 mmol, 0.05 equiv.), 
NTBS
O
BocHN
O NNs
O
x
y
z
c
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Pd(OAc)2/ 1,2-bis(phenylsulfinyl)ethane catalyst 1 (5.02 mg, 0.001 mmol, 0.10 equiv.) 
and a Teflon stir bar. In a separate flask, O2 gas was simultaneously bubbled through 
1,2-dichloroethane for thirty minutes. The oxygenated 1,2-dichloroethane (0.66 M) was 
then added to the previous one dram vial, O2 gas was blown over the vial for 5 seconds, 
and the vial was sealed with a Teflon lined cap. The reaction vial was stirred in a 45° C 
oil bath for 24 hours. The solution was allowed to cool to room temperature and then 
transferred using dichloromethane (30 mL) to a 60 mL separatory funnel. The organic 
solution was washed with sat. aq. NH4Cl solution (25 mL) and brine (30 mL). The 
organic solution was dried over MgSO4, filtered and concentrated in vacuo. The crude 
reaction mixture was checked by 1H NMR to determine the dr and then purified using 
flash column chromatography. Run 1 (43 mg, 0.071 mmol, 71% [5.7:1 dr (syn:anti), 
relative to Hy and Hc]); run 2 (49 mg, 0.081 mmol, 81% [5.9:1 dr (syn:anti)]). Average 
Yield: 76%, 5.8:1 dr (syn:anti). The major syn-diastereisomer can be isolated by flash 
chromatography (15-50% gradient EtOAc/hexanes) directly from the crude reaction 
mixture. White solid, 1H NMR (500 MHz, CDC13) 8.36 (2H, d, J = 9.0 Hz, Ns), 8.29 (2H, 
d, J = 9.0 Hz, Ns), 5.51-5.44 (1H, m, CH=CH2), 5.36 (1H, d, J = 17.0 Hz, CH=CH2), 
5.30-5.25 (2H, m, CH=CH2 and BocNHCH), 5.11 (1H, d, J = 9.0 Hz, BocNHCH), 5.06 
(1H, ap q, J = 8.5 Hz, CH2=CHCHNNs), 4.55 (1H, ap dt, J = 12.0, 2.0, 
TBSNCHCHOCONNs), 3.85 (1H, dd, J = 5.5, 2.0 Hz, TBSNCH), 2.43-2.39 (1H, m, 
CH2CHCH=CH2), 1.91 (1H, ddd, J = 14.0, 12.0, 8.5 Hz, CH2CHCH=CH2), 1.40 (9H, s, 
Boc), 0.94 (9H, s, TBS), 0.27 (3H, s, TBS), 0.23 (3H, s, TBS); 13C NMR (125 MHz, 
CDCl3) 171.7, 154.9, 150.9, 149.7, 143.9, 136.0, 131.3, 123.9, 120.0, 81.1, 75.9, 59.7, 
58.7, 56.6, 31.9, 28.4, 26.1, 18.7, -5.0, -5.3; IR (film, cm-1):2960, 2931, 2891, 2860, 
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1749, 1716, 1533, 1510, 1473, 1392, 1367, 1352, 1254, 1178, 842, 825, 742, 611; 
HRMS (ESI) m/z calc’d for C26H38N4O9SiSNa [M+Na]
+: 633.2026, found 
633.2015;[a]D
265.4 (c 0.25, CHCl3). 
The stereochemistry of the syn- and anti-diastereomers of oxazinanone was 
determined through their vicinal coupling constants (3JHzHc). In general, syn-
oxazinanones show a coupling constant between CzHa and CzHb with CcH within 7.5-8.0 
Hz and 9.5-10.5 Hz, and the anti-oxazinanones show a coupling constant within 2.5-3.5 
Hz and 4.5-5.5 Hz respectively. The title oxazinanone (+)-35 showed the coupling 
constant is 8.5 Hz, which is assigned to be the syn-diastereomer. Reference4e provides 
a more detailed description of the relative data.  
The same reaction was set up with Cr(III)(salen)Cl (3.8 mg, 0.006 mmol, 0.06 
equiv.) as the only additive providing the same product with full conversion in 6 hours. 
Run 1 (49 mg, 0.081 mmol, 81% [2.9:1 dr (syn:anti), relative to Hy and Hc]); run 2 (49 
mg, 0.081 mmol, 81% [3.3:1 dr (syn:anti)]). Average Yield: 81%, 3.1:1 dr (syn:anti).  
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Chapter 3 
Catalyst Controlled, Stereodivergent Amination of Terminal Olefins for 
Preparation of syn- or anti-1,2-Diamines. 
 
 
3.1 INTRODUCTION 
 
Vicinal diamines represent an important structural sub-class of nitrogen containing 
molecules with many applications in medicine and catalysis.1 A variety of C—H 
oxidation reactions have been developed allowing for the streamlined access of 
pharmacologically important motifs.  In place of reactive oxygen and nitrogen 
functionality, C—H oxidation reactions enable  inert C—H bonds to be carried through 
synthetic sequences and strategically transformed into the desired oxidized functionality 
at late stages improving overall synthetic efficiency.2 While C—H amination methods 
have provided efficient access to many structural units prevalent in biologically active 
motifs, reactions for vicinal diamines have met with limited success.3 Numerous 
palladium-catalyzed aminopalladation methods of E-olefins4 and dienes5 furnish anti-
1,2-diamines; however, allylic C—H amination methods that use readily available 
terminal olefins and may provide an alternate stereo-outcome, are not known. 
 A challenge in allylic C—H aminations with urea nucleophiles is effecting the 
desired functionalization. Typically, basic conditions are required for amino-
functionalization of urea nucleophiles. Unfortunately, within the construct of a process 
involving a highly electrophilic catalyst, increasingly basic conditions may  lead to metal 
deactivation either inhibiting electrophilic C—H cleavage and/or isomerization of the 
products to the thermodynamically favored anti diastereomer.6 We envisioned a novel 
approach for doing this in which an azaphilic Lewis acid co-catalyst7 activates the 
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nucleophile by binding to a nitrogen of the urea tether and promoting deprotonation with 
the proximal π-allylPd acetate counterion under neutral conditions (Figure 5).   
 
 In support of this proposal, we recognized that isomerizations of terminal olefins 
catalyzed by Pd(II)-salts8 are well documented. Furthermore, the addition of Lewis acid 
additives9 has been shown to promote these processes.  However, our group has 
shown that the bis-sulfoxide ligand used for the promotion of C―H oxidations retards 
olefin isomerization.10 We recognized that the exclusion of the bis-sulfoxide ligand may 
allow access to an oxidative amination type pathway (amino-palladation/β-hydride 
elimination).  We hypothesized that the difference in mechanism for these two pathways 
would allow access to different diastereomeric products from common starting materials 
(Figure 5).   
 
3.2  RESULTS AND DISCUSSION 
3.2.1 Method Development 
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We began our study by subjecting N-nosyl urea 36 to our Pd(II)/sulfoxide 
catalysis and we were met with poor yields and diastereoselectivities for the formation 
of imidazolidinone 37 (Table 6, entry 1).  The large discrepancy between substrate 
conversion (100%) and yield of 37 (33%) led us to conclude that functionalization was 
not rapid enough to compete with π-allylPd polymerization pathways. The inclusion of 
an oxophilic Lewis acid co-catalyst [Cr(salen)Cl], previously shown to activate 
intermediate π-allylPd(BQ) electrophiles towards functionalizations with nitrogen 
nucleophiles, led to diminished yields (entry 2).11 The inclusion of a Bronsted base co-
catalyst (DIPEA) did not improve yields and resulted in strong preference for the anti-
diastereomer (entry 3). Consistent with our design plans, we found that catalytic 
amounts of B(C6F5)312 (entry 4) or silver triflate13 (entry 5), previously shown to have 
azaphilic properties with amides, increased the desired yield of 37 to 55% and 61%, 
respectively. Additionally, both exhibited an increase in the overall diastereoselectivity 
favoring the formation of the desired syn-imidazolidinone 37A (5:1 dr and 8:1 d.r., 
respectively). We found that by switching solvent from THF to DCM for the silver triflate 
promoted process the yield and diastereoselectivity were both improved to synthetically 
useful levels (entry 6, 76% yield, 11:1 syn:anti).  To the best of our knowledge, this 
represents the first syn- selective amination reaction for generating diamines. 
Upon removal of the bis-sulfoxide ligand by replacing catalyst 1 with Pd(OAc)2 
we were delighted to observe the exclusive formation of anti-imidazolidinone 37B (>20:1 
anti:syn) in synthetically useful yields using either silver triflate (entry 9, 59% yield) or 
B(C6F5)3 (entry 10, 61% yield). The omission of these Lewis acid co-catalysts resulted in 
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lower product formation (32% yield) due to competitive direct aminopalladation of the 
terminal olefin (entry 11). Additionally, omission of the palladium catalyst resulted in no 
reactivity of the terminal olefin starting material in both the syn- and anti- systems 
i-Pr
HN
S S
O O
Ph Ph
Pd(OAc)2
BQ or MeBQ
45 C
i-Pr
L.A.
co-catalyst
(8 - 10 mol%)
isolated
yield (%)c
d.r.
(syn:anti)d
none
Cr(salen)Cl
DIPEA
B(C6F6)3
AgOTf
AgOTf
AgOTf
AgOTf
AgOTf
B(C6F6)3
none
B(C6F6)3
33%e
16%f
32%e
55%e
62%
76%
0%
46%e
59%
61%
32%
0%
1:1.6
1:1.1
1:>20
5:1
8:1
11:1
-
1:>20
1:>20
1:>20
1:>20
-
NHNs
O
NNsHN
O
Pd
catalyst
(10 mol%)
cat. 1
1
1
1
1
1
1
none
Pd(OAc)2
Pd(OAc)2
Pd(OAc)2
Pd(OAc)2
none
syn - 37A
i-Pr
NNsHN
O
anti - 38B
a All reactions were run using THF (1.0M) as solvent, MeBQ (methyl-p-benzoquinone, 1.5
equiv.) as terminal oxidant and 8 mol% L.A. co-catalyst for 6 hours unless otherwise noted. b
Reactions with cat. 1 were run with an additional 5 mol% BisSO ligand [1,2-
bis(phenylsulfinyl)ethane]. c Average of 2 runs at 0.3 mmol. d Determined by 1H NMR
analysis of the crude reaction mixture. e Reactions run to complete conversion: entry 1, 24h;
entry 3, 18h; entry 4, 2h; entry 8, 72h. f Reaction stopped before complete conversion at 2h.
Increased reaction times resulted in product decomposition. g DCM (dichloromethane, 1.0M).
h >99% rsm, 0% E-internal olefin, 0% syn-37A. i Reaction run using THF (1.66M) as solvent,
BQ (p-benzoquinone, 1.05 equiv.) as terminal oxidant and 10 mol% L.A. co-catalyst for 72
hours. j >99% rsm, 0% E-internal olefin, 0% anti-37B.
entrya,b
1
2
3
4
5
6g
7g,h
8
9i
10i
11i
12i,j
36
Table 6. Reaction Development to form Vicinal Diamine Motifs
Pd cat. (10 mol%)/
L.A. cat. (8-10 mol%)
Pd(OAc)2
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(entries 7 and 12). Collectively, these two processes represent the first stereodivergent 
olefin amination reactions. 
As outlined in Tables 7 and 8, we have found that a range of N-nosyl urea olefin 
substrates can be effectively aminated using these heterobimetallic catalytic systems to 
furnish either syn- or anti-imidazolidinones in good yields and selectivities. Substrates 
containing moderate to high levels of steric bulk adjacent to the urea tether (R = 
NNsHN
tBu
O
( )-38
81% yield
>20:1 dr
NNsHN
O
OTBS
( )-41
79% yielda
>20:1 dr
NNsHN
O
OTBS
( )-42
64% yielda
14:1 dr
R
HN NHNs
O
AgOTf (8 mol%)
MeBQ (1.5 equiv.)
DCM (1.0M), 45 C, 6h
a Reaction run at 40 C with a 0.12:1 DMA:DCM solvent mixture.
NNsHN
R
O
NNsHN
O
OBnBnO
( )-40
68% yielda
19:1 dr
NNsHN
O
Me
( )-39
82% yield
>20:1 dr
NNsHN
O
Me
F
( )-43
72% yielda
13:1 dr
1
S S
OO
Ph Ph
75% average isolated yield
11:1 to 20:1 syn:anti
Table 7. PdII/bis-sulfoxide/Ag catalyzed syn- allylic C H amination reaction
H
Pd(OAc)2 (10 mol%)
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isopropyl, t-Bu) furnished aminated products in high yields and diastereoselectivities 
with both systems (37A, 37B, 38, 44).  syn-and anti-Imidazolidinones (39 and 45), 
derived from a common tertiary amine, can also be accessed in excellent yields and 
selectivities (82%, >20:1 d.r.; 76%, >20:1 d.r., respectively). These represent a class of 
sterically challenging vicinal diamine products that are difficult to access otherwise in 
optically enriched form. Substrates containing proximal benzylated diols capable of 
catalyst deactivation via metal chelation are also tolerated under both reaction 
manifolds ((-)-40, (-)-46, (-)-47). Significantly, in substrates such as these that contain 
multiple stereogenic centers, the diastereomeric outcome of both reactions is highly 
predictable and dependent solely on the palladium catalyst in combination with the 
stereogenic center that bears the N-nosyl urea (e.g. (-)-40, (+)-41, (-)-42, (-)-43, (-)-46, 
(-)-47). In general, the Pd(II)/sulfoxide/Ag(OTf)-catalyzed allylic C—H amination system 
proceeds with high yields and syn diastereoselectivities whose magnitudes are 
dependent on the steric properties of the functionality adjacent to the urea tether. In 
contrast, the Pd(II)/B(C6F5)3-catalyzed isomerization/oxidative amination system 
proceeds with moderate yields and excellent anti diastereoselectivities that are 
uniformly >20:1 independent of the steric properties of adjacent functionality on the 
substrate. For example, while evaluating pharmacophoric aryl moieties, we noted that 
despite the minimal steric bulk of the adjacent benzyl group in anti-product versus syn-
product (-)-43, anti-49 was generated with higher diastereoselectivity (>20:1 vs. 13:1), 
albeit a more modest yield (49% vs. 72%). Mechanistically, we postulate this is due to 
products arising from amino-palladation of the E-olefin: a process that is well known to 
favor the anti-stereochemistry (vide infra).4 
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 3.2.2 Origin of Switch in Diastereoselectivity  
In order to confirm that it is a switch in palladium catalyst alone that is causing 
the reversal in diastereomeric outcomes in these two reactions, we subjected a 
common starting material 50 to either 10 mol% Pd(II)/bis-sulfoxide catalyst 1 or  
Pd(OAc)2 under otherwise identical reaction conditions of Lewis acid co-catalyst, 
solvent, oxidant, and temperature (Scheme 3). Remarkably, both Lewis acid co-
catalysts B(C6F5)3 and Ag(OTf) furnished imidazolidinone products anti-44 and syn-38 
R
HN NHNs
O
B(C6F5)3 (8 mol%)
BQ (1.05 equiv.)
THF (1.66M)
45 C, 72h
NNsHN
R
O
NNsHN
O
OBnBnO
( )-47
51% Yield
>20:1 dr
NNsHN
tBu
O
( )-44
63% Yield
>20:1 dr
NNsHN
O
( )-49
49% Yield
>20:1 dr
Pd(OAc)2 (10 mol%)
58% average isolated yield
>20:1 anti:syn
Table 8. PdII/B catalyzed isomerization/oxidative amination reaction
NNsHN
O
Me
( )-45
76% Yield
>20:1 dr
MeO
NNsHN
O
OBnBnO
( )-46
42% Yield
>20:1 dr
NNsHN
O
( )-48
63% Yield
>20:1 dr
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in comparable yields with a complete reversal in diastereomeric outcome dependent 
solely on the nature of the palladium catalyst. Reactions that take a common 
intermediate and obtain diastereodivergent outcomes based on catalyst control have 
the potential to significantly advance synthetic efficiency and flexibility.14 
 
3.2.3 Further Mechanistic Insights 
We propose that the observed reversal in diastereomeric outcomes when 
switching from Pd(II)/bis-sulfoxide 1 to Pd(OAc)2 arises from a change in mechanism 
from allylic C—H amination that furnishes syn-imidazolidinone products to olefin 
isomerization/oxidative amination that generates anti-imidazolidinones. Pd(II)/sulfoxide 
catalysis has been well established to proceed via an allylic C—H cleavage/π-allylPd 
functionalization mechanism for terminal olefins with a wide range of nucleophiles under 
varying reaction conditions.15 We therefore focused our attention on determining if anti-
imidazolidinone products were arising with Pd(OAc)2/B(C6F5)3 via an olefin 
isomerization/amino-palladation mechanism.  We evaluated the rate of functionalization 
for terminal olefin substrate 36 and the corresponding E-internal olefin substrate 51, 
HN
O
NHNsHN
O
NNs HN
O
NNs
Scheme 3. Ligand effects on diastereoselectivity
( )-50 syn-( )-38anti-( )-44
Pd(OAc)2
S S
O
PhPh
O
.
Pd(OAc)2
(10 mol%)
LA (10 mol%)
BQ (1.05 equiv)
THF (1.66M)
45 C, 72h
same
(10 mol%)
LA (10 mol%)
a Isolated yield, average of 2 runs at 0.3 mmol; b d.r. determined by 1H NMR analysis
of crude reaction..
B(C6F5)3: syn, 61%, >20:1 d.r.; anti, 64%, >20:1 d.r.
Ag(OTf): syn, 60%, >20:1 d.r.; anti, 61%, >20:1 d.r.
Lewis acids (LA)a,b
1
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which would lead to the observed anti-stereochemistry via an amino palladation 
mechanism (Scheme 4).  Consistent with our hypothesis, both substrates formed the 
anti-imidazolidinone product with comparable rates, yields and diastereoselectivities 
(data not shown).  Additionally, 1HNMR analysis of the reaction with terminal olefin 
substrate 36 revealed complete conversion to the corresponding E-internal olefin 51 
after only 1 hour. Although powerful chiral ligands have long been known to effect 
diastereochemically different outcomes by exerting external stereocontrol on catalyst 
reactivity,16 this represents a rare example of an achiral ligand-dependent switch in 
reaction mechanism resulting in diastereodivergent reactivity. 
 
3.3 CONCLUSIONS 
We have developed a novel heterobimetallic process that uses transition-metal 
catalysis in combination with azaphilic Lewis acid co-catalysis for the formation of either 
syn- or anti- imidazolidinone products from common hydrocarbon precursors. While the 
Lewis-acid co-catalysts are critical for improving the yields in both reactions, the 
stereodivergent outcomes are effected solely by the choice of palladium transition metal 
catalyst and originate in a switch in mechanism from allylic C—H cleavage mediated by 
Pd(II)/bis-sulfoxide to oxidative amination promoted by Pd(II)carboxylate salts. We 
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anticipate that the ability to use a common hydrocarbon precursor to generate valuable 
syn- or anti-1,2-diamine synthons will find immediate use in streamlining and 
diversifying the synthesis of medicinal agents and natural products. 
 
3.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic amination 
reaction were used as received; Pd(OAc)2 (Johnson-Matthey Chemicals), Pd[1,2-
bis(phenylsulfinyl)ethane](OAc)2 “Catalyst 1” (Strem Chemicals and Sigma-Aldrich), 
(R,R)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) 
chloride “Cr(salen)Cl” (Sigma-Aldrich) and Tris(pentafluorophenyl)borane “B(C6F5)3” 
(Strem Chemicals) were stored in a glove box under an argon atmosphere at -20°C and 
weighed out in the glove box prior to use. Catalyst 1 was also prepared according to the 
published procedure17 and used interchangeably with commercial catalyst. Methyl-p-
benzoquinone (Sigma-Aldrich) and p-benzoquinone (Sigma-Aldrich) were sublimed and 
stored in the glove box up to two weeks prior to use. Silver trifluoromethanesulfonate 
“AgOTf” (Strem Chemicals) was recrystallized immediately prior to use following the 
outlined procedure below. p-Nitrobenzenesulfonyl isocyanate was prepared according 
to the published procedure.18 Solvents tetrahydrofuran and dichloromethane were 
purified prior to use by passage through a bed of activated alumina (Glass Contour, 
Laguna Beach, California). All allylic amination reactions were run under argon gas. The 
following precautions were taken in order to exclude moisture while the reactions were 
set up: the vials were flame dried prior to use, all of the solid reagents were combined in 
a glove box and the liquid components of the reaction mixture were added outside of 
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the glove box under a flow of argon. All other reactions were run over a stream of N2 
gas unless otherwise stated. Thin-layer chromatography (TLC) was conducted with E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV and 
potassium permanganate stain. Flash chromatography was performed as described by 
Still using ZEOprep 60 ECO 43-60 micron silica gel (American International Chemical, 
Inc.).19 1H NMR spectra were recorded on a Varian Unity-400 (400 MHz), Varian Inova-
500 (500 MHz), or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm 
using solvent as an internal standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, 
d = doublet, t = triplet, q = quartet, p = pentet, sext. = sextet, sept. = septet, m = 
multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 13C NMR spectra were recorded on a Varian Unity-400 (100 MHz) and 
Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an 
internal standard (CDCl3 at 77.16 ppm). Diastereoselectivity of the allylic amination 
reaction was determined by 1H NMR analysis of the crude reaction mixture unless 
otherwise noted. IR spectra were recorded as thin films on NaCl plates on a Perkin-
Elmer Spectrum BX and are reported in frequency of absorption (cm-1). HPLC analysis 
was performed on an Agilent Technologies 1100 HPLC system with a model 1100 
Quaternary Pump, Diode Array Detector, Thermostat, and Autosampler using a Chiral 
Technologies Inc. Chiralcel OJ-H column (0.46 cm x 25 cm). High-resolution mass 
spectra were obtained at the University of Illinois Mass Spectrometry Laboratory. 
Optical rotations were obtained using a JASCO DIP-360 digital polarimeter and a 3.5 x 
50 mm cell and are reported as follows: [a]λ
T°C (c = g/100 mL, solvent). 
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Synthesis of Homoallylic N-Nosyl Ureas 
 
 
 
 General Procedure: The allylic amine salt was synthesized according to the 
procedure described by Ellman and coworkers.20 The crystalline amine salt was 
dissolved in THF (0.35M) in a flame dried N2 filled round-bottom flask. Et3N (2 equiv.) 
was added next via syringe and the reaction mixture was stirred at room temperature for 
5 minutes. Nosyl isocyanate (1 equiv.) was then added in one portion. The reaction was 
stirred at room temperature until completed by TLC analysis. A solution of 1M HCl was 
added dropwise until the solution became acidic (pH<2). The aqueous layer was 
extracted with EtOAc (3 times) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash chromatography 
(EtOAc/hexanes/1% AcOH) provided the pure homoallylic N-nosyl urea as a white solid, 
which was further recrystallized from hexanes using minimal EtOAC. The 
recrystallization is necessary to ensure optimal reactivity. 
 
 (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: Product 
obtained as a white solid. 1H NMR (500 MHz, CDCl3) δ 8.36 (d, J = 
9.0 Hz, 2H), 8.10 (d, J = 9.0 Hz, 2H), 6.43 (d, J = 9.0 Hz, 1H), 5.68 
(m, 1H), 5.04 (m, 2H), 3.73 (m, 1H), 2.30 (m, 1H), 2.16 (m, 1H), 1.80 
(m, 1H), 0.88 (ap t, J = 6.0 Hz, 6H); 13C NMR (125 MHz, CDCl3)  δ 151.5, 150.9, 145.6, 
134.3, 128.5, 124.6, 118.0, 55.7, 36.7, 31.6, 19.3, 17.9; IR (film, cm-1): 3340, 3072 (br), 
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2964, 2881, 1670, 1527; HRMS (ESI) m/z calc'd for C14H20N3O5S [M+H]
+: 342.1124, 
found 342.1123. 
 
 (±)-N-((6-methylhept-1-en-4-yl)carbamoyl)-4-nitrobenzenesulfonamide: Product 
obtained as a white solid. 1H NMR (500 MHz, CDCl3) δ 9.62 (bs, 
1H), 8.36 (m, 2H), 8.09 (m, 2H), 6.37 (d, J = 9.0 Hz, 1H), 5.69 (m, 
1H), 5.04 (m, 2H), 3.94 (m, 1H), 2.29 (m, 1H), 2.17 (m, 1H), 1.49 
(m, 1H), 1.34 (m, 2H), 0.90 (d, J = 6.5 Hz, 3H), 0.88 (d, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 151.3, 150.8, 145.4, 133.7, 128.5, 124.6, 118.6, 48.7, 43.8, 39.7, 25.1, 
23.1, 22.2; IR (film, cm-1): 3348, 3130 (br), 3105, 2958, 2904, 1664, 1533; HRMS (ESI) 
m/z calc'd for C15H22N3O5S [M+H]
+: 356.1280, found 356.1281. 
 
 (±)-N-((2,2-dimethylhex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: Product 
obtained as a white solid. 1H NMR (500 MHz, CDCl3) δ 9.74 (bs, 1H), 
8.34 (d, J = 9.0 Hz, 2H), 8.09 (d, J = 8.5 Hz, 2H), 6.46 (d, J = 10.0 Hz, 
1H), 5.63 (m, 1H), 4.99 (d, J = 17.0 Hz, 1H), 4.91 (d, J = 10.0 Hz, 1H), 
3.70 (m, 1H), 2.47 (m, 1H), 1.95 (m, 2H), 0.89 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
151.8, 150.8, 145.6, 135.4, 128.4, 124.6, 117.4, 58.7, 35.0, 34.9, 26.5; IR (film, cm-1): 
3348 (br), 3111, 2962, 2873, 1662, 1533; HRMS (ESI) m/z calc'd for C15H22N3O5S 
[M+H]+: 356.1280, found 356.1277. 
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 (±)-N-((2,3-dimethylhex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: Product 
obtained as a white solid. 1H NMR (500 MHz, CDCl3) δ 9.07 (bs, 1H), 
8.37 (d, J = 9.0 Hz, 2H), 8.09 (d, J = 9.0 Hz, 2H), 6.41 (bs, 1H), 5.61 
(ddd, J = 24.5, 10.0, 7.5 Hz, 1H), 5.05 (d, J = 17.5 Hz, 1H), 5.01 (d, J 
= 10.0 Hz, 1H), 2.53 (dd, J = 14.0, 7.5 Hz, 1H), 2.37 (dd, J = 14.0, 7.0 Hz, 1H), 2.21 
(sept, J = 6.8 Hz, 1H), 1.20 (s, 3H), 0.88 (d, J = 3.0 Hz, 3H), 0.87 (d, J = 3.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 150.7, 150.1, 145.4, 133.2, 128.5, 124.6, 119.2, 60.1, 
40.1, 34.0, 20.1, 17.2, 17.2; IR (film, cm-1): 3356, 3205 (br), 3089, 2970, 1666, 1533; 
HRMS (ESI) m/z calc'd for C15H22N3O5S [M+H]
+: 356.1280, found 356.1282. 
 
General Synthesis for (-)-N-(((2S,3R)- and (-)-N-(((2S,3S)-2-((tert-
butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: 
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(-)-(S)-2-((tert-butyldimethylsilyl)oxy)propanal: The spectral data are in agreement 
with the data reported in the literature.21   1H NMR (500 MHz, CDCl3) δ 9.62 
(s, 1H), 4.10 (q, J = 6.7 Hz, 1H), 1.28 (d, J = 7.0 Hz, 3H), 0.92 (s, 9H), 0.01 
(s, 3H), 0.09 (s, 3H); [α]D
23.9 = -11.4 (c = 1.90, CHCl3) [Lit.: [α]D
24.7 = -12.1 (c 
= 1.96, CHCl3).] 
 
(+)-(S,E)-N-((S)-2-((tert-butyldimethylsilyl)oxy)propylidene)-2-methylpropane-2-
sulfinamide:  The spectral data are in agreement with the data reported 
in the literature.20  1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 4.0 Hz, 1H), 
4.57 (m, 1H), 1.36 (d, J = 6.5 Hz, 3H), 1.20 (s, 9H), 0.89 (s, 9H), 0.08 (s, 
3H), 0.07 (s, 3H);  [α]D
24.4 = +165.8 (c = 2.13, CH2Cl2). 
 
(S)-N-((2S,3S)-2-((tert-butyldimethylsilyl)oxy)hex-5-en-3-yl)-2-methylpropane-2-
sulfinamide: Product obtained as a clear oil.  1H NMR (500 MHz, 
CDCl3) δ 5.77 (m, 1H), 5.06 (m, 2H), 3.91 (d, J = 6.5 Hz, 1H), 3.89 (qd, 
J = 6.5, 3.0 Hz, 1H), 3.12 (ddd, J = 13.0, 6.8, 3.0 Hz, 1H), 2.37 (ddd, J 
= 14.5, 7.0, 6.0 Hz, 1H), 2.21 (m, 1H), 1.23 (d, J = 6.5 Hz, 3H), 1.21 (s, 
9H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 135.2, 117.4, 
69.4, 61.3, 56.0, 38.3, 25.9, 23.0, 20.9, 18.1, -3.9, -4.7; IR (film, cm-1): 3207 (br), 2954, 
2929, 2858, 1471, 1387; HRMS (ESI) m/z calc'd for C16H36NO2SiS [M+H]+: 334.2236, 
found 334.2246; [α]D
22.2 = +32.8 (c = 1.0, CHCl3). 
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(-)-(4S,5S)-4-allyl-5-methyloxazolidin-2-one: The spectral data are in agreement with 
the data reported in the literature.22 1H NMR (500 MHz, CDCl3) δ 5.72 (m, 
1H), 5.49 (bs, 1H), 5.18 (m, 1H), 4.34 (p, J = 6.1 Hz, 1H), 3.46 (dd, J = 
12.5, 5.5 Hz, 1H), 2.25-2.37 (m, 2H), 1.42 (d, J = 3H); [α]D
24.0 = -34.2 (c = 
0.65, CHCl3) [Lit. for (+)-(4R,5R)-4-allyl-5-methyloxazolidin-2-one: [α]D
 = +36.5  (c = 0.40, 
CHCl3).] 
(-)-N-(((2S,3S)-2-((tert-butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide: Product obtained as a white solid.  1H 
NMR (500 MHz, CDCl3) δ 8.34 (m, 2H), 8.11 (d, J = 9.0 Hz, 2H), 6.99 
(d, J = 9.0 Hz, 1H), 5.67 (m, 1H), 5.01 (m, 2H), 3.92 (ap. q, J = 6.2 Hz, 
1H), 3.71 (ap. q, J = 7.7 Hz, 1H), 2.25 (m, 2H), 1.04 (d, J = 6.0 Hz, 
3H), 0.97 (s, 9H), 0.13 (s, 3H), 0.11 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 151.8 150.7, 
145.6, 134.4, 128.5, 124.6, 117.9, 68.4, 55.7, 37.7, 25.9, 21.5, 18.1, -3.9, -4.8; IR (film, 
cm-1): 3383, 3105, 2954, 2929, 2889 (br), 2858, 1691, 1531; [α]D
24.8 = -12.7 (c = 0.45, 
CHCl3). 
 
(+)-(S)-N-((2S,3R)-2-((tert-butyldimethylsilyl)oxy)hex-5-en-3-yl)-2-methylpropane-2-
sulfinamide: Product obtained as a clear oil.  1H NMR (500 MHz, 
CDCl3) δ 5.85 (m, 1H), 5.14 (m, 2H), 3.79 (qd, J = 6.2, 4.9 Hz, 1H), 
3.36 (ap. d, J = 6.5 Hz, 1H), 3.19 (m, 1H), 2.40 (m, 2H), 1.19 (s, 9H), 
1.13 (d, J = 6.5 Hz, 3H), 0.87 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H); 13C 
NMR (500 MHz, CDCl3) δ 134.8, 118.8, 70.8, 61.3, 56.1, 36.1, 25.9, 22.9, 19.9, 18.1, -
3.9, -4.7; IR (film, cm-1): 3230 (br), 2956, 2929, 2858, 1473; HRMS (ESI) m/z calc'd for 
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C16H36NO2SiS [M+H]+: 334.2236, found 334.2246; [α]D
24.7 = +35.6 (c = 1.10, CHCl3). 
 
(-)-N-(((2S,3R)-2-((tert-butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide: Product obtained as a white solid. 1H 
NMR (500 MHz, CDCl3) δ 9.49 (bs, 1H), 8.34 (d, J = 8.5 Hz, 2H), 
8.10 (d, J = 8.5 Hz, 2H), 6.65 (d, J = 9.0 Hz, 1H), 5.66 (m, 1H), 5.01 
(d, J = 17.0 Hz, 1H), 4.96 (d, J = 10.0 Hz, 1H), 3.93 (m, 1H), 3.78 (m, 
1H), 2.35 (m, 1H), 2.21 (m, 1H), 1.14 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 151.3, 150.7, 145.4, 134.9, 128.5, 124.5, 117.7, 
69.7, 55.6, 33.2, 25.9, 20.2, 18.1, -3.9, -4.6; IR (film, cm-1): 3354, 3150 (br), 3109, 3080, 
2956, 2931, 2858, 1668, 1535; HRMS (ESI) m/z calc'd for C19H32N3O6SSi [M+H]
+: 
458.1781, found 458.1788. [α]D
26.3 = -23.7o (c = 1.0, CHCl3). 
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General Synthesis for (-)-N-(((2S,3R)- and (-)-N-(((2S,3S)-1,2-bis(benzyloxy)hex-5-
en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: 
 
 
(+)-(R)-2,3-bis(benzyloxy)propanal: The spectral data are in agreement with the data  
reported in the literature.23  1H NMR (500 MHz, CDCl3) δ 9.73 (d, J = 1 
Hz, 1H), 7.37-7.26 (m, 10H), 4.75 (d, J = 12 Hz, 1H), 4.70 (d, J = 12 
Hz, 1H), 4.57 (d, J = 12 Hz, 1H), 4.54 (d, J = 12 Hz, 1H), 3.99 (m, 1H), 3.82-3.76 (m, 
2H). [α]D
25.3 = +33.2o (c = 1.1, CHCl3). [Lit. for (S)-2,3-bis(benzyloxy)propanal: [α]D
25 = -
37.6o (c = 1.1, CHCl3)]. 
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(+)-(S)-N-((2S,3S)-1,2-bis(benzyloxy)hex-5-en-3-yl)-2-methylpropane-2-
sulfinamide: 1H NMR (500 MHz, CDCl3) δ 7.36-7.27 (m, 10H), 
5.76 (m, 1H), 5.04-5.01 (m, 2H), 4.67 (dd, J = 29.5, 11.5 Hz, 2H), 
4.53 (dd, J = 20.5, 12 Hz, 2H), 3.95 (m, 1H), 3.9 (d, J = 8 Hz, 1H), 
3.66 (dd, J = 10, 5.5 Hz, 1H), 3.60-3.54 (m, 2H), 2.35-2.22 (m, 
2H), 1.18 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 138.4, 137.9, 135.2, 128.4, 128.3, 
127.9, 127.7, 127.6,117.2, 79.9, 73.3, 72.8, 69.9, 57.7, 56.2, 34.9, 22.7; IR (film, cm-1): 
3298, 3066, 3032, 2916 (br), 1720, 1641, 1454, 1363; HRMS (ESI) m/z calc'd for 
C24H34NO3S [M+H]
+: 416.2259, found 416.2252. [α]D
24.9 = +15.8o (c = 1.04, CHCl3). 
 
(+)-(S)-N-((2S,3R)-1,2-bis(benzyloxy)hex-5-en-3-yl)-2-methylpropane-2-
sulfinamide: 1H NMR (500 MHz, CDCl3) δ 7.36-7.28 (m, 10H), 
5.74 (m, 1H), 5.07-5.01 (m, 2H), 4.70 (d, J = 11.5 Hz, 1H), 4.56 
(d, J = 11.5 Hz, 1H), 4.50 (q, J = 19, 12 Hz, 2H), 3.74 (m, 1H), 
3.62-3.57 (m, 2H), 3.51-3.44 (m, 2H), 2.60-2.48 (m, 2H), 1.16 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 138.2, 137.9, 134.6, 128.4, 128.3, 127.8, 127.7, 
127.7, 117.9, 77.9, 73.4, 72.8, 70.0, 57.6, 56.2, 37.9, 22.6; IR (film, cm-1): 3315 (br), 
3064, 3032, 2868, 1718, 1639, 1454, 1390, 1363; HRMS (ESI) m/z calc'd for 
C24H34NO3S [M+H]
+: 416.2259, found 416.2253. [α]D
24.6 = +15.5o (c = 1.15, CHCl3). 
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(-)-N-(((2S,3S)-1,2-bis(benzyloxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide: Product obtained as a white solid. 
1H NMR (500 MHz, CDCl3) δ 9.07 (bs, 1H), 8.07 (d, J = 9.0 Hz, 
2H), 7.93 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 9.5 Hz, 1H), 7.32-
7.38 (m, 5H), 7.18-7.24 (m, 5H), 5.68 (m, 1H), 4.96 (m, 2H), 
4.66 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 12.5 Hz, 1H), 4.46 (m, 2H), 4.34 (m, 1H), 3.69 (m, 
2H), 3.55 (m, 1H), 2.24 (m, 1H), 2.12 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 151.6, 
150.3, 145.2, 137.7, 137.2, 134.1, 128.7, 128.7, 128.6, 128.5, 128.3, 128.0, 127.9, 
124.3, 118.0, 77.2, 73.6, 71.8, 68.8, 50.8, 35.8; IR (film, cm-1): 3352, 3102 (br), 3066, 
3033, 2868, 1682, 1531; HRMS (ESI) m/z calc'd for C27H30N3O7S [M+H]
+: 540.1804, 
found 540.1803. [α]D
27 = -25.5o (c = 0.29, CHCl3). 
  
(-)-N-(((2S,3R)-1,2-bis(benzyloxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide: Product obtained as an orange 
thick oil. 1H NMR (500 MHz, CDCl3) δ 8.56 (bs, 1H), 8.10 (d, J 
= 9.0 Hz, 2H), 7.96 (d, J = 8.5 Hz, 2 H), 7.25-7.39 (m, 10H), 
6.86 (d, J = 9.0 Hz, 1H), 5.66 (m, 1H), 4.98 (m, 2H), 4.74 (d, J 
= 11.5 Hz, 1H), 4.59 (d, J = 11.5 Hz, 1H), 4.43 (dd, J = 22.5, 12.0 Hz, 2H), 4.09 (ap q, J 
= 7.5 Hz, 1H), 3.68 (m, 1H), 3.45 (dd, J = 9.5, 5.5 Hz, 1H), 3.30 (dd, J = 9.5, 6.5 Hz, 1H), 
2.23-2.34 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 151.4, 150.5, 145.0, 138.0, 137.7, 
134.1, 128.7, 128.7, 128.6, 128.2, 127.9 (br), 127.7, 124.3, 118.2, 77.2, 73.6, 73.1, 69.8, 
51.1, 37.0; IR (film, cm-1): 3367, 3120 (br), 3104, 3068, 2900, 2872, 1680, 1531; HRMS 
(ESI) m/z calc'd for C27H30N3O7S [M+H]
+: 540.1804, found 540.1796. [α]D
25.8 = -6.7o (c = 
110
0.39, CHCl3). 
 
General Synthesis for N-(((2S,3S)-1-(2-fluorophenyl)-2-methylhex-5-en-3-
yl)carbamoyl)-4-nitrobenzenesulfonamide:   
 
(?)-(S)-3-(2-fluorophenyl)-N,2-dimethyl-N-((2R,3R)-3-phenylbutan-2-
yl)propanamide: Product obtained as a white solid. 1H 
NMR (3.2:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, CDCl3)  δ 6.98-7.37 (m, 10H), 4.56 (d, J 
= 6.8 Hz, 1H), 4.46* (ap. d, J = 9.0 Hz, 1H), 4.39 (bs, 1H), 
4.21* (bs, 1H), 4.09* (p, J = 7.8 Hz, 1H), 3.29* (q, J = 6.8 Hz, 1H), 3.15* (dd, J = 14.0, 
6.8 Hz, 1H), 3.02 (h, J = 6.9 Hz, 1H), 2.86-2.91 (m, 2H), 2.81* (dd, J = 13.5, 8.0 Hz, 1H), 
2.68-2.74 (m, 4H), 1.77* (ap. d, J = 3.0 Hz, 1H), 1.13 (d, J = 7.0 Hz, 3H), 1.11*(d, J = 
N
O
F
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6.5 Hz, 3H), 0.98 (m, 3H); 13C NMR (3.2:1 rotamer ratio, all chemical shifts included, 
125 MHz, CDCl3) δ 178.3, 160.5, 142.6, 132.1, 132.1, 128.9, 128.6, 128.5, 128.3, 128.3, 
127.8, 127.1, 126.5, 124.1, 124.1, 115.3, 115.2, 76.7, 37.2, 34.0, 17.4, 14.5IR (film, cm-
1): 3354 (br), 2981, 2933, 1620 (br); HRMS (ESI) m/z calc'd for C20H25NO2F [M+H]
+: 
330.1869, found 330.1874. [α]D
24.5 = -19.9o (c = 0.85, CHCl3). 
 
(-)-(S)-3-(2-fluorophenyl)-2-methylpropan-1-ol: The spectral data are in agreement 
with the data reported in the literature.25  1H NMR (500 MHz, CDCl3) 
δ 7.18 (m, 2H), 7.06 (t, J = 7.5 Hz, 1H), 7.01 (t, J = 8.8 Hz, 1H), 3.51 
(m, 2H), 2.78 (dd, J = 13.0, 6.3 Hz, 1H), 2.50 (dd, J = 14.0, 7.8 Hz, 
1H), 1.98 (h, J = 6.7 Hz, 1H), 1.35 (t, J = 5.5 Hz, 1H), 0.94 (d, J = 6.5 Hz, 3H); [α]D
23.9 = -
9.1o (c = 0.75, CHCl3). 
 
 (+)-N-(((2S,3R)-1-(2-fluorophenyl)-2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide:  Product obtained as a white 
solid. 1H NMR (500 MHz, CDCl3) δ 9.28 (bs, 1H), 8.32 (d, J = 
9.0 Hz, 2H), 8.10 (d, J = 8.5 Hz, 2H), 7.01-7.22 (m, 4H), 6.60 
(d, J = 9.0 Hz, 1H), 5.71 (m, 1H), 5.11 (m, 2H), 3.84 (m, 1H), 
2.76 (dd, J = 13.5, 4.0 Hz, 1H), 2.43 (m, 1H), 2.20-2.31 (m, 2H), 1.99 (m, 1H), 0.83 (d, J 
= 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 161.3 (d, J = 242.8 Hz), 151.6, 150.7, 
145.4, 134.0, 131.4 (d, J = 4.5 Hz), 128.4, 128.3 (d, 8.3 Hz), 126.9 (d, J = 15.5 Hz), 
124.7, 124.3, 118.6, 115.5 (d, J = 22.0 Hz), 54.7, 37.7, 35.9, 32.3, 15.6; IR (film, cm-1): 
3344, 3182 (br), 3105, 3074, 2978, 2906, 1666, 1533; HRMS (ESI) m/z calc’d for 
HN NHNs
O
F
F OH
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C20H23N3O5SF [M+H]
+: 436.1342, found 436.1346; [α]D
24.5 = +41.8o (c = 0.7, CHCl3). 
 
 (±)-(E)-N-((2-methylhex-4-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide: Product 
obtained as a white solid. 1H NMR (500 MHz, CDCl3) δ 8.38 (m, 2H), 
8.11 (d, J = 9.0 Hz, 2H), 6.51 (m, 1H), 5.55 (dq, J = 15.0, 6.5 Hz, 1H), 
5.33 (m, 1H), 4.06 (m, 1H), 1.77 (m, 1H), 1.70 (d, J = 6.5 Hz, 3H), 
0.87 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 151.3, 
150.7, 145.3, 128.7, 128.5, 128.1, 124.6, 57.9, 32.4, 18.7, 18.3, 17.9; IR (film, cm-1): 
3348, 3150 (br), 3109, 2964, 2875, 1662, 1535; HRMS (ESI) m/z calc'd for 
C14H20N3O5S [M+H]
+: 342.1124, found 342.1114. 
 
 (±)-N-((1-(4-methoxyphenyl)pent-4-en-2-yl)carbamoyl)-4-
nitrobenzenesulfonamide: Product obtained as a 
yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.92 (bs, 1H), 
8.23 (d, J = 8.5 Hz, 2H), 7.79 (d, J = 8.5 Hz, 2H), 7.08 (d, 
J = 8.5 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 6.48 (d, J = 8.0 Hz, 1H), 5.76 (m, 1H), 5.11 (m, 
2H), 4.08 (m, 1H), 3.80 (s, 3H), 2.85 (dd, J = 14.3, 5.8 Hz, 1H), 2.67 (dd, J = 14.5, 8.8 
Hz, 1H), 2.35 (m, 1H), 2.26 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 158.6, 151.0, 150.6, 
145.2, 133.7, 130.2, 129.4, 128.2, 124.5, 118.9, 114.2, 55.4, 51.7, 39.2, 38.6; IR (film, 
cm-1): 3356, 3200 (br), 3106, 2927, 1668, 1533; HRMS (ESI) m/z calc'd for 
C19H22N3O6S [M+H]
+: 420.1229, found 420.1231. 
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Optimization of Allylic Diamination Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i-Pr
HN
S S
O O
Ph Ph
Pd(OAc)2
BQ or MeBQ
45 C
i-Pr
L.A.
co-catalyst
(8 - 10 mol%)
isolated
yield (%)c
d.r.
(syn:anti)d
none
Cr(salen)Cl
DIPEA
B(C6F6)3
AgOTf
AgOTf
AgOTf
AgOTf
AgOTf
B(C6F6)3
none
B(C6F6)3
33%e
16%f
32%e
55%e
62%
76%
0%
46%e
59%
61%
32%
0%
1:1.6
1:1.1
1:>20
5:1
8:1
11:1
-
1:>20
1:>20
1:>20
1:>20
-
NHNs
O
NNsHN
O
Pd
catalyst
(10 mol%)
cat. 1
1
1
1
1
1
1
none
Pd(OAc)2
Pd(OAc)2
Pd(OAc)2
Pd(OAc)2
none
syn - 37A
i-Pr
NNsHN
O
anti - 37B
a All reactions were run using THF (1.0M) as solvent, MeBQ (methyl-p-benzoquinone, 1.5
equiv.) as terminal oxidant and 8 mol% L.A. co-catalyst for 6 hours unless otherwise noted. b
Reactions with cat. 1 were run with an additional 5 mol% BisSO ligand [1,2-
bis(phenylsulfinyl)ethane]. c Average of 2 runs at 0.3 mmol. d Determined by 1H NMR
analysis of the crude reaction mixture. e Reactions run to complete conversion: entry 1, 24h;
entry 3, 18h; entry 4, 2h; entry 8, 72h. f Reaction stopped before complete conversion at 2h.
Increased reaction times resulted in product decomposition. g DCM (dichloromethane, 1.0M).
h >99% rsm, 0% E-internal olefin, 0% syn-37A. i Reaction run using THF (1.66M) as solvent,
BQ (p-benzoquinone, 1.05 equiv.) as terminal oxidant and 10 mol% L.A. co-catalyst for 72
hours. j >99% rsm, 0% E-internal olefin, 0% anti-37B.
entrya,b
1
2
3
4
5
6g
7g,h
8
9i
10i
11i
12i,j
36
Reaction Development to form Vicinal Diamine Motifs
Pd cat. (10 mol%)/
L.A. cat. (8-10 mol%)
Pd(OAc)2
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Entry 1: In a glove box, the following solids were all first weighed onto wax paper then 
sequentially added to a ½ dram borosilicate vial topped with a Teflon-lined cap and 
containing a Teflon stir bar: (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide 36 (102.4 mg, 0.3 mmol), methyl-p-benzoquinone (54.9 mg, 
0.45 mmol), 1,2-bis(phenylsulfinyl)ethane (4.2 mg, 0.015 mmol) and White Catalyst 1 
(15.1 mg, 0.03 mmol). THF (300 µL, 1.0M) was quickly added outside of the glove box, 
the vial was capped and placed in a 45°C aluminum block and stirred for 24 hours. An 
aliquot of the crude reaction mixture was analyzed by 1H NMR to obtain the crude 
diastereoselectivity. After analysis, this sample was added back to the total crude 
reaction mixture, which was concentrated in vacuo. Purification by flash 
chromatography (30% EtOAc/hexanes) provided syn- and anti-(±)-(4R,5R)-4-isopropyl-
1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one. Run 1 (33.1 mg, 0.098 mmol, 33% 
yield [1:1.6 dr]); Run 2 (32.3 mg, 0.095 mmol, 32% yield [1:1.6 dr]). Average: 33% yield, 
1:1.6 dr (syn:anti). 
 
Entry 2: The reaction was set up following the procedure described for Entry 1. 
Additionally, Cr(salen)Cl (15.3 mg, 0.024 mmol, 0.08 equiv.) was also added to the ½ 
dram vial inside of the glove box. The reaction was placed in a 45°C aluminum block 
and stirred for 2 hours upon which maximum product formation was observed. Run 1 
(15.3 mg, 0.045 mmol, 15% yield [1:1.1 dr]); Run 2 (17.7 mg, 0.052 mmol, 17% yield 
[1:1.1 dr]). Average: 16% yield, 1:1.1 dr (syn:anti). 
 
Entry 3: The reaction was set up following the procedure described for Entry 1.  
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Additionally, DIPEA (4.2 µL, 0.024 mmol, 0.08 equiv.) was added outside of the glove 
box at the same time as the solvent addition. The reaction was placed in a 45°C 
aluminum block and stirred for 18 hours upon which complete conversion was observed. 
Run 1 (18.6 mg, 0.055 mmol, 30% yield [1:>20 dr]); Run 2 (34.8 mg, 0.102 mmol, 34% 
yield [>20:1 dr]). Average: 32% yield, 1:>20 dr (syn:anti). 
 
Entry 4: The reaction was set up following the procedure described for Entry 1. 
Additionally, B(C6F5)3 (12.7 mg [97% via Strem], 0.024 mmol, 0.08 equiv.) was also 
added to the ½ dram vial inside of the glove box. The reaction was placed in a 45°C 
aluminum block and stirred for 2 hours upon which complete conversion was observed. 
Run 1 (57.4 mg, 0.169 mmol, 56% yield [5:1 dr]); Run 2 (54.3 mg, 0.160 mmol, 53% 
yield [5:1 dr]). Average: 55% yield, 5:1 dr (syn:anti). 
 
Entry 5: The reaction was set up following the procedure described for Entry 1. 
Additionally, freshly recrystallized Ag(OTf) (6.2 mg, 0.024 mmol, 0.08 equiv.) was also 
added to the ½ dram vial inside of the glove box. The reaction was placed in a 45°C 
aluminum block and stirred for 6 hours upon which complete conversion was observed. 
Run 1 (61.1 mg, 0.180 mmol, 60% yield [8:1 dr]); Run 2 (62.5 mg, 0.184 mmol, 61% 
yield [8:1 dr]). Average: 61% yield, 8:1 dr (syn:anti). 
 
Entry 6: The reaction was set up following the procedure described for Entry 5 
replacing THF with DCM as the solvent for the reaction. The reaction was placed in a 
45°C aluminum block and stirred for 6 hours upon which complete conversion was 
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observed. Run 1 (75.8 mg, 0.222 mmol, 74% yield [11:1 dr]); Run 2 (78.9 mg, 0.232 
mmol, 77% yield [11:1 dr]). Average: 76% yield, 11:1 dr (syn:anti). 
 
Entry 7: The reaction was set up following the procedure described for Entry 6 omitting 
the addition of the White catalyst 1. The reaction was placed in a 45°C aluminum block 
and stirred for 6 hours. No conversion of the starting material and no product formation 
were observed by 1H NMR analysis of the crude reaction mixture.  
 
Entry 8: In a glove box, the following solids were all first weighed onto wax paper then 
sequentially added to a ½ dram borosilicate vial topped with a Teflon-lined cap and 
containing a Teflon stir bar: (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide 36 (102.4 mg, 0.3 mmol), methyl-p-benzoquinone (54.9 mg, 
0.45 mmol), Pd(OAc)2 catalyst (6.7 mg, 0.03 mmol) and freshly recrystallized AgOTf 
(6.2 mg, 0.024 mmol). THF (300 µL, 1.0M) was quickly added outside of the glove box, 
the vial was capped and placed in a 45°C aluminum block and stirred for 72 hours. An 
aliquot of the crude reaction mixture was analyzed by 1H NMR to obtain the crude 
diastereoselectivity. After analysis, this sample was added back to the total crude 
reaction mixture, which was concentrated in vacuo. Purification by flash 
chromatography (30% EtOAc/hexanes) provided anti-(±)-(4R,5R)-4-isopropyl-1-((4-
nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one. Run 1 (46.9 mg, 0.138 mmol, 46% yield 
[1:>20 dr]); Run 2 (45.9 mg, 0.135 mmol, 45% yield [1:1.6 dr]). Average: 46% yield, 
1:>20 dr (syn:anti). 
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Entry 9: In a glove box, the following solids were all first weighed onto wax paper then 
sequentially added to a 1 dram borosilicate vial topped with a Teflon-lined cap and 
containing a Teflon stir bar: (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide 36 (102.4 mg, 0.3 mmol), p-benzoquinone (34.1 mg, 0.315 
mmol), freshly recrystallized AgOTf (7.7 mg, 0.03 mmol) and Pd(OAc)2 (6.7 mg, 0.03 
mmol). THF (180 µL, 1.66M) was quickly added outside of the glove box, the vial was 
capped and placed in a 45°C aluminum block and stirred for 72 hours. An aliquot of the 
crude reaction mixture was analyzed by 1H NMR to obtain the crude diastereoselectivity. 
After analysis, this sample was added back to the total crude reaction mixture, which 
was concentrated in vacuo. Purification by flash chromatography (30% EtOAc/hexanes) 
provided anti-(±)-(4R,5R)-  4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-
one. Run 1 (61.1 mg, 0.18 mmol, 60% yield [1:>20 dr]); Run 2 (59.2 mg, 0.174 mmol, 
58% yield [1:>20 dr]). Average: 59% yield, 1:>20 dr (syn:anti). 
 
Entry 10: The reaction was set up following the procedure described for Entry 9. 
B(C6F5)3 (15.8 mg, 0.03 mmol, 0.010 equiv.) was added in place of AgOTf to the 1 dram 
vial inside of the glove box. Run 1 (61.9 mg, 0.182 mmol, 61% yield [1: >20 dr]); Run 2 
(62.1 mg, 0.183 mmol, 61% yield [1:>20 dr]). Average: 61% yield, 1:>20 dr (syn:anti). 
 
Entry 11: The reaction was set up following the procedure described for Entry 10 
omitting B(C6F5)3 from the reaction vial. Run 1 (32.3 mg, 0.095 mmol, 32% yield [1:>20 
dr]); Run 2 (32 mg, 0.094 mmol, 31% yield [1:>20 dr]). Average: 32% yield, 1:>20 dr 
(syn:anti). 
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 Entry 12: The reaction was set up following the procedure described for Entry 10 
omitting the Pd(OAc)2 catalyst. No conversion of starting material and no product 
formation were observed by 1H NMR analysis of the crude reaction mixture. 
 
Scope of Allylic Diamination Reaction 
 
General Procedure for syn-Allylic Diamination Reaction: A ½ dram borosilicate vial 
containing a Teflon stir bar was flame dried, sealed with a Teflon lined cap and taken 
inside a glove box. The homoallylic N-nosyl urea starting material (1 equiv.), freshly 
sublimed methyl-p-benzoquinone (1.5 equiv.), White Catalyst (0.10 equiv.), 1,2-
bis(phenylsulfinyl)ethane (0.05 equiv.) and AgOTf (0.08 equiv.) were added to the ½ 
dram vial in the glove box, in the order specified. The vial was securely sealed with the 
Teflon lined cap and taken out of the glove box. Dichloromethane (1.0M) was quickly 
added to the ½ dram vial outside of the glove box, under a flow of Argon gas. The vial 
was then sealed, vortexed and placed in an aluminum block to stir at 45 °C for exactly 6 
hours. If the reaction is allowed to run longer than 6 hours an erosion of the 
diastereoselectivity is observed. The solution was allowed to cool to room temperature 
and then transferred using dichloromethane to a 250 mL separatory funnel.  The 
solution was diluted with 15 mL of dichloromethane and rinsed 1x 15 mL aqueous 
NH4Cl (sat.) and 1x 15 mL Brine. The organic layer was collected and dried over MgSO4, 
filtered and concentrated in vacuo. The crude reaction mixture was purified using flash 
column chromatography (in general, gradient 25-30% EtOAc/hexanes was used).  
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 General Procedure for Recrystallization of Silver Triflate:  syn- selectivity is dependent 
on proper recrystallization of the silver triflate. Poor recrystallization can result in 
diminished diastereoselectivities. In a glove box, silver triflate (0.5 – 0.8 g) was added to 
a flame dried, 25 mL pear shaped flask.  The flask was sealed with a septum and 
removed from the glove box.  In darkness, the flask was placed under a nitrogen 
atmosphere followed by the addition of dry benzene (12.0 – 15.0 mL).  Using a heating 
mantle, the slurry was gently heated until all of the silver triflate had completely 
dissolved (refluxing solvent is not necessary; however condensation of solvent may be 
seen on the upper portion of the flask).  Upon dissolution, the entire solution was taken 
up into a 25 mL syringe and immediately passed through a 0.2 µm PVDF ACRODisc 
into a second flame dried, 25 mL pear shaped flask under nitrogen atmosphere (slow 
transfer can result in precipitates forming within the syringe requiring the entire process 
to be restarted).  The transfer should be done by quickly removing the needle from the 
syringe, attaching the ACRODisc and a 16G needle, and then immediately dispelling 
the liquid into the second, septum sealed flask. The clear solution is then allowed to 
cool to room temperature at which point the silver triflate will begin to precipitate.  If 
precipitation does not occur, the solution can either be briefly cooled using an ice bath, 
or a gentle stream of nitrogen can be passed over the solution until precipitation begins.  
Upon qualitative completion of precipitation, the benzene was removed via canulation 
into a separate receiving flask.  The silver triflate is then re-dissolved in a minimum 
amount of benzene (~5.0 – 8.0 mL) under mild heat.  Upon complete solvation the flask 
was allowed to cool to room temperature.  Upon qualitative completion of precipitation, 
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the benzene was again removed via canulation into a separate receiving flask.  This 
step was repeated once more yielding pure, white needles of silver triflate (ACRODisc 
filtration is only necessary on the first step).  Upon completion of the third 
recrystallization and canulation the flask was placed under vacuum to remove any 
remaining benzene.  The flask was then covered in aluminum foil and placed in a glove 
box for use in the syn-allylic diamination reaction.  Preparation of the silver triflate must 
be done immediately prior to the diamination reaction.  All unused silver triflate 
(including what is lost in the benzene canulations) can be reconstituted and 
recrystallized again for future reactions. 
 
 
 
 
The stereochemistry of the syn- and anti-diastereomers was determined through 
their vicinal coupling constants (3JH4H5). In general, syn-imidazolidinones show larger 
coupling constants between C4H and C5H (around 7.9-9.1 Hz reported; 5.5-6.3 Hz 
observed) than anti- imidazolidinones (around 3.0-4.4 Hz reported; 1.5-3.0 Hz 
observed). Reference 6 provides a more detailed description of this data. 
 
 (±)-(4R,5S)-4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one:  
Racemic (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (102.4 mg, 0.30 mmol) was reacted according 
to the general syn- procedure.  Purification by flash chromatography 
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(gradient 25-40% EtOAc/hexanes) provided the syn- imidazolidinone as a white solid.  
Run 1 (75.3 mg, 0.222 mmol, 74% yield [11:1 dr]); run 2 (78.4 mg, 0.231 mmol, 77% 
yield [11:1 dr]). Average: 76% yield, 11:1 dr (syn:anti).  1H NMR (500MHz, CDCl3) δ 
8.32 (d, J = 9.0 Hz, 2H), 8.11 (d, J = 8.5 Hz, 2H), 7.66 (bs, 1H), 5.86 (ddd, J = 17.3, 
10.5, 6.8 Hz, 1H), 5.45 (d, J = 17.0 Hz, 1H), 5.39 (d, J = 10.5 Hz, 1H), 4.83 (t, J = 6.3 Hz, 
1H), 3.58 (t, J = 6.0 Hz, 1H), 1.89 (sext., J = 6.7, 1H), 0.99 (d, J = 6.5 Hz, 3H), 0.96 (d, J 
= 6.5 Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 161.1, 149.9, 148.0, 133.3, 127.8, 124.2, 
120.6, 82.8, 66.1, 32.0, 18.0, 17.8; IR (film, cm-1): 3217 (br), 3114, 2966, 2935, 2875, 
1631, 1531; HRMS (ESI) m/z calc’d for C14H18N3O5S [M+H]
+: 340.0967, found 340.0966. 
 
 (±)-(4R,5S)-4-(tert-butyl)-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one:  
Racemic (±)-N-((2,2-dimethylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (106.6 mg, 0.30 mmol) was reacted according 
to the general syn- procedure.  Purification by flash chromatography 
(gradient 25-40% EtOAc/hexanes) provided the syn- imidazolidinone as 
a white solid. Run 1 (85.9 mg, 0.243 mmol, 81% [>20:1 dr]); run 2 (84.8 mg, 0.240 mmol, 
80% [20:1 dr]).  Average Yield: 81%, >20:1 dr (syn:anti). 1H NMR (500MHz, CDCl3) δ 
8.33 (d, J = 8.5 Hz, 2H), 8.11 (d, J = 8.5 Hz, 2H), 7.65 (bs, 1H), 5.85 (ddd, J = 17.5, 
10.3, 6.5 Hz, 1H), 5.44 (d, J = 17.5 Hz, 1H), 5.37 (d, J = 10.5 Hz,1H), 4.89 (t, J = 5.5 Hz, 
1H), 3.50 (d, J = 5.0 Hz, 1H), 0.94 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 161.2, 149.8, 
148.0, 133.7, 127.8, 124.2, 120.0, 81.0, 69.4, 33.9, 25.0; IR (film, cm-1): 3384, 3307 (br), 
3105, 2966, 2873, 1628, 1529; HRMS (ESI) m/z calc’d for C15H20N3O5S [M+H]
+: 
354.1124, found 354.1124. 
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  (±)-(4R,5S)-4-isopropyl-4-methyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-
one:  Racemic (±)-N-((2,3-dimethylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (107.0 mg, 0.30 mmol) was reacted according 
to the general syn- procedure.  Purification by flash chromatography 
(gradient 25-40% EtOAc/hexanes) provided the syn- imidazolidinone as 
a white solid. Run 1 (92.6 mg, 0.252 mmol, 84% [>20:1 dr]); run 2 (87.1 mg, 0.237 mmol, 
79% [>20:1 dr]).  Average Yield: 82%, >20:1 dr (syn:anti). 1H NMR (500MHz, CDCl3) 
δ 8.32 (d, J = 8.5 Hz, 2H), 8.10 (d, J = 9.0 Hz, 2H), 7.59 (bs, 1H), 5.79 (ddd, J = 17.0, 
10.5, 6.8 Hz, 1H), 5.45 (m, 2H), 4.84 (d, J = 6.5 Hz, 1H), 1.93 (m, 1H), 1.21 (s, 3H), 0.99 
(d, J = 7.0 Hz, 3H), 0.95 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 160.2, 149.9, 
148.1, 130.4, 127.8, 124.2, 121.6, 85.8, 66.7, 37.1, 18.8, 17.2, 17.0; IR (film, cm-1): 
3199 (br), 3116, 2978, 1631, 1527; HRMS (ESI) m/z calc’d for C15H20N3O5S [M+H]
+: 
354.1124, found 354.1132. 
 
 (+)-(4S,5S)-4-((S)-1-((tert-butyldimethylsilyl)oxy)ethyl)-1-((4-nitrophenyl)sulfonyl)-
5-vinylimidazolidin-2-one: (-)-N-(((2S,3S)-2-((tert-
butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (45.8 mg, 0.10 mmol) was reacted according 
to the general syn- procedure with the following slight modifications: 12 
µL of dimethylacetamide was added in addition to the DCM solvent and the reaction 
was run at 40°C instead of the original 45°C. Purification by flash chromatography 
(gradient 25-40% EtOAc/hexanes) provided the syn- imidazolidinone as a light yellow oil. 
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Run 1 (36.4 mg, 0.080 mmol, 80% [>20:1 dr]); run 2 (35.1 mg, 0.077 mmol, 77% [>20:1 
dr]).  Average Yield: 79%, >20:1 dr (syn:anti).  1H NMR (500MHz, CDCl3) δ 8.31 (d, J 
= 9.0 Hz, 2H), 8.10 (d, J = 9.0 Hz, 2H), 7.69 (bs, 1H), 5.87 (ddd, J = 17.0, 10.5, 6.5 Hz, 
1H), 5.45 (d, J = 17.0 Hz, 1H), 5.40 (d, J = 10.5 Hz, 1H), 4.83 (t, J = 6.3 Hz, 1H), 3.84 (p, 
J = 6.0 Hz, 1H), 3.67 (t, J = 5.5 Hz, 1H), 1.17 (d, J = 6.0 Hz, 3H), 0.86 (s, 9H), 0.11 (s, 
3H), 0.09 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 161.2, 149.9, 148.0, 132.9, 127.9, 
124.1, 120.7, 81.5, 69.2, 66.0, 25.7, 19.5, 17.9, -4.1, -4.8; IR (film, cm-1): 3365 (br), 
3107, 2954, 2931, 2858, 1630, 1531; HRMS (ESI) m/z calc’d for C19H30N3O6SiS [M+H]
+: 
456.1625, found 456.1624; [α]D
26.0 = +55.2o (c = 0.5, CHCl3). 
 
 (-)-(4R,5R)-4-((S)-1-((tert-butyldimethylsilyl)oxy)ethyl)-1-((4-nitrophenyl)sulfonyl)-
5-vinylimidazolidin-2-one: (-)-N-(((2S,3R)-2-((tert-
butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide(-)-N-(((2S,3S)-2-((tert-
butyldimethylsilyl)oxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (45.8 mg, 0.10 mmol) was reacted according to the general 
syn- procedure with the following slight modifications: 12 µL of dimethylacetamide was 
added in addition to the DCM solvent and the reaction was run at 40°C instead of the 
original 45°C. Purification by flash chromatography (gradient 25-40% EtOAc/hexanes) 
provided the syn- imidazolidinone as a light yellow oil. Run 1 (28.2 mg, 0.062 mmol, 
62% [15:1 dr]); run 2 (29.6 mg, 0.065 mmol, 65% [13:1 dr]).  Average Yield: 64%, 14:1 
dr (syn:anti).  1H NMR (500MHz, CDCl3) δ 8.31 (bs, 1H), 8.30 (d, J = 9.0 Hz, 2H), 8.09 
(d, J = 9.0 Hz, 2H), 5.84 (ddd, J = 17.0, 10.8, 6.5 Hz, 1H), 5.43 (d, J = 17.5 Hz, 1H), 
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5.35 (d, J = 10.5 Hz, 1H), 5.18 (t, J = 6.0 Hz, 1H), 4.03 (m, 1H), 3.69 (m, 1H), 1.11 (d, J 
= 6.5 Hz, 3H), 0.77 (s, 9H), 0.07 (s, 3H), 0.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
161.1, 149.8, 148.0, 133.7, 128.2, 124.0, 119.8, 81.2, 67.6, 65.5, 25.7, 19.7, 17.8, -4.3, 
-4.7; IR (film, cm-1): 3307 (br), 3265, 3168, 3107, 2954, 2931, 2887, 2858, 1637, 1531; 
HRMS (ESI) m/z calc’d for C19H30N3O6SiS [M+H]
+: 456.1625, found 456.1624; [α]D
25.6 = 
-12.4o (c = 0.4, CHCl3). 
 
 (-)-(4S,5S)-4-((S)-1,2-bis(benzyloxy)ethyl)-1-((4-nitrophenyl)sulfonyl)-5-
vinylimidazolidin-2-one: (-)-N-(((2S,3S)-1,2-bis(benzyloxy)hex-5-
en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide (53.9 mg, 0.1 
mmol) was reacted according to the general syn- procedure with 
the following slight modifications: 12 µL of dimethylacetamide was 
added in addition to the DCM solvent and the reaction was run at 40°C instead of the 
original 45°C. Purification by flash chromatography (gradient 25-40% EtOAc/hexanes) 
provided the syn- imidazolidinone as a light yellow oil. Run 1 (37.8 mg, 0.070 mmol, 
70% [17:1 dr]); run 2 (35.6 mg, 0.066 mmol, 66% [>20:1 dr]).  Average Yield: 68%, 
19:1 dr (syn:anti).  1H NMR (500MHz, CDCl3) δ 8.19 (d, J = 9.0 Hz, 2H), 7.99 (d, J = 
9.0 Hz, 2H), 7.67 (bs, 1H), 7.20-7.39 (m, 10H), 5.82 (ddd, J = 17.0, 10.5, 6.0 Hz, 1H), 
5.35 (d, J = 17.0 Hz, 1H), 5.30 (d, J = 10.5 Hz, 1H), 5.11 (t, J = 5.8 Hz, 1H), 4.66 (d, J = 
11.5 Hz, 1H), 4.53 (m, 2H), 4.46 (d, J = 12.0 Hz, 1H), 3.95 (m, 1H), 3.63-3.67 (m, 2H), 
3.54-3.58 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 161.4, 149.7, 147.9, 137.0, 137.0, 
133.1, 128.8, 128.8, 128.4, 128.3, 128.2, 127.8, 127.6, 124.0, 119.5, 81.5, 74.0, 72.7, 
68.3, 62.3; IR (film, cm-1): 3365 (br), 3105, 3064, 3032, 2927, 2860, 1626, 1529; HRMS 
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(ESI) m/z calc’d for C27H28N3O7S [M+H]
+: 538.1648, found 538.1648; [α]D
26.9 = -6.7o (c = 
1.4, CHCl3). 
 
 (-)-(4S,5R)-4-((S)-1-(2-fluorophenyl)propan-2-yl)-1-((4-nitrophenyl)sulfonyl)-5-
vinylimidazolidin-2-one: (+)-N-(((2R,3S)-1-(2-fluorophenyl)-2-
methylhex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide 
(43.6 mg, 0.1 mmol) was reacted according to the general syn- 
procedure with the following slight modifications: 12 µL of 
dimethylacetamide was added in addition to the DCM solvent and the reaction was run 
at 40°C instead of the original 45°C. Purification by flash chromatography (gradient 25-
40% EtOAc/hexanes) provided the syn- imidazolidinone as a light yellow oil. Run 1 
(31.2 mg, 0.072 mmol, 72% [14:1 dr]); run 2 (30.8 mg, 0.071 mmol, 71% [11:1 dr]).  
Average Yield: 72%, 13:1 dr (syn:anti). 1H NMR (500MHz, CDCl3) δ 8.32 (d, J = 9.0 
Hz, 2H), 8.10 (d, J = 9.0 Hz, 2H), 7.73 (bs, 1H), 7.23-7.28 (m, 1H), 7.05-7.14 (m, 3H), 
5.85 (ddd, J = 17.0, 10.5, 6.5 Hz, 1H), 5.47 (d, J = 17.0 Hz, 1H), 5.40 (d, J = 10.5 Hz, 
1H), 4.92 (t, J = 6.0 Hz, 1H), 3.68 (t, J = 6.0 Hz, 1H), 2.75 (dd, J = 14.0, 5.0 Hz, 1H), 
2.54 (dd, J = 13.5, 8.5 Hz, 1H), 2.12 (m, 1H), 0.92 (d, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 161.2 (d, J = 242.8 Hz), 161.1, 149.9, 147.9, 133.0, 131.6 (d, J = 4.5 Hz), 
128.9 (d, J = 8.3 Hz), 127.9, 125.1 (d, J = 15.5 Hz), 124.5, 124.2, 120.8, 115.8 (d, J = 
21.9 Hz), 82.3, 64.4, 37.9, 32.2, 14.8; IR (film, cm-1): 3334 (br), 3105, 2968, 2933, 1628, 
1529; HRMS (ESI) m/z calc’d for C20H21N3O5SF [M+H]
+: 434.1186, found 434.1193; 
[α]D
24.9 = -59.4o (c = 1.1, CHCl3). 
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General Procedure for the Anti Selective Allylic Diamination Reaction: A 1 dram 
borosilicate vial containing a Teflon stir bar was flame dried, sealed with a Teflon lined 
cap and taken inside a glove box. The homoallylic N-nosyl urea starting material (0.3 
mmol, 1 equiv.), benzoquinone (0.315 mmol, 1.05 equiv.), Pd(OAc)2 (0.03 mmol, 0.1 
equiv.) and B(C6F5)3 (0.03 mmol, 0.1 equiv.) were added to the 1 dram vial in the glove 
box, in the order specified. The vial was securely sealed with the Teflon lined cap and 
taken out of the glove box. Tetrahydrofuran (1.66M) was quickly added to the 1 dram 
vial outside of the glove box, under a flow of argon gas. The vial was then sealed and 
stirred in an aluminum block at 45 °C for 72 hours. The solution was allowed to cool to 
room temperature and the crude reaction mixture was directly purified using flash 
column chromatography (in general, gradient 25-30% EtOAc/hexanes was used). 
 
(±)-(4R,5R)-  4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: 
Racemic (±)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (102.4 mg, 0.30 mmol) was reacted 
according to the general procedure.  Purification by flash column 
chromatography (gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone 
as a solid. Run 1 (63.1 mg, 0.186 mmol, 62% yield [>20:1 dr]); run 2 (62.1 mg, 0.183 
mmol, 61% yield [>20:1 dr]). Average: 62% yield, >20:1 dr (anti:syn). 1H NMR (500 
MHz, CDCl3) δ 8.35 (d, J = 9.0 Hz, 2H), 8.24 (d, J = 9.0 Hz, 2H), 5.76 (ddd, J = 17.0, 
10.0, 8.3 Hz, 1H), 5.43 (d, J = 17.0 Hz, 1H), 5.31 (d, J = 10.0 Hz, 1H), 5.16 (m, 1H); 
4.63 (dd, J  = 8.3, 2.3 Hz, 1H); 3.11 (dd, J = 5.5, 2.3 Hz, 1H); 1.79 (m, 1H); 0.94 (ap t, J 
= 6.8 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 154.2, 150.6, 145.0, 135.1, 129.9, 124.1, 
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119.5, 62.6, 61.8, 32.7, 17.8, 17.2; IR (film, cm-1): 3253 (br), 3109, 2964, 1734, 1531; 
HRMS (ESI) m/z calc'd for C14H18N3O5S [M+H]
+ : 340.0967, found 340.0965. 
 
(±)-(4R,5R)-4-isobutyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: 
Racemic (±) N-((6-methylhept-1-en-4-yl)carbamoyl)-4-
nitrobenzenesulfonamide (106.6 mg, 0.30 mmol) was reacted 
according to the general procedure.  Purification by flash 
chromatography (gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone 
as a solid. Run 1 (68.2 mg, 0.193 mmol, 64% [>20:1 dr]); run 2 (65.4 mg, 0.185 mmol, 
62% [>20:1 dr]).  Average Yield: 63%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDCl3) 
δ 8.35 (m, 2H), 8.23 (m, 2H), 5.77 (ddd, J = 17.0, 10.0, 8.5 Hz, 1H), 5.43 (d, J = 17.0 Hz, 
1H), 5.33 (d, J = 10.0 Hz, 1H), 5.02 (bs, 1H), 4.45 (dd, J = 8.5, 2.8 Hz, 1H), 3.38 (m, 1H), 
1.64 (m, 1H),1.43-1.52 (m, 2H), 0.94 (d, J = 6.5 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 154.5, 150.6, 144.7, 134.4, 129.8, 124.0, 119.9, 65.6, 54.7, 
44.1, 24.5, 23.0, 21.9; IR (film, cm-1): 3219 (br), 3109, 2956, 2872, 1738, 1529; HRMS 
(ESI) m/z calc'd for C15H20N3O5S [M+H]
+ : 354.1124, found 354.1127. 
 
(±)-(4R,5R)-4-(tert-butyl)-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: 
Racemic (±)-N-((2,2-dimethylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (106.6 mg, 0.30 mmol) was reacted according 
to the general procedure.  Purification by flash chromatography 
(gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone as 
a solid. Run 1 (67.6 mg, 0.191 mmol, 64% [>20:1 dr]); run 2 (66.8 mg, 0.189 mmol, 63% 
NNsHN
O
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[>20:1 dr]).  Average Yield: 64%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDCl3) δ 
8.34 (m, 2H), 8.24 (m, 2H), 5.75 (ddd, J = 17.8, 9.3, 8.5 Hz, 1H), 5.41 (d, J = 17.0 Hz, 
1H), 5.30 (d, J = 10.5 Hz, 1H), 5.26 (bs, 1H), 4.71 (dd, J = 8.0, 2.0 Hz, 1H), 3.01 (dd, J = 
2.3, 1.3 1H), 0.91 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.4, 150.6, 145.0, 135.5, 
129.9, 124.0, 119.1, 65.2, 60.7, 34.8, 24.6; IR (film, cm-1): 3369, 3292, 3246, 2964, 
2870, 1762, 1734, 1531; HRMS (ESI) m/z calc'd for C15H20N3O5S [M+H]
+ : 354.1124, 
found 354.1125. 
 
(±)-(4R,5R)-4-isopropyl-4-methyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-
one: 
Racemic (S)-N-((2,3-dimethylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (53.5 mg, 0.15 mmol) was reacted according 
to the general procedure.  Purification by flash chromatography 
(gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone as a solid. Run 1 
(40.0 mg, 0.113 mmol, 75% [>20:1 dr]); run 2 (40.1 mg, 0.113 mmol, 76% [>20:1 dr]).  
Average Yield: 76%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDCl3) δ 8.34 (m, 2H), 
8.24 (m, 2H), 5.63 (ddd, J = 17.0, 10.0, 9.0 Hz, 1H), 5.41 (d, J = 17.0 Hz, 1H), 5.37 (d, J 
= 10.0 Hz, 1H), 4.87 (bs, 1H), 4.65 (d, J = 9.0 Hz, 1H), 1.88 (m, 1H), 1.04 (s, 3H), 0.97 
(d, J = 7.0 Hz, 3H), 0.96 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 153.3, 150.6, 
145.1, 132.5, 129.9, 124.0, 121.0, 66.6, 61.3, 37.4, 18.6, 17.3, 16.5; IR (film, cm-1): 
3217 (br), 3118, 2968, 1732, 1533; HRMS (ESI) m/z calc'd for C15H20N3O5S [M+H]
+ : 
354.1124, found 354.1119. 
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(-)-(4S,5R)-4-((S)-1,2-bis(benzyloxy)ethyl)-1-((4-nitrophenyl)sulfonyl)-5-
vinylimidazolidin-2-one: Optically pure (-)-N-(((2S,3S)-1,2-
bis(benzyloxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (53.9 mg, 0.1 mmol) was reacted 
according to the general procedure.  Purification by flash 
chromatography (gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone 
as a solid. Run 1 (28.0 mg, 0.052 mmol, 52% [>20:1 dr]); run 2 (26.9 mg, 0.050 mmol, 
50% [>20:1 dr]).  Average Yield: 51%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDCl3) 
δ 8.19 (m, 2H), 8.11 (m, 2H), 7.22-7.38 (m, 10H), 5.80 (ddd, J = 17.0, 10.0, 7.3 Hz, 1H), 
5.39 (d, J = 17.5 Hz, 1H), 5.29 (d, J = 10.5 Hz, 1H), 4.97 (bs, 1H), 4.88 (dd, J = 7.5, 1.5 
Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.51 (ap. q, J = 11.8 Hz, 2H), 4.42 (d, J = 12.0 Hz, 
1H), 3.62-3.56 (m, 2H), 3.54 (ddd, J = 6.0, 2.0, 1.5 Hz, 1H), 3.44 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 154.1, 150.5, 144.8, 137.3, 137.2, 135.0, 129.8, 128.8, 128.8, 128.4, 
128.3, 128.0, 128.0, 123.9, 119.1, 77.7, 73.8, 72.4, 67.3, 61.1, 57.4; IR (film, cm-1): 
3280 (br), 3111, 2868, 1736, 1531; HRMS (ESI) m/z calc'd for C27H28N3O7S [M+H]
+ : 
538.1648, found 538.1650. [α]D
26.8 = -40.3o (c = 0.17, CHCl3). 
 
(-)-(4R,5S)-4-((S)-1,2-bis(benzyloxy)ethyl)-1-((4-nitrophenyl)sulfonyl)-5-
vinylimidazolidin-2-one: Optically pure (-)-N-(((2S,3R)-1,2-
bis(benzyloxy)hex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide (53.9 mg, 0.1 mmol) was reacted 
according to the general procedure.  Purification by flash 
chromatography (gradient 25-30% EtOAc/hexanes) provided the anti- imidazolidinone 
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as a solid. Run 1 (22.0 mg, 0.041 mmol, 41% [>20:1 dr]); run 2 (23.1 mg, 0.043 mmol, 
43% [>20:1 dr]).  Average Yield: 42%, >20:1 dr (anti:syn). 1H NMR (500 MHz, CDCl3) 
δ 8.17 (m, 2H), 8.13 (m, 2H), 7.37-7.23 (m, 10H), 5.81 (ddd, J = 17.0, 10.0, 8.0 Hz, 1H), 
5.32 (bs, 1H), 5.27 (d, J = 10.0 Hz, 1H), 5.26 (d, J = 16.5 Hz, 1H), 4.65 (d, J = 12.0 Hz, 
1H), 4.63-4.61 (m, 1H), 4.50 (s, 2H), 4.42 (d, J = 11.5 Hz, 1H), 3.66 (dd, J = 10.5, 4.5 
Hz, 1H), 3.55 (dd, J = 10.5, 3.5 Hz, 1H), 3.50 (dd, J = 3.8, 3.5 Hz, 1H), 3.44 (dd, J = 7.5, 
4.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 154.3, 150.5, 144.7, 137.2, 137.1, 135.0, 
129.6, 128.8, 128.8, 128.4, 128.3, 128.1, 128.0, 124.0, 119.5, 76.6, 73.8, 72.0, 68.2, 
62.2, 58.3; IR (film, cm-1): 3316 (br), 2922, 2854, 1738, 1531; HRMS (ESI) m/z calc'd for 
C27H28N3O7S [M+H]
+ : 538.1648, found 538.1644. [α]D
24 = -3.1o (c = 0.05, CHCl3). 
 
(±)- (4R,5R)-4-(4-methoxybenzyl)-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-
one: 
Racemic (±)-N-((1-(4-methoxyphenyl)pent-4-en-2-
yl)carbamoyl)-4-nitrobenzenesulfonamide (41.9 mg, 0.10 
mmol) was reacted according to the general procedure.  
Purification by flash chromatography (gradient 25-30% EtOAc/hexanes) provided the 
anti- imidazolidinone as a solid. Run 1 (20.9 mg, 0.050 mmol, 50% [>20:1 dr]); run 2 
(20.0 mg, 0.048 mmol, 48% [>20:1 dr]).  Average Yield: 49%, >20:1 dr (anti:syn). 1H 
NMR (500 MHz, CDCl3) δ 8.33 (d,  J = 9.0 Hz, 2H), 8.16 (d, J = 9.5 Hz, 2H), 7.06 (d, J = 
9.0 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 5.77 (ddd, J = 17.0, 10.0, 8.5 Hz, 1H), 5.38 (d, J = 
17.0 Hz, 1H), 5.31 (d, J = 10.0 Hz, 1H), 5.07 (bs, 1H), 4.56 (dd, J = 8.5, 2.5 Hz, 1H), 
3.79 (s, 3H), 3.51 (m, 1H), 2.87 (dd, J = 14.0, 5.3 Hz, 1H), 2.72 (dd, J = 13.8, 8.5 Hz, 
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1H); 13C NMR (125 MHz, CDCl3) δ 159.1, 153.7, 150.7, 144.7, 134.4, 130.4, 129.9, 
127.1, 124.1, 119.9, 114.6, 64.4, 57.6, 55.4, 40.2; IR (film, cm-1): 3339 (br), 2929, 1738, 
1531; HRMS (ESI) m/z calc'd for C19H20N3O6S [M+H]
+ : 418.1073, found 418.1072. 
 
Determination of Stereochemical Stability 
 
(+)-(S)-benzyl(2-methylhex-5-en-3-yl)carbamate: The allylic amine hydrochloride salt 
was synthesized according to the procedure described by 
Ellman and coworkers.20 The amine salt (1 equiv.) was dissolved 
in THF (0.2M) and the reaction flask was cooled to 0 °C. DIPEA 
(4 equiv.) was added via syringe and the reaction mixture was stirred at 0 °C for 2-3 
minutes. Benzyl chloroformate (1.05 equiv.) was then added dropwise via syringe, 
followed by the immediate formation of a white precipitate. The reaction mixture was 
stirred at 0 °C until complete by TLC. A saturated solution of ammonium chloride was 
added to quench the reaction and the aqueous layer was extracted with ethyl ether (3x). 
The organic layers were dried with MgSO4, filtered through a pad of Celite and 
concentrated in vacuo. The crude reaction mixture was purified via column 
chromatography using 15% EtOAc/Hexanes. The product was obtained as a white solid 
in quantitative yield. 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.38 (m, 5H), 5.77 (m, 1H), 
5.04 - 5.14 (m, 4H), 4.55 and 4.33 (rotomer, m, 0.85H:0.15H), 3.50-3.62 (rotomer, m, 
1H, peaks overlap), 2.28 (m, 1H), 2.13 (m, 1H), 1.77 (m, 1H), 0.93 (d, J = 7.0 Hz, 3H), 
0.89 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 156.4, 136.8, 134.9, 128.5, 
128.0 (br), 117.4, 66.5, 55.8, 36.9, 31.5, 19.3, 17.8; IR (film, cm-1): 3329, 3068, 3033, 
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2962, 2873, 1695, 1535; HRMS (ESI) m/z calc'd for C15H22NO2 [M+H]
+: 248.1651, found 
248.1646. [α]D
23.9 = +31.5o (c = 0.25, CHCl3).  
Racemic standard (±)-benzyl(2-methylhex-5-en-3-yl)carbamate was synthesized 
according to this procedure.  Chrial HPLC (Chiral Technologies Inc. Chiralcel OJ-H 
column (0.46 cm x 25 cm)) was used to determine the enantio-purity of (+)-(S)-benzyl(2-
methylhex-5-en-3-yl)carbamate which was determined to be >99% ee. 
 
(+)-(4R,5S)-4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: 
Enantiopure (+)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide was synthesized from the same enantiopure 
chiral amine used in the formation of the above (+)-(S)-benzyl(2-
methylhex-5-en-3-yl)carbamate. (+)-N-((2-methylhex-5-en-3-yl)carbamoyl)-4-
nitrobenzenesulfonamide was then subjected to the standard syn- reaction conditions to 
yield (+)-(4R,5S)-4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: 
[α]D
25.7 = +25.8o (c = 0.46, CHCl3).  Chiral HPLC (Chiral Technologies Inc. Chiralcel OJ-
H column (0.46 cm x 25 cm)) was used to determine the enantio-purity to be >99% ee.  
This result indicates that the syn- allylic C—H amination proceeds with no erosion of ee. 
 
(+)-(4R,5R)-4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: (*)-N-
((2-methylhex-5-en-3-yl)carbamoyl)-4-nitrobenzenesulfonamide was 
subjected to the standard anti- reaction conditions to yield (+)-(4R,5R)-
4-isopropyl-1-((4-nitrophenyl)sulfonyl)-5-vinylimidazolidin-2-one: [α]D
27.0 
= +66.3o (c = 1.0, CHCl3). Chiral HPLC (Chiral Technologies Inc. 
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Chiralcel OJ-H column (0.46 cm x 25 cm)) was used to determine the enantio-purity to 
be >99% ee.  This result indicates that the anti- allylic C—H amination proceeds with no 
erosion of ee. 
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Chapter 4 
Pd(II) Catalyzed Intramolecular C—H Oxidation of Non-Acidic Phenol Nucleophiles 
to Form Chroman Heterocycles 
 
4.1 INTRODUCTION 
Heterocycles are ubiquitous motifs in natural products and pharmaceutical 
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compounds; in 2011 40 of the top 50 drugs contained at least one heterocycle. Owing to 
this prevalence, a plethora of methods have been developed to construct heterocycles, 
and specifically chromans.1 Highly functionalized chromans form the core architecture of 
numerous natural products and other biologically active molecules (Figure 6). We 
believe that using C—H activation to access heterocycles provides a unique, powerful 
retrosynthetic disconnect that will be of interest to medicinal chemists.2 
 
   
 
 
 
 
 
 
 
 
 
Using Palladium (II)/sulfoxide catalyst 1 our group has demonstrated a variety of 
functionalization reactions using Brønsted acidic nucleophiles.3 We have shown that 
decreasing the acidity of the nucleophile results in decreased conversions.3e  We 
postulate that non-acidic nucleophiles can be detrimental to desired reactivity in three 
ways: attenuation of the highly electrophilic catalyst 1 via direct nucleophile-catalyst 
interaction inhibits C―H cleavage (Figure 7A), deprotonation of the non-acidic pro-
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nucleophile by the acetate counterion is significantly reduced resulting in decreased 
concentration of active nucleophilic species (Figure 7B), and direct olefin-nucleophile 
functionalization (Figure 7C).  Despite these potential limitations, we report a modified 
Pd(II)/sulfoxide catalyst that enables a concise, flexible route to the important chroman 
motif.   
 
4.2 RESULTS AND DISCUSSION 
4.2.1 Reaction Optimization 
 When subjecting phenol 59 to our standard reaction conditions low yields of the 
chroman product 60 and high conversion of starting material was observed (18% yield, 
71% conversion; Table 9, Entry 1).  We have previously demonstrated that catalytic 
amounts of both CrSalenCl3f and DIPEA3g enhance reactivity for allylic C―H 
functionalizations. Interestingly, the addition of CrSalenCl showed a modest 
improvement in the desired product formation (40% yield, 100% conversion; Table 9, 
Entry 2) while DIPEA did not show any conversion towards the desired reactivity (0% 
yield, <5% conversion; Table 9, Entry 3).  This result indicated that activation via a 
Lewis Acid/electrophile interaction is possible while activation via a Brønsted 
Base/nucleophile interaction is not.  Additionally, we recognized that directly altering the 
nucleophile to increase the overall acidity through aryl substitutions would come at the 
expense of substrate generality. In addition to additive effects on allylic C―H 
functionalizations  we have also shown that slight modifications to the bis-sulfoxide 
ligand can improve the overall reactivity of previously inaccessible nucleophiles.4  By 
switching from the standard catalyst 1 to the benzyl bis-sulfoxide catalyst 61, we 
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observed improved reaction selectivity (41% yield, 69% conversion; Table 9, Entry 4).  
Encouraged by this result, we used the slightly less electrophilic n-propyl bis-sulfoxide 
catalyst 62, resulting in even further improved yields while maintaining modest 
selectivity (55% yield, 80% conversion; Table 9, Entry 5).  For both catalysts 61 and 62 
palladium mirror was observed and increased reaction time did not improve conversion.  
Interestingly, switching solvent from THF to DCE improved the yields for all three 
catalysts.  Under these conditions catalyst 1 and 61 reached modest overall yields, 
although the reaction selectivities were still poor (60% yield, 100% conversion; Table 9, 
Entry 6 : 50% yield, 90% conversion; Table 9, Entry 7). Excitingly, using catalyst 62, this 
solvent switch further improved the yield of chroman product 60 while maintaining high 
selectivity (79% yield, 100% conversion; Table 9, Entry 7).  Interestingly, even this 
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simple, unsubstituted motif has shown activity as a Prostaglandin D2 receptor 
antagonist (Figure 6, compound 52).5 
4.2.2 Reaction Scope 
 After optimization of the reaction conditions to form chroman 60 (79% yield) we 
were excited to test the substrate generality of this reaction.  Gratifyingly, we  have 
reached our goal of a substrate general palladium catalyzed allylic C―H oxidation to 
form chroman motifs. Both electron donating p-methyl substituted chroman 63 (80% 
yield) and p-methoxy substituted chroman 64 (78% yield) were formed in synthetically 
useful yields.  Interestingly, electron withdrawing p-triflate 65 (80% yield) and p-nitro 66 
(84% yield) chromans were produced in similarly high yields.  The p-nitro motif maps 
onto a K-opioid agonist (Figure 6, compound 55).6  Additionally, p-triflate chroman 65 
demonstrates the orthogonality of this method to traditional palladium(0) catalyzed cross 
coupling reactions, allowing for a readily accessible handle for future diversification. 
Additionally, electron donating and withdrawing functionality is tolerated in the meta 
position.  Chroman 67, containing pharmacologically useful m-fluoro substitution, is 
produced in good yield (69% yield). This chroman substitution pattern has shown 
activity for the treatment of depression (Figure 6, compound 53).7 Chroman 68, 
containing m-methoxy substitution, is accessed in high yield (81% yield) and represents 
a motif found in biologically active compounds shown to be both gastric fundus 
relaxants and guanidine selective vasoconstrictors (Figure 6, compounds 548 and 569).  
Substitutions along the alkyl ring are also tolerated under these reaction conditions.  
Sterically bulky, cyclic-ketal containing 69 proceeds in high yield (72% yield). Chromans 
with ketone substitution at this position have shown promise as MRSA antibiotics as 
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well as poly (ADP-ribose) polymerase inhibitors (Figure 6, compounds 5710 and 5811).  
Additionally, direct carbon-oxygen substitution is tolerated, allowing for modest yields of 
complex heterocycles such as 70 (53% yield, 23% RSM).  This modification was shown 
to improve the Prostaglandin D2 receptor antagonism previously mentioned during the 
discussion of Table 1 (Figure 6, compound 52).5 
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4.2.3 Mechanistic Insights 
Due to the overall substrate generality for both electron rich and poor phenol 
starting materials we were interested to see if this process was undergoing a similar 
mechanism as our acid nucleophile C―H activation systems.3 Upon determination of 
the intital rates of formation for chromans 60, 63, 64, 65 and 66 a Hammett analysis 
was conducted (Figure 8).12  The results show a positive ρ value of 0.43 (R2 = 0.96) 
indicating a slight negative charge build up for this reaction.  A ρ value that is greater 
than zero but less than 1 demonstrates that the reaction is less sensitive to substituent 
effects than benzoic acid pKa values, a result that provides a rational for the high 
substrate generality for this method.   
 
Additionally, when subjecting internal olefin substrate 71 (86:14 E:Z) to our 
standard reaction conditions, no chroman product formation was observed (Figure 9).  It 
has been previously demonstrated that internal olefins are competent electrophiles for 
Figure 8. Hammett Plot of Initial Rate Data for Pd-Catalyzed Chroman Formation
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direct olefin interaction under Pd(II) catalyzed oxy-palladation conditions to form both 
chroman and dihydrobenzofuran motifs.13  The lack of reactivity of internal olefin 
substrate 71 under our standard reaction conditions indicate that an isomerization/oxy-
palladation pathway is not operative.   
 
Figure 10a depicts our favored mechanism for acid nucleophile functionalization 
in which endogenous acetate base deprotonates the phenol nucleophile before 
functionalization.  Interestingly, despite the significant increase in pKa for the phenol 
proton relative to traditional acidic nucleophiles, our results suggest that this reaction is 
proceeding through a similar mechanism to the methods previously developed by our 
group (Figure 10b).3   
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4.3 CONCLUSIONS 
We have developed a novel C—H oxidation reaction that uses a tuned 
Pd(II)/nPr-bissulfoxide catalyst in combination with a Lewis acid co-catalyst to promote 
the functionalization of non-acidic phenol nucleophiles to form chroman heterocycles.  
We have demonstrated the biological importance of this method by showcasing a broad 
substrate scope that contains key chroman motifs found within a variety of biologically 
active complex molecules.  Additionally, we have performed preliminary mechanistic 
studies that suggest this reaction is proceeding through a similar mechanism to our 
previously published C—H activation systems.  These results further demonstrated the 
potential for complex substrate generality due to the minimal substituent effect of aryl 
substitution.  As a result, we anticipate that this method will be used to generate 
libraries of medicinally relevant chroman synthons with an immediate impact on the 
medicinal chemistry field.  Furthermore, we anticipate that the strategies used to 
promote the functionalization of non-acidic phenols will be applied to future methods 
using similarly non-acidic nucleophiles. 
 
4.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic amination 
reaction were used as received; Pd(OAc)2 (Johnson-Matthey Chemicals) and Pd[1,2-
bis(phenylsulfinyl)ethane](OAc)2 “Catalyst 1” (Strem Chemicals and Sigma-Aldrich) 
were stored in a glove box under an argon atmosphere at -20°C and weighed out in the 
air prior to use. Catalyst 1 was also prepared according to the published procedure
2c
 
and used interchangeably with commercial catalyst. Catalyst 61 was prepared 
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according to the published procedure.
4  Tetrahydrofuran was purified prior to use by 
passage through a bed of activated alumina (Glass Contour, Laguna Beach, California). 
1,2-dichloroethane was obtained from Sigma-Aldrich and used as received. 1,2-
bis(propylthio)ethane was synthesized according to the published procedure.
4
 All allylic 
oxidation reactions were run under ambient air with no precautions taken to exclude 
moisture. All other reactions were run over a stream of N2 gas unless otherwise stated. 
Thin-layer chromatography (TLC) was conducted with E. Merck silica gel 60 F254 
precoated plates (0.25 mm) and visualized with UV and potassium permanganate stain. 
Flash chromatography was performed as described by Still using ZEOprep 60 ECO 43-
60 micron silica gel (American International Chemical, Inc.).21 1H NMR spectra were 
recorded on a Varian Unity-400 (400 MHz), Varian Inova-500 (500 MHz), or Varian 
Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal 
standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sext. = sextet, sept. = septet, m = multiplet, b = broad, ap = 
apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C NMR spectra 
were recorded on a Varian Unity-400 (100 MHz) and Varian Unity-500 (125 MHz) 
spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 
77.16 ppm). IR spectra were recorded as thin films on NaCl plates on a Perkin-Elmer 
Spectrum BX and are reported in frequency of absorption (cm-1). High-resolution mass 
spectra were obtained at the University of Illinois Mass Spectrometry Laboratory.  
 
General Procedure for Synthesis of Catalyst 62 
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(±)-(meso)-1,2-bis(propylsulfinyl)ethane: In a pressure sealed tube was added 1,2-
bis(propylthio)ethane (1 equiv.), DMSO (XX M), HCl (conc., XX M) 
and a Teflon stir bar.  The tube was capped and placed into a 100°C 
oil bath and stirred overnight (16 hours). The sealed tube was then cooled in an ice bath 
until white precipitate formed. The solid was filtered and rinsed with Et2O. The 
supernatant was then chilled in an ice bath and any newly formed precipitate filtered in 
the same manner as before.  This was continued until no precipitate forms.  The crude 
solids were combined and then dissolved into a minimum amount of refluxing acetone. 
Upon dissolution, the flask was cooled to -20°C resulting in the precipitation of a white 
solid.  The solid was filtered and rinsed with ice cold acetone yielding (±)-(meso)-1,2-
bis(propylsulfinyl)ethane as a white solid (>95% yield meso, >32% yield based upon 
total starting sulfide).   1H NMR (500MHz, CDCl3) δ 3.19 (m, 2H), 2.99 (m, 2H), 2.82 (m, 
2H), 2.67 (m, 2H), 1.83 (o, J = 7.4 Hz, 4H), 1.10 (t, J = 7.3 Hz, 6H); 13C NMR (125 MHz, 
CDCl3) δ 55.3, 45.1, 16.5, 13.5; IR (film, cm
-1): 3340 (br), 2959, 2914, 2873, 1011; 
HRMS (ESI) m/z calc’d for C8H18O2S2Na [M+Na]+: 233.0646; found 233.0650. 
 
Recrystallization of Pd(OAc)2: Pd(OAc)2 was dissolved in minimal refluxing benzene. 
A black precipitate was removed by hot Acrodisc® filtration. The resulting solution was 
cooled to room temperature without further manipulation. Amber crystals began to form 
after ~2 hours. After 24 hours the solution was filtered to give the recrystallized 
Pd(OAc)2. For spectral data see reference 6a. 
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Catalyst 62: A flame dried 50 mL flask fitted with a condenser under argon atmosphere 
was charged with (±)-(meso)-1,2-bis(propylsulfinyl)ethane (0.42 g, 
2.0 mmol), Pd(OAc)2 (0.45 g, 2.0 mmol), and CH2Cl2 (22 mL). The 
mixture was stirred at 45°C for exactly 1h (longer complexation 
times result in lower catalyst activity). The solution becomes dark red and 
homogenous during the reaction time. The solution was concentrated in vacuo and 
dried with a stream of N2 for 24 h to give a dark red solid used without further 
purification. NOTE: The catalyst must be stored at or below 4°C. The catalyst slowly 
decomposes at ambient temperature; however, it may be stored for prolonged periods 
(months) at reduced temperatures. 1H NMR and IR spectra of this catalyst look like (±)-
(meso)-1,2-bis(propylsulfinyl)ethane and Pd(OAc)2.  
 
General Synthesis of Phenol Starting Materials 
*Route used was dependent upon availability of starting material* 
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General Starting Material Synthesis A: To a flask opened to air was added a Teflon 
stir bar, the corresponding α-tetralone starting material (1.0 
equiv.) and dichloromethane (0.50 M) then placed on a 
magnetic stir plate.  mCPBA (1.8 equiv.) was then added to the stirring reaction flask at 
room temperature.  The temperature was then raised to reflux and allowed to stir until 
conversion by TLC analysis (24-72h).  Upon complete conversion, the reaction was 
cooled in an ice bath and quenched SLOWLY with sat. aq. Sodium Bisulfite solution.  
The solution was then transferred to an appropriate sepratory funnel.  The organic layer 
was then washed 5 X 10% aqueous NaOH (wash volumes being equal to the organic 
volume).  The organic layers were combined and dried over MgSO4, filtered and 
concentrated in vacuo. The crude lactone was carried forward with no further 
purification. 
 To a flame dried flask containing a Teflon stir bar was added the corresponding 
lactone (1.0 equiv.) and toluene (0.10 M).  The reaction was taken to -78°C followed by 
the dropwise addition of DIBAL-H (1.0 M in hexanes; 1.1 equiv.).  Upon complete 
conversion by TLC analysis (2h) the reaction was slowly quenched with sat. aq. 
Rochelle’s salt.  The quenched reaction was allowed to warm to room temperature at 
which point additional sat. aq. Rochelle’s salt (equal volume to the organic layer) was 
added.  The biphasic mixture was stirred vigorously overnight.  The solution was then 
transferred to an appropriate separatory funnel.  The aqueous layer was washed 3 X 
EtOAc. The organic layers were combined and dried over MgSO4, filtered and 
concentrated in vacuo. The crude aldehyde was carried forward with no further 
purification. 
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 To a flame dried flask containing a Teflon stir bar was added Ph3P―CH2Br (4.0 
equiv.) and THF (0.10 M).  The flask was place in an ice bath followed by the rapid 
addition of solid KtBuO (3.9 equiv.).  The solution immediately turns bright yellow 
(heterogeneous mixture) and is allowed to stir for 30 min.  The corresponding aldehyde 
(1.0 equiv.) in THF (1.0 M) was then added via canula and stirred for an additional 2 
hours.  Upon completion by TLC analysis the reaction was quenched with sat. aq. 
NH4Cl solution. The solution was transferred to an appropriate separatory funnel and 
the aqueous layer is extracted 3 X Et2O. The organic layers were combined and dried 
over MgSO4, filtered and concentrated in vacuo.  The crude reaction mixture was 
purified using flash column chromatography (7-10% EtOAc/Hexanes) providing the 
corresponding phenol starting materials.   
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General Starting Material Synthesis A: To a flask containing a Teflon stir bar was 
added the aryl iodide starting material (1.0 equiv.), 
tetrabutylammonium chloride (1 equiv.), NaHCO3 (2.5 equiv.) 
and DMF (1.0 M).  The solution was then degassed by passing a stream of N2 gas 
directly through the solution for 1 hour.  Pd(OAc)2 (2.0 mol%) was then added quickly in 
one portion followed by the addition of but-3-en-1-ol (1 equiv.).  The flask was placed in 
an 85°C oil bath and stirred until completion by TLC analysis (24-72h).  Upon complete 
conversion, the mixture was dissolved in water (equal volume to DMF used), transferred 
to an appropriate separatory funnel and extracted 3X EtOAc (equal volume to DMF 
used).  The organic layers were then combined and washed 3X sat. aq. Na2CO3 and 3X 
10% aq. HCl solution.  The organic layers were combined and dried over MgSO4, 
filtered and concentrated in vacuo. The crude aldehyde was carried forward with no 
further purification.   
 To a flame dried flask containing a Teflon stir bar was added Ph3P―CH2Br (4.0 
equiv.) and THF (0.10 M).  The flask was place in an ice bath followed by the rapid 
addition of solid KtBuO (3.9 equiv.).  The solution immediately turns bright yellow 
(heterogeneous mixture) and is allowed to stir for 30 min.  The corresponding aldehyde 
(1.0 equiv.) in THF (1.0 M) was then added via canula and stirred for an additional 2 
hours. Upon completion by TLC analysis the reaction was quenched with sat. aq. NH4Cl 
solution. The solution was transferred to an appropriate separatory funnel and the 
aqueous layer is extracted 3 X Et2O. The organic layers were combined and dried over 
MgSO4, filtered and concentrated in vacuo.  The crude reaction mixture was purified 
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using flash column chromatography (7-10% EtOAc/Hexanes) providing the 
corresponding methyl protected phenol precursor. 
 To a flame dried flask fitted with a reflux condenser and containing a Teflon stir 
bar was added NaH (2.2 equiv.) and DMF (0.66 M based upon starting methyl protected 
phenol precursor).  The flask was then placed into an ice bath followed by the dropwise 
addition of ethanethiol (2.4 equiv.).  Upon complete addition the solution becomes clear 
yellow (if the solution is still heterogeneous, add ethanethiol dropwise until clear).  The 
corresponding methyl protected phenol precursor (1 equiv.) in DMF (0.66 M) was then 
added via canula.  The reaction was then refluxed until complete conversion by TLC 
analysis (~2h).  The solution was cooled to room temperature, dissolved in water (equal 
volume to DMF used), transferred to an appropriate separatory funnel and extracted 3X 
EtOAc (equal volume to DMF used). The organic layers were combined and dried over 
MgSO4, filtered and concentrated in vacuo.  The crude reaction mixture was purified 
using flash column chromatography (7-10% EtOAc/Hexanes) providing the 
corresponding phenol starting materials.   
 
 (±)-2-(pent-4-en-1-yl)phenol: Product obtained as a clear oil.  1H NMR (500MHz, 
CDCl3) δ 7.11 (m, 2H), 6.88 (ap. t, J = 7.3 Hz, 1H), 6.77 (d, J = 
8.0 Hz, 1H), 5.87 (m, 1H), 5.06 (d, J = 17.0 Hz, 1H), 5.00 (d, J = 
9.5 Hz, 1H), 4.70 (bs, 1H), 2.63 (t, J = 7.5 Hz, 2H), 2.14 (q, J = 7.0 Hz, 2H), 1.74 (p, J = 
7.5 Hz, 2H);  13C NMR (125 MHz, CDCl3) δ 153.5, 138.8, 130.4, 128.3, 127.3, 120.9, 
115.4, 115.0, 33.5, 29.4, 29.0; IR (film, cm-1): 3448 (br), 2929, 2860, 1639, 1591, 1502, 
1454; HRMS (EI) m/z calc’d for C11H14O [M]+: 162.10447; found 162.10534. 
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 (±)- 4-methyl-2-(pent-4-en-1-yl)phenol: Product obtained as a clear oil.  1H NMR 
(500MHz, CDCl3) δ 6.90 (m, 2H), 6.66 (d, J = 8.0 Hz, 1H), 5.86 
(m, 1H), 5.05 (d, J = 17.0 Hz, 1H), 4.99 d, J = 10 Hz, 1H), 4.46 
(s, 1H), 2.58 (t, J = 7.8 Hz, 2H), 2.26 (s, 3H), 2.13 (ap. q, J = 7.2 Hz, 2H), 1.72 (p, J = 
7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 151.3, 138.8, 131.1, 130.1, 128.1, 127.6, 
115.2, 33.6, 29.4, 29.2, 20.7; IR (film, cm-1): 3438 (br), 3076, 3008, 2976, 2927, 2861, 
1508; HRMS (EI) m/z calc’d for C12H16O [M]+: 176.12012; found 176.12041. 
 
 (±)-4-methoxy-2-(pent-4-en-1-yl)phenol: Product obtained as a white solid.  1H NMR 
(500MHz, CDCl3) δ 6.62-6.70 (m, 3H), 5.85 (m, 1H), 4.98-
5.08 (m, 2H), 4.36 (s, 1H), 3.76 (s, 3H), 2.59 (ap t, J = 7.8 
Hz, 2H), 2.13 (ap. q, J = 7.2 Hz, 2H), 1.72 (p, J = 7.5 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 153.8, 147.6, 138.8. 129.6, 116.0, 116.0, 115.0, 111.9, 55.9, 33.5, 29.7, 29.0; 
IR (film, cm-1): 3402 (br), 2935, 2860, 2835, 1506, 1434; HRMS (EI) m/z calc’d for 
C12H16O2 [M]+: 192.11503; found 192.11553. 
 
 (±)-4-hydroxy-3-(pent-4-en-1-yl)phenyl trifluoromethanesulfonate: Product 
obtained as a clear oil.  1H NMR (500MHz, CDCl3) δ 7.01 (m, 
2H), 6.77 (d, J = 9.0 Hz, 1H), 5.84 (m, 1H), 5.06 (d, J = 17.0 
Hz, 1H), 5.02 (d, J = 10.0 Hz, 1H), 4.86 (s, 1H), 2.62 (ap. t, J = 7.8 Hz, 2H), 2.12 (q, J = 
7.2 Hz, 2H), 1.72 (p, J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 153.3, 143.2, 138.3, 
130.7, 123.0, 119.9, 117.6, 116.2, 115.4, 33.3, 29.3, 28.5; IR (film, cm-1): 3560, 3469 
OH
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(br), 3080, 2933, 2864, 1504; HRMS (EI) m/z calc’d for C12H13O4F3S [M]+: 310.04867; 
found 310.04787. 
 
 (±)-4-nitro-2-(pent-4-en-1-yl)phenol: Product obtained as a light yellow solid.  1H NMR 
(500MHz, CDCl3) δ 8.01-8.07 (m, 2H), 6.85 (d, J = 9.0 Hz, 
1H), 5.80-5.88 (m, 1H), 5.80 (bs, 1H), 5.07 (d, J = 17.0 Hz, 
1H), 5.02 (d, J = 10.5 Hz, 1H), 2.68 (ap. t, J = 7.8 Hz, 2H), 2.14 (q, J = 7.0 Hz, 2H), 1.76 
(p, J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 159.5, 141.7, 138.2, 129.6, 126.3, 
123.8, 115.5, 115.5, 33.3, 29.2, 28.4; IR (film, cm-1): 3307 (br), 3078, 2997, 2956, 2929, 
2887, 1637, 1587, 1489; HRMS (EI) m/z calc’d for C11H13O3N [M]+: 207.08955; found 
207.08907. 
 
 (±)-3-fluoro-2-(pent-4-en-1-yl)phenol: Product obtained as a clear oil.  1H NMR 
(500MHz, CDCl3) δ 7.03 (m, 1H), 6.65 (ap. t, J = 8.8 Hz, 1H), 6.58 
( d, J = 8.0 Hz, 1H), 5.88 (m, 1H), 5.08 (d, J = 17.0 Hz, 1H), 5.01 
(d, J = 9.5 Hz, 1H), 4.77 (s, 1H), 2.68 (t, J = 7.5 Hz, 2H), 2.15 (q, 
J = 7.0 Hz, 2H), 1.71 (p, J = 7.5 Hz, 2H); 162.1 (d, J = 242.1 Hz), 154.9 (d, J = 5.4 Hz), 
138.8, 127.1 (d, J = 10.8 Hz), 116.5 (d, J = 19.5 Hz), 115.0, 111.0 (d, J = 2.9 Hz), 107.9 
(d, J = 22.4 Hz), 33.5, 28.4, 22.2 (d, J = 2.9 Hz); IR (film, cm-1): 3438 (br), 3078, 2933, 
2864, 1620, 1599, 1468; HRMS (EI) m/z calc’d for C11H13OF [M]+: 180.09505; found 
180.09598. 
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 (±)-3-methoxy-2-(pent-4-en-1-yl)phenol: Product obtained as a clear oil.  1H NMR 
(500MHz, CDCl3) δ 7.03 (ap. t, J = 8.3 Hz, 1H), 6.46 (dd, J = 19.0, 
8.5 Hz, 2H), 5.88 (m, 1H), 5.04-5.08 (m. 1H), 4.97-5.00 (m, 1H), 
4.69 (s, 1H), 3.81 (s, 3H), 2.64 (ap. t, J = 7.8 Hz, 2H), 2.12 (m, 
2H), 1.64 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 158.8, 154.5, 139.3, 126.9, 116.9, 
114.6, 108.4, 103.3, 55.8, 33.7, 28.3, 22.5; IR (film, cm-1): 3413 (br). 3076, 2935, 2836, 
1595, 1470; HRMS (EI) m/z calc’d for C11H13OF [M]+: 192.11503; found 192.11519. 
  
(±)-2-(2-(but-3-en-1-yl)-1,3-dioxolan-2-yl)phenol: Product obtained as a clear oil.  1H 
NMR (500MHz, CDCl3) δ 7.19-7.27 (m, 2H), 6.86 (m, 2H), 5.79 
(m, 1H), 4.99 (m, 1H), 4.92 (m, 1H), 4,06-4.21 (m, 2H), 3,86-3.93 
(m, 2H), 2.15-2.20 (m, 2H), 2.02-2.05 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 154.9, 138.0, 130.1, 127.1, 125.5, 120.0, 117.2, 114.7, 111.6, 64.7, 38.7, 
27.6; IR (film, cm-1): 3390 (br), 3090, 3030, 3000, 2990, 1580, 1500; HRMS (EI) m/z 
calc’d for C13H16O3 [M]+: 220.10995; found 220.11058. 
 
 (±)-2-(but-3-en-1-yloxy)phenol: Product obtained as a clear oil.  1H NMR (500MHz, 
CDCl3) δ 6.82-6.94 (m, 4H), 5.89 (m, 1H), 5.64 (s, 1H), 5.19 (d, J 
= 16.5 Hz, 1H), 5.14 (d, J = 9.5 Hz, 1H), 4.11 (t, J = 6.5 Hz, 2H), 
2.57 (q, J = 6.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 146.1, 145.9, 134.3, 121.8, 120.2, 
117.7, 114.7, 112.2, 68.2, 33.8; IR (film, cm-1): 3535 (br), 3076, 2933, 2877, 1597, 1500, 
1470; HRMS (EI) m/z calc’d for C10H12O2 [M]+: 164.08373; found 164.08362. 
OH
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Optimization of Vinylchroman Reaction 
 
Entry 1: To a ½ dram borosilicate vial containing a Teflon stir bar was added Racemic 
(±)-2-(pent-4-en-1-yl)phenol (16.2 mg, 0.10 mmol), benzoquinone (21.6 mg, 0.20 mmol) 
and Catalyst 1 (5.0 mg, 0.01 mmol).   Tetrahydrofuran (0.33M) was then added to the ½ 
dram vial. The vial was then sealed and placed in an aluminum block to stir at 45 C for 
72 hours. The solution was allowed to cool to room temperature and then transferred 
using dichloromethane (10 mL) to a 60 mL separatory funnel. The organic solution was 
washed with sat. aq. NH4Cl solution (25 mL). The aqueous layer was then rinsed 2 X 10 
mL dichloromethane. The organic layers were combined and dried over MgSO4, filtered 
and concentrated in vacuo. The crude reaction mixture was purified using flash column 
chromatography (7-10% EtOAC/Hexanes) providing (±)-2-vinylchroman.  Run 1 (3.0 mg,  
Pd(OAc)2
(10 mol%)
BQ (2 equiv.),
Additive (10 mol%)
Solvent (0.33 M), 45°C ( )-60
Entry R Time Isolated
Yielda
1
2
3
4
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6
7
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Phenyl (1)
1
1
Benzyl (61)
n-Propyl (62)b
1
61
62b
72 h
16 h
24 h
16 h
16 h
16 h
16 h
16 h
18%
40%
0%
41%
57%
60%
50%
79%
S S
OO
R R
OH O
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THF
THF
THF
THF
THF
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DCE
DCE
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CrSalenCl
DIPEA
CrSalenCl
CrSalenCl
CrSalenCl
CrSalenCl
CrSalenCl
a Average of 2 runs at 0.1 - 0.3 mmol. b Meso ligand used; use of racemic ligand
results in slightly lower yields (see SI).
( )-59
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71%
100%
<5%
69%
80%
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90%
100%
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0.019 mmol, 19% yield, 69% conversion); Run 2 (2.7 mg, 0.017 mmol, 17% yield, 74% 
Conversion). Average: 18% Yield, 71% Conversion. 
 
Entry 2: To a ½ dram borosilicate vial containing a Teflon stir bar was added Racemic 
(±)-2-(pent-4-en-1-yl)phenol (16.2 mg, 0.10 mmol), benzoquinone (21.6 mg, 0.20 mmol), 
Catalyst 1 (5.0 mg, 0.01 mmol), and Cr(III)(salen)Cl (6.3 mg, 0.01 mmol).   
Tetrahydrofuran (0.33M) was then added to the ½ dram vial. The vial was then sealed 
and placed in an aluminum block to stir at 45 °C for 16 hours. The solution was allowed 
to cool to room temperature and then transferred using dichloromethane (10 mL) to a 60 
mL separatory funnel. The organic solution was washed with sat. aq. NH4Cl solution (25 
mL). The aqueous layer was then rinsed 2 X 10 mL dichloromethane. The organic 
layers were combined and dried over MgSO4, filtered and concentrated in vacuo. The 
crude reaction mixture was purified using flash column chromatography (7-10% 
EtOAC/Hexanes) providing (±)-2-vinylchroman.  Run 1 (6.9 mg, 0.043 mmol, 43% yield, 
100% conversion); Run 2 (6.1 mg, 0.038 mmol, 38% yield, 100% conversion). Average: 
40% Yield, 100% Conversion. 
 
Entry 3: To a ½ dram borosilicate vial containing a Teflon stir bar was added Racemic 
(±)-2-(pent-4-en-1-yl)phenol (16.2 mg, 0.10 mmol), benzoquinone (21.6 mg, 0.20 mmol), 
Catalyst 1 (5.0 mg, 0.01 mmol), and N,N-Diisopropylethylamine (1.7 µL, 0.01 mmol).   
Tetrahydrofuran (0.33M) was then added to the ½ dram vial. The vial was then sealed 
and placed in an aluminum block to stir at 45 °C for 24 hours. The solution was allowed 
to cool to room temperature and then transferred using dichloromethane (10 mL) to a 60 
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mL separatory funnel. The organic solution was washed with sat. aq. NH4Cl solution (25 
mL). The aqueous layer was then rinsed 2 X 10 mL dichloromethane. The organic 
layers were combined and dried over MgSO4, filtered and concentrated in vacuo. The 
crude reaction mixture was purified using flash column chromatography (7-10% 
EtOAC/Hexanes) providing (±)-2-vinylchroman.  Run 1 (0.0 mg, 0.0 mmol, 0.0% yield); 
Run 2 (0.0 mg, 0.0 mmol, 0.0% yield). Average: 0.0% Yield, <5% Conversion. 
 
Entry 4: Following the procedure outlined in Entry 2, Catalyst 1 was replaced with 
Catalyst 61 (5.3 mg, 0.01 mmol). Run 1 (6.7 mg, 0.042 mmol, 42% yield, 68% 
conversion); Run 2 (6.4 mg, 0.040 mmol, 40% yield, 70% conversion). Average: 41% 
Yield, 69% Conversion. 
 
Entry 5: Following the procedure outlined in Entry 2, Catalyst 1 was replaced with 
Catalyst 62 (4.4 mg, 0.01 mmol). Run 1 (9.1 mg, 0.057 mmol, 57% yield, 79% 
conversion); Run 2 (9.5 mg, 0.059 mmol, 59% yield, 81% conversion). Average: 58% 
Yield, 80% Conversion. 
 
Entry 6: Following the procedure outlined in Entry 2, tetrahydrofuran was replaced with 
1,2-dichloroethane (0.33M). Run 1 (9.5 mg, 0.059 mmol, 59% yield, 100% conversion); 
Run 2 (9.8 mg, 0.061 mmol, 61% yield). Average: 60% Yield, 100% Conversion. 
 
Entry 7: Following the procedure outlined in Entry 2, Catalyst 1 was replaced with 
Catalyst 61 (5.3 mg, 0.01 mmol) and tetrahydrofuran was replaced with 1,2-
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dichloroethane (0.33M). Run 1 (7.7 mg, 0.048 mmol, 48% yield, 90% conversion); Run 
2 (8.3 mg, 0.052 mmol, 52% yield, 90% conversion). Average: 50% Yield, 90% 
Conversion. 
 
Entry 2: To a ½ dram borosilicate vial containing a Teflon stir bar was added Racemic 
(±)-2-(pent-4-en-1-yl)phenol (32.4 mg, 0.20 mmol), benzoquinone (43.2 mg, 0.40 mmol), 
Catalyst 62 (8.8 mg, 0.02 mmol), and Cr(III)(salen)Cl (12.6 mg, 0.02 mmol).   1,2-
Dichloroethane (0.33M) was then added to the ½ dram vial. The vial was then sealed 
and placed in an aluminum block to stir at 45 °C for 16 hours. The solution was allowed 
to cool to room temperature and then transferred using dichloromethane (10 mL) to a 60 
mL separatory funnel. The organic solution was washed with sat. aq. NH4Cl solution (25 
mL). The aqueous layer was then rinsed 2 X 10 mL dichloromethane. The organic 
layers were combined and dried over MgSO4, filtered and concentrated in vacuo. The 
crude reaction mixture was purified using flash column chromatography (7% 
EtOAC/Hexanes) providing (±)-2-vinylchroman.  Run 1 (26.3 mg, 0.164 mmol, 82% 
yield, 100% conversion); Run 2 (24.4 mg, .152 mmol, 76% yield, 100% conversion). 
Average: 79% Yield, 100% Conversion. 
 
General Procedure for Phenol Functionalization Reaction to form vinylchromans: 
To a ½ dram borosilicate vial containing a Teflon stir bar was added the corresponding 
phenol starting material (1 equiv.), benzoquinone (2.0 equiv.), Catalyst 62 (0.10 equiv.) 
and Cr(III)(salen)Cl  (0.10 equiv.). 1,2-Dichloroethane (0.33M) was then added to the ½ 
dram vial. The vial was then sealed and placed in an aluminum block to stir at 45 °C for 
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16 hours (unless otherwise noted). The solution was allowed to cool to room 
temperature and then transferred using dichloromethane (10 mL) to a 60 mL separatory 
funnel. The organic solution was washed with sat. aq. NH4Cl solution (25 mL). The 
aqueous layer was then rinsed 2 X 10 mL dichloromethane. The organic layers were 
combined and dried over MgSO4, filtered and concentrated in vacuo. The crude reaction 
mixture was purified using flash column chromatography (7-10% EtOAC/Hexanes). 
 
 (±)-2-vinylchroman:  Racemic (±)-2-(pent-4-en-1-yl)phenol (32.4 mg, 0.20 mmol) was 
reacted according to the general procedure. Purification by flash 
column chromatography (7% EtOAc/hexanes) provided the 
vinylchroman as a clear oil. Run 1 (26.3 mg, 0.164 mmol, 82% yield); Run 2 (24.4 
mg, .152 mmol, 76% yield). Average: 79% Yield. 1H NMR (500MHz, CDCl3) δ 7.09 (m, 
1H), 7.04 (d, J = 7.5 Hz, 1H), 6.82-6.86 (m, 2H), 5.99 (ddd, J = 17.5, 10.5, 5.6 Hz, 1H), 
5.38 (d, J = 17.0 Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 4.56 (m, 1H), 2.86 (ddd, J = 16.5, 
10.5, 5.9 Hz, 1H), 2.77 (dt, J = 16.5, 5.0 Hz, 1H), 2.05-2.10 (m, 1H), 1.81-1.89 (m, 1H); 
13C NMR (125 MHz, CDCl3) δ 154.6, 137.7, 129.6, 127.4, 121.9, 120.3, 116.9, 116.3, 
76.2, 27.6, 24.3; IR (film, cm-1): 2926, 2854, 1583, 1489, 1458; HRMS (EI) m/z calc’d for 
C11H12O [M]+: 160.08882; found 160.08875. 
 
 (±)-6-methyl-2-vinylchroman: Racemic (±)- 4-methyl-2-(pent-4-en-1-yl)phenol (Run 1: 
35.3 mg, 0.20 mmol; Run 2: 17.6 mg, 0.10 mmol) was reacted 
according to the general procedure. Purification by flash column 
chromatography (7% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 
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(28.6 mg, 0.164 mmol, 82% yield); Run 2 (13.6 mg, .078 mmol, 78% yield). Average: 
80% Yield. 1H NMR (500MHz, CDCl3) δ 6.86-6.91 (m, 2H), 6.76 (d, J = 8.5 Hz, 1H), 
5.99 (ddd, J = 17.0, 10.8, 5.8 Hz, 1H), 5.38 (d, J = 17.5 Hz, 1H), 5.23 (d, J = 10.5 Hz, 
1H), 4.53 (m, 1H), 2.83 (ddd, J = 16.0, 10.8, 6.0 Hz, 1H), 2.73 (dt, J = 16.5, 5.0 Hz, 1H), 
2.25 (s, 3H), 2.06 (m, 1H), 1.84 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 152.4, 137.8, 
130.0, 129.4, 128.0, 121.6, 116.7, 116.3, 76.2, 27.7, 24.3, 20.6; IR (film, cm-1): 3006, 
2926, 2856, 1500, 1244, 1226; HRMS (EI) m/z calc’d for C12H14O [M]+: 174.10477; 
found 174.10468. 
 
(±)-6-methoxy-2-vinylchroman: Racemic (±)-4-methoxy-2-(pent-4-en-1-yl)phenol (38.4 
mg, 0.20 mmol) was reacted according to the general 
procedure. Purification by flash column chromatography (7% 
EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (30.4 mg, 0.160 mmol, 
80% yield); Run 2 (28.9 mg, .152 mmol, 76% yield). Average: 78% Yield.  1H NMR 
(500MHz, CDCl3) δ 6.78 (d, J = 9.0 Hz, 1H), 6.68 (dd, J = 9.0, 3.0 Hz, 1H), 6.59 (d, J = 
2.5 Hz, 1H), 5.98 (ddd, J = 17.0, 11.3, 5.9 Hz, 1H), 5.37 (d, J = 17.0 Hz, 1H), 5.23 (d, J 
= 10.5 Hz, 1H), 4.50 (m, 1H), 3.75 (s, 3H), 2.85 (ddd, J = 16.5, 10.8, 6.1 Hz, 1H), 2.75 
(dt, J = 16.5, 5.0 Hz, 1H), 2.05 (m, 1H), 1.84 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
153.4, 148.7, 137.8, 122.4, 117.5, 116.3, 114.2, 113.5, 76.1, 55.9, 27.7, 24.6; IR (film, 
cm-1): 2931, 2846, 1495, 1425; HRMS (EI) m/z calc’d for C12H14O2 [M]+: 190.09938; 
found 190.09961. 
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 (±)-2-vinylchroman-6-yl trifluoromethanesulfonate: Racemic (±)-4-hydroxy-3-(pent-
4-en-1-yl)phenyl trifluoromethanesulfonate (31.0 mg, 0.10 
mmol) was reacted according to the general procedure. 
Purification by flash column chromatography (7% EtOAc/hexanes) provided the 
vinylchroman as a clear oil. Run 1 (25.6 mg, 0.083 mmol, 83% yield); Run 2 (26.5 
mg, .086 mmol, 86% yield). Average: 85% Yield.  1H NMR (500MHz, CDCl3) δ 6.98 (m, 
2H), 6.87 (d, J = 8.5 Hz, 1H), 5.96 (ddd, J = 16.5, 10.8, 5.9 Hz, 1H), 5.38 (d, J = 16.5 Hz, 
1H), 5.26 (d, J = 11.0 Hz, 1H), 4.58 (m, 1H), 2.76-2.90 (m, 2H), 2.09 (m, 1H), 1.85 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 154.3, 142.6, 136.9, 123.6, 122.1, 120.3, 118.2, 
117.6, 116.9, 76.6, 26.9, 24.3; IR (film, cm-1): 2929, 2852, 1489, 1421; HRMS (EI) m/z 
calc’d for C12H11O4F3S [M]+: 308.03302; found 308.03231. 
 
 (±)-6-nitro-2-vinylchroman: Racemic (±)-4-nitro-2-(pent-4-en-1-yl)phenol (20.7 mg, 
0.10 mmol) was reacted according to the general procedure. 
Purification by flash column chromatography (7% 
EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (17.2 mg, 0.084 mmol, 
84% yield); Run 2 (XX mg, XX mmol, XX% yield). Average: XX% Yield. ( 1H NMR 
(500MHz, CDCl3) δ 8.00 (m, 2H), 6.90 (m, 1H), 5.96 (ddd, J = 17.0, 10.8, 5.6 Hz, 1H), 
5.27-5.40 (m, 2H), 4.69 (m, 1H), 2.87 (m, 2H), 2.14 (m, 1H), 1.88 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 160.2, 141.1, 136.4, 125.8, 123.8, 122.4, 117.4, 117.2, 77.4, 26.7, 
24.0; IR (film, cm-1): 2939, 2906, 1614, 1583, 1504, 1481; HRMS (EI) m/z calc’d for 
C11H11O3N [M]+: 205.07390; found 205.07465. 
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 (±)-5-fluoro-2-vinylchroman: 1H NMR (500MHz, CDCl3) δ 7.06 (q, J = 7.7 Hz, 1H), 
6.68 (d, J = 8.0 Hz, 1H), 6.61 (t, J = 8.5 Hz, 1H), 6.00 (ddd, J = 17.0, 
10.5, 5.5 Hz, 1H), 5.40 (m, 1H), 5.27 (m, 1H), 4.56 (m, 1H), 2.84 (dt, 
J = 16.5, 5.0 Hz, 1H), 2.74 (ddd, J = 16.5, 10.8, 6.3 Hz, 1H), 2.11 (m, 
1H), 1.84 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 161.2 (d, J = 242.3 Hz), 155.9, 137.2, 
127.3 (d, J = 10.3), 116.7, 112.5 (d, J = 2.9 Hz), 110.3 (d, J = 21.8), 106.6 (d, J = 21.6), 
76.1, 26.5, 17.8 (d, J = 3.9 Hz); IR (film, cm-1): 2927, 2854, 1624, 1587, 1468; HRMS 
(EI) m/z calc’d for C11H11OF [M]+: 178.07940; found 178.07853. 
 
 (±)-5-methoxy-2-vinylchroman: Racemic (±)-3-methoxy-2-(pent-4-en-1-yl)phenol 
(38.4 mg, 0.20 mmol) was reacted according to the general 
procedure. Purification by flash column chromatography (7% 
EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 
(30.4 mg, 0.160 mmol, 80% yield); Run 2 (30.8 mg, .162 mmol, 81% yield). Average: 
81% Yield. 1H NMR (500MHz, CDCl3) δ 7.06 (t, J = 8.3 Hz, 1H), 6.53 (d, J = 8.5 Hz, 1H), 
6.42 (d, J = 8.5 Hz, 1H); 5.99 (ddd, J = 17.0, 10.5, 6.0 Hz, 1H), 5.38 (d, J = 17.5 Hz, 1H), 
5.23 (d, J = 11.0 Hz, 1H), 4.49 (m, 1H), 3.82 (s, 3H), 2.73-2.79 (m, 1H), 2.62 (ddd, J = 
17.0, 10.5, 6.6 Hz, 1H), 2.08 (m, 1H), 1.80 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 157.9, 
155.4, 137.7, 127.0, 116.4, 111.0, 109.8, 101.9, 75.9, 55.6, 27.1, 18.8; IR (film, cm-1): 
2937, 2850, 2838, 1591, 1470; HRMS (EI) m/z calc’d for C12H15O2 [M]+: 191.10721; 
found 191.10914. 
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 (±)-2-vinylspiro[chroman-4,2'-[1,3]dioxolane]: Racemic (±)-2-(2-(but-3-en-1-yl)-1,3-
dioxolan-2-yl)phenol (Run 1: 22.0 mg, 0.10 mmol; Run 2: 44.0 mg, 
0.20 mmol) was reacted according to the general procedure for 24 
hours. Purification by flash column chromatography (10% 
EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (15.5 mg, 0.071 mmol, 
71% yield); Run 2 (31.9 mg, .146 mmol, 73% yield). Average: 72% Yield.  1H NMR 
(500MHz, CDCl3) δ 7.41 (ap. d, J = 5.0 Hz, 1H), 7.23 (m, 1H), 6.94 (m, 1H), 6.87 (d, J = 
8.5 Hz, 1H), 6.03 (m, 1H), 5.46 (d, J = 17.0 Hz, 1H), 5.28 (d, J = 10.5 Hz, 1H), 4.79 (dd, 
J = 11.5, 6.0 Hz, 1H), 4.30 (m, 1H), 4.19 (m, 2H), 4.09 (m, 1H), 2.04-2.16 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 155.5, 136.9, 130.6, 126.4, 123.3, 120.8, 117.0, 117.0, 104.1, 
75.8, 66.3, 64.4, 38.8; IR (film, cm-1): 2964, 2885, 1612, 1585, 1483, 1458; HRMS (EI) 
m/z calc’d for C12H15O2 [M]+: 218.09430; found 218.09472. 
 
 (±)-2-vinyl-2,3-dihydrobenzo[b][1,4]dioxine: Racemic (±)-2-(but-3-en-1-yloxy)phenol 
(16.4, 0.10 mmol) was reacted according to the general procedure 
for 72 hours at 55°C. Purification by flash column chromatography 
(10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (8.6 mg, 0.053 
mmol, 53% yield, 23% Recovered Starting Material); Run 2 (8.6 mg, 0.053 mmol, 53% 
yield, 23% Recovered Starting Material). Average: 53% Yield.  1H NMR (500MHz, 
CDCl3) δ 6.84-6.93 (m, 4H), 5.91 (ddd, J = 16.5, 10.5, 5.8 Hz, 1H), 5.53 (d, J = 17.5 Hz, 
1H), 5.39 (d, J = 11.0 Hz, 1H), 4.64 (ap. t, J = 6.5 Hz, 1H), 4.26 (dd, J = 11.5, 2.0 Hz, 
1H), 3.92 (dd, J = 10.5, 7.8 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 143.3, 132.6, 121.8, 
165
121.6, 119.4, 117.5, 117.2, 73.8, 67.8; IR (film, cm-1): 2926, 2870, 1593, 1493, 1261; 
HRMS (EI) m/z calc’d for C10H10O2 [M]+: 162.06808; found 162.06764. 
 
Mechanistic Studies for Phenol Functionalization Reaction to Form 
Vinylchromans 
 
General Procedure for Phenol Functionalization Reaction to form vinylchromans for 
Initial Rate Analysis: To a ½ dram borosilicate vial containing a Teflon stir bar was 
added the corresponding phenol starting material (0.10 mmol, 1 equiv.), benzoquinone 
(0.20 mmol, 2.0 equiv.), Catalyst 62 (0.01 mmol, 0.10 equiv.) and Cr(III)(salen)Cl  (0.01 
mmol, 0.10 equiv.). 1,2-Dichloroethane-d4 (0.33M) and Nitrobenzene standard (0.004 
mmol, 0.04 equiv.) were then added to the ½ dram vial. The vial was then sealed and 
placed in an aluminum block to stir at 45 °C. 10 µL aliquots were taken at the 
corresponding times from the reaction flask, added directly to an NMR tube and diluted 
with CDCl3 for direct analysis. The yield was determined by integration of the olefinic 
product peaks relative to the nitrobenzene standard. Yields are reported as the average 
of three runs, with error bars representing standard deviation.  Initial rates were then 
determined and applied to the corresponding Hammett Plot. 
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Hammett Plot of Initial Rate Data for Pd-Catalyzed Chroman Formation 
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Reactivity of Internal Olefin Under Standard Pd(II) Conditions 
 
 (±)-(E)-2-(pent-3-en-1-yl)phenol: Product obtained as a clear oil (86:14, e:z).  1H NMR 
(500MHz, CDCl3) δ 7.05-7.15 (m, 2H), 6.87 (ap. t, J = 7.3 Hz, 1H), 
6.77 (d, J = 8.0 Hz, 1H), 5.51 (m, 1H), 4.66 (m, 1H), 2.66 (ap. t, J 
= 6.0 Hz, 2H), 2.30 (m, 2H), 1.66 (d, J = 3.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
153.6, 130.8, 130.4, 128.1, 127.3, 126.0, 120.9, 115.5, 32.9, 30.4, 18.1; IR (film, cm-1): 
3410 (br), 3014, 2920, 2856, 1591, 1456; HRMS (EI) m/z calc’d for C11H14O [M]+: 
162.10447; found 162.10551. 
 
 
 
 
 
To a ½ dram borosilicate vial containing a Teflon stir bar was added (±)-(E)-2-(pent-3-
en-1-yl)phenol (0.10 mmol, 1 equiv.), benzoquinone (0.20 mmol, 2.0 equiv.), Catalyst 62 
(0.01 mmol, 0.10 equiv.) and Cr(III)(salen)Cl  (0.01 mmol, 0.10 equiv.). 1,2-
Dichloroethane-d4 (0.33M) and Nitrobenzene standard (0.004 mmol, 0.04 equiv.) were 
then added to the ½ dram vial. The vial was then sealed and placed in an aluminum 
block to stir at 45 °C. 10 µL aliquots were taken at the corresponding times from the 
reaction flask, added directly to an NMR tube and diluted with CDCl3 for direct analysis. 
The yield was determined by integration of the olefinic product peaks relative to the 
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nitrobenzene standard. At 2h: 0% Yield, 0% Conversion of SM.  At 16h: 0% Yield, 
20% Conversion of SM to unidentifiable biproducts. 
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